Form 425 Zymergen Inc. Filed by: Zymergen Inc.

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):
July 24, 2022

Zymergen Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-40354	46-2942439
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

5980 Horton Street, Suite 105

Emeryville CA 94608

(Address of Principal Executive Offices) (Zip Code)

(415) 801-8073

(Registrant’s telephone number, including
area code)

(Former name or former address, if changed since
last report)

Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):

x	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)
of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.001 par value per share	ZY	Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨

Item 1.01

Entry into a Material Definitive Agreement.

Agreement and Plan of Merger

On July 24, 2022, Zymergen Inc., a Delaware public benefit corporation
(the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Ginkgo
Bioworks Holdings, Inc., a Delaware corporation (“Parent”), and Pepper Merger Subsidiary Inc., a Delaware corporation and
an indirect wholly owned subsidiary of Parent (“Merger Sub”), providing for the merger of Merger Sub with and into
the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Capitalized
terms used herein but not otherwise defined have the meaning set forth in the Merger Agreement.

Merger Consideration

At the effective time of the Merger (the “Effective Time”),
each share of common stock, par value $0.001 per share, of the Company (“Company Common Shares”) that is issued and
outstanding as of immediately prior to the Effective Time (other than certain excluded shares specified in the Merger Agreement) will
be automatically cancelled, extinguished and converted into the right to receive 0.9179 of a share of Class A Common Stock, par value
$0.0001 per share, of Parent (“Parent Class A Shares,” and such consideration, the “Merger Consideration”)
and cash in lieu of any fractional Parent Class A Shares, without interest.

Treatment of Equity Awards

At the Effective
Time, each option to purchase Company Common Shares (each, a “Company Option”) with an exercise price per share
less than the Merger Consideration Value that is outstanding immediately prior to the Effective Time, whether vested or unvested, will
be cancelled and converted into the right to receive a number of Parent Class A Shares equal to the Option Consideration Value with respect
such Company Option divided by the Parent Class A Share Price, and each Company Option with an exercise price per share that is
equal to or greater than the Merger Consideration Value will be cancelled for no consideration. “Option Consideration Value”
means an amount, without interest, equal to the product of (i) the excess of (A) the Merger Consideration Value over (B) the exercise
price per share of such Company Option, and (ii) the total number of Company Common Shares issuable upon exercise in full of such Company
Option. “Merger Consideration Value” means an amount (rounded down to the nearest whole cent) equal to the product
of (x) the Merger Consideration and (y) the Parent Class A Share Price. “Parent Class A Share Price” means the volume-weighted
average price of Parent Class A Shares on the New York Stock Exchange (“NYSE”) for the period of five consecutive trading
days ending on and including the second full trading day prior to the Effective Time.

At the Effective Time, each vested Company restricted stock unit
(each, a “Company RSU”) that is outstanding immediately prior to the Effective Time (including after giving
effect to any acceleration of vesting to which such Company RSU is entitled as of immediately prior to the Effective Time) will be
cancelled and converted into a right to receive the Merger Consideration. each unvested Company RSU that is outstanding immediately
prior to the Effective Time will be cancelled and converted into a Parent restricted stock unit award (“Parent
RSU”) with respect to the number of Parent Class A Shares that is equal to the product of (A) the number of Company Common
Shares subject to such unvested Company RSU as of immediately prior to the Effective Time and (B) the Merger Consideration, rounded
down to the nearest whole share, which such Parent RSU award will be subject to the same vesting terms and conditions applicable to
the Company RSU to which it relates as of immediately prior to the Effective Time, including any applicable vesting acceleration
provisions in connection with such holder’s termination of employment or service but otherwise will be subject to the terms
and conditions of Parent’s 2021 stock incentive award plan.

Conditions
to Closing

The parties’ obligation to consummate the Merger is subject to
the satisfaction or waiver of certain conditions set forth in the Merger Agreement, including, among others: (i) the adoption of the Merger
Agreement by the holders of a majority of the Company Common Shares outstanding, (ii) the expiration or termination of the waiting periods
applicable to the consummation of the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and, if a merger
control inquiry is initiated or commenced by a governmental authority outside of the United States, approval in that jurisdiction, (iii)
the absence of any law or order restraining, enjoining or otherwise prohibiting the Merger, (iv) Parent’s registration statement
on Form S-4 having been declared effective in accordance with the provisions of the Securities Act of 1933, as amended, (v) authorization
and approval of the shares of Parent Class A Common Stock for listing on NYSE (or any successor inter-dealer quotation system or stock
exchange thereto), (vi) no material adverse effect has occurred on the other party since the signing of the Merger Agreement that is continuing
and (vii) certain other customary conditions relating to the other party’s representations and warranties in the Merger Agreement
and the performance of its respective obligations.

Parent’s obligation to consummate the Merger is also subject
to the satisfaction or waiver of the condition that (i) the Company has not incurred or otherwise become liable for additional costs,
expenses or liabilities to the Company or its subsidiaries with respect to its leased real property not contemplated under a specified
schedule outlining its real estate plans and (ii) certain specified litigation matters are not reasonably expected to result in future
money damages payable by the Company or its subsidiaries (in excess of any applicable insurance deductible and coverage amounts), where,
the aggregate of clauses (i) and (ii), exceed $25,000,000.

Representations and Warranties; Covenants

The Company and Parent have made customary representations and
warranties in the Merger Agreement and have agreed to certain covenants regarding the operation of the business of the Company and
its subsidiaries and the business of Parent and its subsidiaries prior to the Effective Time. The Company will be also subject to
customary “no-shop” restrictions on its ability to solicit alternative acquisition proposals from third parties and to
provide information to, and participate in discussions and engage in negotiations with, third parties regarding any alternative
acquisition proposals, subject to a “fiduciary out” provision that allows the Company, under certain specified
circumstances, to provide information to, and participate in discussions and engage in negotiations with, third parties with respect
to an alternative acquisition proposal if the Company Board (or a committee thereof) has determined in good faith (after
consultation with its outside legal counsel and financial advisors) that (i) such alternative acquisition proposal either
constitutes a Superior Proposal or would reasonably be expected to lead to a Superior Proposal and (ii) the failure to take such
actions would be reasonably likely to be inconsistent with the directors’ fiduciary duties under applicable law. The parties
have also agreed to use their reasonable best efforts to consummate the Merger.

Termination

The Merger Agreement contains certain termination rights for each of
the Company and Parent. The Merger Agreement may be terminated at any time prior to the Effective Time by the mutual written consent of
the parties and in certain other circumstances, including among others, if (i) the Merger has not been consummated by January 24, 2023,
subject to two extension rights by the parties of three months each (for a total of twelve months from the signing of the Merger Agreement)
if all of the closing conditions other than certain conditions related to receipt of regulatory approvals are satisfied or waived (or
are capable of being satisfied at such time) and (ii) the other party has breached any of its representations and warranties or failed
to perform any of its covenants under the Merger Agreement such that a closing condition is not satisfied (subject to notice and cure
and other customary exceptions). Additionally, Parent may terminate the Merger Agreement in certain circumstances where there is a material
and adverse development in certain specified litigation matters.

Upon termination of the Merger Agreement in accordance with its terms,
under specified circumstances, either party may be required to pay a termination fee to the other party. If the Merger Agreement is validly
terminated in connection with certain specified circumstances, including due to the Company accepting a Superior Proposal, willful and
material breach of its no-shop obligations, or the Company Board’s withdrawal or change of its recommendation of the Merger to its
stockholders, then the Company will be required to pay a termination fee to Parent equal to $10,000,000. Additionally, the Company will
be required to pay this termination fee to Parent if the Merger Agreement is terminated in certain circumstances and the Company enters
into an agreement or completes an alternative proposal to acquire the Company within twelve months of such termination. Parent will be
required to pay a termination fee to the Company equal to $10,000,000 only if the Merger Agreement is validly terminated under specified
circumstances upon the failure to satisfy certain conditions related to receipt of regulatory approvals if all other conditions have been
satisfied or waived (or are capable of being satisfied at such time).

The above description of the Merger Agreement is only a summary, does
not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is
attached hereto as Exhibit 2.1 and is incorporated herein by reference. The Merger Agreement has been attached as an exhibit to provide
investors and stockholders of the Company with information regarding its terms. It is not intended to provide any other factual information
about the Company, Parent or Merger Sub. The representations, warranties and covenants contained in the Merger Agreement were made only
for the purposes of the Merger Agreement and as of specified dates, were solely for the benefit of the parties to the Merger Agreement
and may be subject to limitations agreed upon by the contracting parties. The representations and warranties may have been made for the
purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts and
may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors
and stockholders of the Company accordingly should not rely on the representations, warranties and covenants or any descriptions thereof
as characterizations of the actual state of facts or condition of the Company, Parent, Merger Sub or any of their respective subsidiaries
or affiliates. In addition, the assertions embodied in the representations and warranties contained in the Merger Agreement are qualified
by information in confidential disclosure schedules that the Company exchanged with Parent and Merger Sub and Parent and Merger Sub exchanged
with the Company in connection with the execution of the Merger Agreement. Moreover, information concerning the subject matter of the
representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully
reflected in the Company’s public disclosures. The Merger Agreement should not be read alone, but should instead be read in conjunction
with the other information regarding the parties to the Merger Agreement and the Merger that will be contained in, or incorporated by
reference into, the proxy statement/prospectus that the Company and Parent will be filing in connection with the Merger, as well as in
the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
other documents that the Company has filed or may file with the Securities and Exchange Commission (the “SEC”).

Voting
Agreements

In connection with the Merger Agreement, each of SVF Excalibur (Cayman)
Limited, Data Collective II, L.P. and certain of its affiliates, and True Ventures IV, L.P. and certain of its affiliates (collectively,
the “Signing Stockholders”) entered into a voting agreement with Parent with respect to the Company Common Shares beneficially
owned now or in the future by such Signing Stockholder (collectively, the “Voting Agreements”).

The Signing Stockholders beneficially own, in the aggregate, approximately
40% of the outstanding shares of Company Common Stock as of July 24, 2022, and have separately agreed, pursuant to their respective Voting
Agreements, among other things, to vote all Company Common Stock beneficially owned and entitled to vote in favor of approval of the Merger
Agreement and the Merger and the other transactions contemplated by the Merger Agreement. Each Voting Agreement will terminate upon the
earliest of (i) the Closing; (ii) the date on which the Merger Agreement is terminated in accordance with its terms; (iii) the
outside date under the Merger Agreement; (iv) the making of certain changes to the terms of the Merger without the prior written consent
of the applicable Signing Stockholder; and (v) with respect to any Signing Stockholder, the mutual written consent of Parent and such
Signing Stockholder.

The foregoing description of the Voting Agreements is only a summary,
does not purport to be complete and is qualified in its entirety by reference to the full text of the Voting Agreements, copies of which
are attached hereto as Exhibit 99.2 with respect to the Voting Agreement entered into by SVF Excalibur (Cayman) Limited, Exhibit 99.3
with respect to the Voting Agreement entered into by Data Collective II, L.P. and certain of its affiliates, and Exhibit 99.4 with respect
to the Voting Agreement entered into by True Ventures IV, L.P. and certain of its affiliates and are incorporated herein by reference.

Item 2.05

Costs Associated with Exit or Disposal Activities.

On July 25, 2022, the Company also announced a reduction in force
as part of its efforts to continue to execute on its previously announced strategic plan, including managing costs and conserving cash
resources. The initial phase of this reduction in force is expected to result in the termination of approximately 80 employees. The Company
currently estimates that it will incur severance costs of approximately $4.0 million related to the initial phase of this reduction in
force, as well as stock-based compensation and employee restructuring costs, the amount of which has not yet been estimated. The Company
also announced that, together with its partner Sumitomo Chemical Co. Ltd. (“Sumitomo”),
it has determined to pause work on its Z-1 program. The Company’s collaboration agreement with Sumitomo remains in effect and the
Company is exploring opportunities for the biomolecules created under the collaboration and other potential opportunities.

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 24, 2022, the Compensation Committee of the Company Board
approved the payment of annual bonuses to each Company employee who is eligible to participate in the Company’s annual bonus
program for the fiscal year ended December 31, 2022, including each executive officer other than the Company’s Acting Chief
Executive Officer, at target levels and otherwise in accordance with the Company’s standard practices after the fiscal year
end. In the event that the Effective Time occurs prior to the end of the Company’s current fiscal year, such bonuses will be
paid at target levels, pro-rated for the portion of the year elapsed prior to the Effective Time. The target bonus percentage for
each of the Company’s named executive officers (other than the Company’s Acting Chief Executive Officer) is 50% of such
officer’s base salary.

On July 25, 2022, the Company and Parent issued a joint press release
announcing the entry into the Merger Agreement. A copy of the joint press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.

Additional Information and Where to Find
It

In connection with the Merger, Parent intends
to file with the SEC a registration statement on Form S-4 that will include a proxy statement of the Company and that also constitutes
a prospectus of Parent. Each of the Company and Parent may also file other relevant documents with the SEC regarding the Merger.
This document is not a substitute for the proxy statement/prospectus or registration statement or any other document that the Company
or Parent may file with the SEC. The definitive proxy statement/prospectus (if and when available) will be mailed to stockholders of the
Company. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT
DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY
IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE MERGER. Investors and security
holders will be able to obtain free copies of the registration statement and proxy statement/prospectus (if and when available) and other
documents containing important information about the Company, Parent and the Merger, once such documents are filed with the SEC through
the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Company will be available
free of charge on the Company’s website at https://investors.zymergen.com or by contacting the Company’s Investor Relations
department by email at [email protected] Copies of the documents filed with the SEC by Parent will be available free of charge
on Parent’s website at https://investors.ginkgobioworks.com or by contacting Parent’s Investor Relations department by email
at [email protected]

Participants in the Solicitation

The Company, Parent, their respective directors
and certain of their executive officers and other employees may be deemed to be participants in the solicitation of proxies from the Company’s
stockholders in connection with the Merger. Information regarding the persons who may, under the rules of the SEC, be deemed participants
in the solicitation of the Company’s stockholders in connection with the Merger, including a description of their direct or indirect
interests, by security holdings or otherwise, will be set forth in the proxy statement/prospectus when it is filed with the SEC. Information
about the directors and executive officers of the Company, including a description of their direct or indirect interests, by security
holdings or otherwise, is set forth in the Company’s proxy statement for its 2022 annual meeting of shareholders, which was filed
with the SEC on April 20, 2022, and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which
was filed with the SEC on March 30, 2022. Information about the directors and executive officers of Parent, including a description
of their direct or indirect interests, by security holdings or otherwise, is set forth in Parent’s proxy statement for its 2022
annual meeting of shareholders, which was filed with the SEC on April 26, 2022, and Parent’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2021, which was filed with the SEC on March 29, 2022. Other information regarding the participants
in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained
in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Merger when such materials become
available. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or
investment decisions. You may obtain free copies of these documents from the Company or Parent using the sources indicated above.

No Offer or Solicitation

This communication is not intended to and
shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote
or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made,
except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Forward Looking Statements

This communication contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “explore,”
“evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,”
“project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon
or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties,
many of which are beyond the Company’s and Parent’s control. Statements in this communication regarding the Company,
Parent and the combined company that are forward-looking, including projections as to the anticipated benefits of the Merger, the impact
of the Merger on the Company’s and Parent’s businesses and future financial and operating results, the amount and timing of
synergies from the Merger, and the aggregate amount of indebtedness of the combined company following the closing of the Merger are based
on management’s estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of
which are beyond the Company’s and Parent’s control. These factors include, among other things, general economic and business
conditions; changes in global, political, economic, business, competitive, market and regulatory forces; judicial decisions; changes in
tax laws, regulations, rates and policies; future business acquisitions or disposals; litigation and the ability of the combined company
to protect its intellectual property rights; and the timing and occurrence (or non-occurrence) of other events or circumstances that may
be beyond the Company’s and Parent’s control. Additional information concerning these risks, uncertainties and assumptions
can be found in the Company’s and Parent’s respective filings with the SEC, including the risk factors discussed in the Company’s
most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q, in Parent’s most recent Annual Report
on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and in each company’s future filings with the SEC. Important
risk factors could cause actual future results and other future events to differ materially from those currently estimated by management,
including, but not limited to, the risks that: a condition to the closing the proposed acquisition may not be satisfied; a regulatory
approval that may be required for the proposed acquisition is delayed, is not obtained or is obtained subject to conditions that are not
anticipated; Parent is unable to achieve the synergies and value creation contemplated by the proposed acquisition; Parent is unable to
promptly and effectively integrate the Company’s businesses; management’s time and attention is diverted on transaction related
issues; disruption from the transaction makes it more difficult to maintain business, contractual and operational relationships; legal
proceedings are instituted against the Company, Parent or the combined company; the Company, Parent or the combined company is unable
to retain key personnel; and the announcement or the consummation of the proposed acquisition has a negative effect on the market price
of the capital stock of the Company or Parent or on the Company’s or Parent’s operating results. No assurances can be
given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do occur, what impact
they will have on the results of operations, financial condition or cash flows of the Company or Parent. Should any risks and uncertainties
develop into actual events, these developments could have a material adverse effect on the Merger and/or the Company or Parent, Parent’s
ability to successfully complete the Merger and/or realize the expected benefits from the Merger. You are cautioned not to rely
on the Company’s and Parent’s forward-looking statements. These forward-looking statements are and will be based upon
management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of
the dates of such statements. Neither the Company nor Parent assumes any duty to update or revise forward-looking statements, whether
as a result of new information, future events or otherwise, as of any future date.

Item 9.01.

Financial Statements and Exhibits.

Exhibit No.		Description

2.1		Agreement and Plan of Merger, dated as of July 24, 2022, by and among Ginkgo Bioworks Holdings, Inc., a Delaware corporation, Pepper Merger Subsidiary Inc., a Delaware corporation and indirect wholly owned subsidiary of Ginkgo Bioworks Holdings, Inc., and Zymergen Inc., a Delaware public benefit corporation.*

99.1		Joint Press Release, dated as of July 25, 2022.

99.2		Voting Agreement, dated as of July 24, 2022, entered into by SVF Excalibur (Cayman) Limited.

99.3		Voting Agreement, dated as of July 24, 2022, entered into by Data Collective II, L.P. and certain of its affiliates.

99.4		Voting Agreement, dated as of July 24, 2022, entered into by True Ventures IV, L.P. and certain of its affiliates.

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

*	Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted schedule upon request.

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Zymergen Inc.

Date: July 25, 2022	By:	/s/ Enakshi Singh
		Name: Enakshi Singh
		Title: Chief Financial Officer

Exhibit 2.1

Execution Version

July 24, 2022

GINKGO BIOWORKS HOLDINGS, INC.

PEPPER MERGER SUBSIDIARY INC.

ZYMERGEN INC.

AGREEMENT AND PLAN OF
MERGER

Contents

Article I DEFINITIONS &
INTERPRETATIONS

1.2

Index
of Defined Terms

1.3

Certain
Interpretations

2.4

Effect
of the Merger

2.5

Certificate
of Incorporation and Bylaws

2.6

Directors
and Officers

2.7

Effect
on Capital Stock

2.9

Exchange
Procedures

2.10

No
Further Ownership Rights in Company Common Stock

2.11

Lost,
Stolen or Destroyed Certificates

2.12

FIRPTA
Certificates

2.13

Required
Withholding

Article III REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

3.1

Organization;
Good Standing

3.2

Corporate
Power; Enforceability

3.3

Company
Board Approval; Opinion of Financial Advisor; Anti-Takeover Laws

3.5

Requisite
Stockholder Approval

3.7

Requisite
Governmental Approvals

3.8

Company
Capitalization

3.10

Company
SEC Reports

3.11

Company
Financial Statements; Internal Controls

3.12

No
Undisclosed Liabilities

3.13

Absence
of Certain Changes

3.14

Material
Contracts; Government Contracts

3.15

Customers
and Suppliers

3.17

Environmental
Matters

3.18

Intellectual
Property; Privacy Matters

3.22

Regulatory
Matters

3.23

Compliance
with Laws

3.24

Legal
Proceedings; Orders

3.26

Information
Supplied

3.27

Related
Person Transactions

3.28

No
Other Representations or Warranties

Article IV REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB

4.1

Organization;
Good Standing; Anti-Takeover Laws

4.2

Power;
Enforceability

4.5

Requisite
Governmental Approvals

4.6

Compliance
with Laws

4.7

Legal
Proceedings; Orders

4.8

Ownership
of Company Common Stock

4.10

Ownership
of Merger Sub

4.11

No
Parent Vote or Approval Required

4.12

Availability
of Funds

4.13

Stockholder
and Management Arrangements

4.14

No
Other Negotiations

4.15

Parent
Capitalization

4.16

Parent
SEC Reports

4.17

Parent
Financial Statements; Internal Controls

4.18

No
Undisclosed Liabilities

4.19

Absence
of Certain Changes

4.20

Information
Supplied

4.22

Exclusivity
of Representations and Warranties

Article V INTERIM
OPERATIONS

5.1

Company
Affirmative Obligations

5.2

Company
Forbearance Covenants

5.3

Parent
and Merger Sub Obligations

5.4

No
Solicitation; Company Board Recommendation Change

5.5

No
Control of the Other Party’s Business

Article VI ADDITIONAL
COVENANTS

6.1

Required
Action and Forbearance; Efforts

6.3

Registration
Statement; Proxy Statement/Prospectus and Other Required SEC Filings

6.4

Company
Stockholder Meeting

6.6

Access;
Integration Planning

6.7

Section 16(b) Exemption

6.8

Directors’
and Officers’ Exculpation, Indemnification and Insurance

6.10

Obligations
of Merger Sub

6.11

Public
Statements and Disclosure

6.12

Transaction
Litigation

6.13

Stock
Exchange Delisting; Deregistration

6.15

No
Employment Discussions

6.16

Specified
Legal Proceedings

6.17

Tax
Treatment of the Merger

6.19

Additional
Agreements

Article VII CONDITIONS
TO THE MERGER

7.1

Conditions
to Each Party’s Obligations to Effect the Merger

7.2

Conditions
to the Obligations of Parent and Merger Sub

7.3

Conditions
to the Company’s Obligations to Effect the Merger

Article VIII TERMINATION,
AMENDMENT AND WAIVER

8.2

Manner
and Notice of Termination; Effect of Termination

Article IX GENERAL
PROVISIONS

100

9.4

Confidentiality
Agreement

102

9.6

Third
Party Beneficiaries

102

9.10

Consent
to Jurisdiction

104

9.11

Waiver
of Jury Trial

105

9.13

Disclosure
Letter References

105

EXHIBITS

Exhibit A

Form of
Certificate of Incorporation of the Surviving Corporation

AGREEMENT
AND PLAN OF MERGER

THIS
AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 24, 2022, by and
among Ginkgo Bioworks Holdings, Inc., a Delaware corporation (“Parent”), Pepper Merger Subsidiary Inc., a Delaware
corporation and an indirect wholly-owned Subsidiary of Parent (“Merger Sub”), and Zymergen Inc., a Delaware public
benefit corporation (the “Company”). Each of Parent, Merger Sub and the Company are sometimes referred to as a “Party.”
All capitalized terms that are used in this Agreement have the respective meanings given to them in Article I or elsewhere
in this Agreement.

Recitals

WHEREAS, the Company Board
has (i) considered each of (A) the Company Stockholders’ pecuniary (financial) interests, (B) the best interests
of those materially affected by the Company’s conduct (including customers, employees, partners and the communities in which it
operates) and (C) the Company’s Public Benefit Purpose, engaged in the balancing required by the General Corporation Law of
the State of Delaware (the “DGCL”), and declared it advisable to enter into this Agreement providing for the merger
of Merger Sub with and into the Company (the “Merger”), with the Company being the surviving corporation in the Merger,
in accordance with the DGCL, upon the terms and subject to the conditions set forth herein; (ii) determined that the Merger is fair
and in the best interests of the Company, the Company Stockholders and those materially affected by the Company’s conduct, and
promotes the Public Benefit Purpose; (iii) approved the execution and delivery of this Agreement by the Company, the performance
by the Company of its covenants and other obligations hereunder, and the consummation of the Merger upon the terms and subject to the
conditions set forth herein; and (iv) resolved to recommend that the Company Stockholders adopt this Agreement in accordance with
the DGCL.

WHEREAS, each of the board
of directors of Parent and the board of directors of Merger Sub have (i) declared it advisable to enter into this Agreement; and
(ii) approved the execution and delivery of this Agreement, the performance of their respective covenants and other obligations
hereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth herein.

WHEREAS, Merger Sub is a
direct or indirect, wholly-owned Subsidiary of Ginkgo Bioworks, Inc., a Delaware corporation (“Midco”), and Midco
is a direct, wholly-owned Subsidiary of Parent, the Parties to this Agreement intend the Merger to be treated for United States federal
income tax purposes as a taxable purchase of the Company and not as a “reorganization” under Section 368(a) of
the Code and the Treasury Regulations promulgated thereunder.

WHEREAS, Parent, Merger Sub
and the Company desire to (i) make certain representations, warranties, covenants and agreements in connection with this Agreement
and the Merger; and (ii) prescribe certain conditions with respect to the consummation of the Merger.

WHEREAS, concurrently with
the execution and delivery of this Agreement, certain stockholders of the Company are each entering into a Voting Agreement, dated as
of the date hereof (each, a “Voting Agreement”), pursuant to which each such stockholder has agreed to take certain
actions to support the transactions contemplated by this Agreement, including the Merger.

NOW, THEREFORE, in consideration
of the foregoing premises and the representations, warranties, covenants and agreements set forth herein, as well as other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound hereby, Parent,
Merger Sub and the Company agree as follows:

Article I
DEFINITIONS & INTERPRETATIONS

1.1            Certain
Definitions. For all purposes of, and pursuant to, this Agreement, the following capitalized terms have the following respective
meanings:

(a)            “Acceptable
Confidentiality Agreement” means an agreement with the Company that contains provisions that require any counterparty thereto
(and any of its Affiliates and Representatives named therein) that receive non-public information of, or with respect to, the Company
to keep such information confidential; provided, however, that the confidentiality and use provisions contained therein
are no less restrictive in any material respect to such counterparty (and any of its Affiliates and Representatives as provided therein)
than the terms of the Confidentiality Agreement (it being understood that such agreement need not contain any “standstill”
or similar provisions or otherwise prohibit the making of any Acquisition Proposal) and such agreement expressly permits the Company
to comply with its obligations under this Agreement.

(b)            “Acquisition
Proposal” means any offer or proposal (other than an offer or proposal by Parent, Merger Sub or any of their respective Subsidiaries)
to engage in an Acquisition Transaction.

(c)            “Acquisition
Transaction” means any transaction or series of related transactions (other than the Merger) involving:

(i)            any
direct or indirect purchase or other acquisition by any Person or Group, whether from the Company or any other Person(s), of shares of
Company Common Stock representing more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such
purchase or other acquisition, including pursuant to a tender offer or exchange offer by any Person or Group that, if consummated in
accordance with its terms, would result in such Person or Group beneficially owning more than 20% of the Company Common Stock outstanding
after giving effect to the consummation of such tender or exchange offer;

(ii)           any
direct or indirect purchase or other acquisition by any Person or Group, or equityholders of any such Person or Group, of more than 20%
of the consolidated assets of the Company and its Subsidiaries taken as a whole (measured by the fair market value thereof as of the
date of such purchase or acquisition), including by means of purchase of equity securities in any Subsidiary of the Company;

(iii)          any
merger, consolidation, business combination, recapitalization, reorganization, liquidation, dissolution or other transaction involving
the Company or any of its Subsidiaries pursuant to which any Person or Group, or equityholders of any such Person or Group, would hold
shares of Company Common Stock representing more than 20% of the Company Common Stock outstanding after giving effect to the consummation
of such transaction, in each case other than the Merger; or

(iv)          any
transaction having a similar effect to those described in the foregoing clauses (i) through (iii).

(d)            “Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control
with such Person. For purposes of this definition, the term “control” (including, with correlative meanings, the terms “controlling,”
“controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly
or indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the ownership
of voting securities or partnership or other ownership interests, by Contract or otherwise.

(e)            “Anti-Bribery
Laws” means the anti-bribery provisions of the Foreign Corrupt Practices Act of 1977 and all other applicable anti-corruption
and bribery Laws (including the U.K. Bribery Act 2010, and any rules or regulations promulgated thereunder or other Laws of other
countries implementing the OECD Convention on Combating Bribery of Foreign Officials).

(f)             “Anti-Money
Laundering Laws” means all applicable Laws related to the prevention of money laundering, including the U.S. Money Laundering
Control Act of 1986, the U.S. Currency and Foreign Transactions Reporting Act of 1970 (commonly referred to as the “U.S. Bank Secrecy
Act”) and similar Laws in other applicable jurisdictions.

(g)            “Antitrust
Law” means the Sherman Antitrust Act, the Clayton Antitrust Act, the HSR Act, the Federal Trade Commission Act and all other
Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint
of trade or significant impediments or lessening of competition or the creation or strengthening of a dominant position through merger
or acquisition, in any case that are applicable to the Merger.

(h)            “Audited
Company Balance Sheet” means the consolidated balance sheet (and the notes thereto) of the Company and its consolidated Subsidiaries
as of December 31, 2021 set forth in the Company’s Annual Report on Form 10-K filed by the Company with the SEC for the
fiscal year ended December 31, 2021.

(i)             “Audited
Parent Balance Sheet” means the consolidated balance sheet (and the notes thereto) of Parent and its consolidated Subsidiaries
as of December 31, 2021 set forth in Parent’s Annual Report on Form 10-K filed by Parent with the SEC for the fiscal
year ended December 31, 2021.

(j)             “Blue
Sky Laws” means any state securities or “blue sky” law.

(k)            “Business
Day” means any day other than Saturday or Sunday or a day on which commercial banks are authorized or required by Law to be
closed in New York, New York, or Boston, Massachusetts.

(l)             “Code”
means the Internal Revenue Code of 1986.

(m)           “Company
Board” means the Board of Directors of the Company.

(n)            “Company
Common Stock” means the common stock, par value $0.001 per share, of the Company.

(o)            “Company
Equity Awards” means Company Options and Company RSUs.

(p)            “Company
ESPP” means the Company’s 2021 Employee Stock Purchase Plan.

(q)            “Company
Material Adverse Effect” means any change, event, effect, development, occurrence or circumstance (each, an “Effect”)
that, individually or in the aggregate, (x) has had or would reasonably be expected to have a material adverse effect on the business,
assets, liabilities, condition (financial or otherwise) or results of operations of the Company and its Subsidiaries, taken as a whole,
or (y) prevents or materially impairs or delays, or would reasonably be expected to prevent or materially impair or delay, the ability
of the Company to consummate the Merger; provided, however, that, solely with respect to clause (x), none of the following,
and no Effects to the extent arising out of or resulting from the following (in each case, by itself or when aggregated) will be deemed
to be or constitute a Company Material Adverse Effect or will be taken into account when determining whether a Company Material Adverse
Effect has occurred or may, would or could occur (subject to the limitations set forth below):

(i)            changes
in general economic conditions, or changes or prospective changes in conditions in the global, international or regional economy generally;

(ii)           any
sequester, stoppage, shutdown, default or similar event or occurrence by or involving any governmental entity affecting a national or
federal government as a whole;

(iii)          any
break-up of any existing political or economic union of or within any country or countries or any actual or potential exit by any country
or countries from, or suspension or termination of its or their membership in, any such political or economic union;

(iv)          changes
in conditions in the financial markets, credit markets or capital markets, including (1) changes in interest rates or credit ratings
generally; (2) changes in exchange rates for the currencies of any country; or (3) any suspension of trading in securities
(whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market;

(v)           changes
in conditions in the industries in which the Company and its Subsidiaries conduct material business or in labor markets for employees
in such industries;

(vi)          changes
in regulatory, legislative or political conditions, including any trade wars or tariffs and any change in applicable Law, in each case
after the date hereof;

(vii)         any
actual or threatened geopolitical conditions, outbreak of hostilities, acts of war, sabotage, cyberterrorism (including by means of cyber-attack
by or sponsored by a Governmental Authority), terrorism or military actions (including any escalation or general worsening of any such
hostilities, acts of war, sabotage, cyberterrorism, terrorism or military actions);

(viii)        earthquakes,
volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wildfires or other natural disasters, weather conditions, pandemics,
epidemics, or other health crises (including COVID-19 and any COVID-19 Measures), or other national or international emergency in the
United States or any other country or region of the world;

(ix)          any
Effect resulting from the negotiation, execution, delivery or performance of this Agreement or the announcement of this Agreement or
the pendency of the Merger, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries
with employees, suppliers, lessors, customers, partners, vendors, regulators, Governmental Authorities, or any other third Person (it
being understood and agreed that this clause (ix) will not apply with respect to any representation or warranty the purpose of which
is to address the consequences of the execution and delivery of this Agreement, the consummation of the transactions contemplated hereby
or the performance of obligations of the Company hereunder);

(x)           the
compliance by any Party with the express terms of this Agreement, including any action taken or refrained from being taken as required
by, pursuant to or in accordance with the express terms of this Agreement;

(xi)          any
action taken or refrained from being taken, in each case at the written request of Parent or to which Parent has expressly approved or
consented to following the date of this Agreement;

(xii)         any
change in, or any action taken for the purpose of complying with any change in, GAAP (or authoritative interpretations of GAAP) after
the date hereof;

(xiii)         changes
in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the facts or causes underlying
or contributing to any such change may be considered in determining whether a Company Material Adverse Effect has occurred so long as
they are not otherwise excluded by this definition);

(xiv)        any
failure, in and of itself, by the Company and its Subsidiaries to meet (A) any public estimates or expectations of the Company’s
revenue, earnings or other financial performance or results of operations for any period; or (B) any internal budgets, plans, projections
or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that the facts or
causes underlying or contributing to any such failure may be considered in determining whether a Company Material Adverse Effect has
occurred so long as they are not otherwise excluded by this definition);

(xv)         any
Transaction Litigation;

(xvi)        the
identity of Parent or Merger Sub, or any public announcement or public disclosure of any plan or intentions of Parent or Merger Sub with
respect to the Company, its Subsidiaries or their respective businesses; or

(xvii)       any
breach by Parent or Merger Sub of this Agreement;

except, in each case of clauses (i),
(ii), (iii), (iv), (v), (vi), (vii), (viii) and (xii), to the extent that such Effect has had a materially disproportionate adverse
effect on the Company relative to other companies operating in the industries in which the Company and its Subsidiaries conduct business,
in which case only the incremental disproportionate adverse impact may be taken into account in determining whether a Company Material
Adverse Effect has occurred.

(r)             “Company
Options” means any options to purchase shares of Company Common Stock granted pursuant to the Company Stock Plans.

(s)            “Company
Owned Intellectual Property” means all Intellectual Property owned, or purported to be owned, solely or jointly by the Company
or any of its Subsidiaries.

(t)            “Company
Preferred Stock” means the preferred stock, par value $0.001 per share, of the Company.

(u)            “Company
Product” means all products, product candidates, Software or, to the extent commercialized or developed to be commercialized,
other technology of the Company or any of its Subsidiaries, including those set forth on Section 1.1(u) of the Company
Disclosure Letter.

(v)            “Company
RSUs” means all Company restricted stock units granted pursuant to the Company Stock Plans.

(w)            “Company
Software” means all Software owned by the Company or any of its Subsidiaries.

(x)            “Company
Stock Plans” means the Company’s 2014 Stock Plan, 2021 Incentive Award Plan and each other Employee Plan that provides
for the award of rights of any kind to receive shares of Company Common Stock or benefits measured in whole or in part by reference to
shares of Company Common Stock.

(y)            “Company
Stockholders” means the holders of shares of Company Common Stock.

(z)            “Company
Termination Fee” means a fee equal to $10,000,000.

(aa)          “Contaminants”
means defects, bugs, errors in accordance with generally accepted industry standards, Trojan horses, worms, viruses, back doors, disabling
codes or instructions, spyware, malicious code, or other self-help mechanisms or programming routines designed or intended to interfere,
damage, corrupt, surreptitiously intercept, or expropriate any system, data, or Personal Information, or cause unauthorized access to,
or disruption, impairment, disablement, or destruction of, software, data, Personal Information, or other materials.

(bb)         “Continuing
Employees” means each individual who is an employee of the Company or any of its Subsidiaries immediately prior to the Effective
Time and continues to be an employee of Parent or one of its Subsidiaries (including the Surviving Corporation) immediately following
the Effective Time.

(cc)          “Contract”
means any contract, subcontract, note, bond, mortgage, indenture, lease, license, sublicense or other agreement (whether written or oral)
that is legally binding.

(dd)         “COVID-19”
means SARS-CoV-2 or COVID-19, and any evolutions, variations or mutations thereof or related or associated epidemics, pandemic or disease
outbreaks.

(ee)          “COVID-19
Measures” means any quarantine, “shelter in place,” “stay at home,” workforce reduction, social distancing,
shut down, closure, sequester, safety or other Law, directive, guidelines or recommendations promulgated by any Governmental Authority,
including the Centers for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response
to COVID-19, including the CARES Act, the Families First Act, the Payroll Tax Executive Order and IRS Notices 2020-22, 2020-65 and 2021-11.

(ff)           “DOJ”
means the United States Department of Justice or any successor thereto.

(gg)         “Environmental
Law” means any Law relating to pollution or protection of the environment (including ambient air, surface water, groundwater
or land) or human health (as it relates to exposure to Hazardous Substances), including all those relating to the generation, storage,
treatment, transportation, recycling, disposal, discharge, release, handling, control or cleanup of any Hazardous Substances, as such
of the foregoing are promulgated and in effect on or prior to the Closing Date.

(hh)         “ERISA”
means the Employee Retirement Income Security Act of 1974.

(ii)            “Exchange
Act” means the Securities Exchange Act of 1934.

(jj)            “FTC”
means the United States Federal Trade Commission or any successor thereto.

(kk)          “GAAP”
means generally accepted accounting principles, consistently applied, in the United States.

(ll)            “Government
Contract” means any Contract for the sale of supplies or services that are actively provided under the relevant statement of
works or subcontract agreements as of the date hereof that is between the Company or any of its Subsidiaries on one hand and a Governmental
Authority on the other or has been entered into by the Company or any of its Subsidiaries as a subcontractor at any tier in connection
with a Contract between another Person and a Governmental Authority.

(mm)        “Government
Proposal” means any proposal or offer, solicited or unsolicited made by the Company or any of its Subsidiaries which, if accepted,
would result in a Government Contract. A Government Proposal: (i) includes any proposal or offer made by the Company or any of its
Subsidiaries that has been accepted by the Company but has not resulted in a Government Contract; and (ii) does not include any
proposal or offer made by the Company or any of its Subsidiaries that has been accepted and has resulted in a Government Contract.

(nn)         “Governmental
Authority” means any government, governmental, administrative, self-regulatory or regulatory entity or body, department, commission,
board, agency or instrumentality, or other legislative, executive or judicial governmental entity, and any court, tribunal or judicial
body, in each case whether federal, state, county, local or provincial, and whether domestic or foreign.

(oo)         “Governmental
Authorization” means any authorizations, approvals, licenses, franchises, clearances, permits, certificates, waivers, consents,
exemptions, variances, expirations and terminations of any waiting period requirements (including, pursuant to Antitrust Laws) issued
by or obtained from, and notices, filings, registrations, qualifications, declarations and designations with, a Governmental Authority.

(pp)         “Group”
has the meaning as used in Section 13 of the Exchange Act.

(qq)         “Hazardous
Substance” means any substance, material or waste that is defined, listed or regulated as contaminant, pollutant, toxic, hazardous,
or words of similar meaning under any Environmental Laws, including, pesticides, petroleum or petroleum products, polychlorinated biphenyls,
friable asbestos, and per- and polyfluoroalkyl substances.

(rr)           “HSR
Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

(ss)          “Indebtedness”
means any of the following obligations: (i) indebtedness for borrowed money (including any principal, premium, accrued and unpaid
interest, related expenses, prepayment premiums or penalties and commitment and other fees); (ii) obligations evidenced by bonds,
debentures, notes or other similar instruments or debt securities; (iii) obligations pursuant to or in connection with letters of
credit, surety bonds, performance bonds or banker’s acceptances (in each case whether or not drawn, contingent or otherwise); (iv) obligations
pursuant to capitalized leases (other than Leases); (v) obligations arising out of interest rate and currency swap arrangements
and any other arrangements designed to provide protection against fluctuations in interest or currency rates; (vi) any obligation
to pay the deferred purchase price of property or services (other than accrued expenses in the ordinary course of business); and (vii) indebtedness
of others of the kind described in clauses (i) through (vi) guaranteed by the Company or any of its Subsidiaries or secured
by any Lien on the assets of the Company or any of its Subsidiaries.

(tt)           “Intellectual
Property” means all rights, title and interests in and to all intellectual property rights throughout the world, including
all: (i) patents, patent applications and inventions, designs and improvements described and claimed therein, patentable inventions,
utility models, registered mask works and applications to register mask works, and other patent rights anywhere in the world (including
all provisional applications, international applications, divisions, substitutions, renewals, continuations, continuations-in-part, reissues,
reexaminations, interferences, and extensions thereof) (“Patents”); (ii) all copyrights, copyrightable works,
copyright registrations and applications therefor, whether or not registered or published, and all other rights corresponding thereto
throughout the world (“Copyrights”) and works of authorship; (iii) trademarks, service marks, logos, designs,
trade names, service names, brand names, and trade dress and other source or business identifiers, including trademarks used in corporate
names, whether registered or unregistered, and registrations, applications for registrations, renewals and extensions of any of the foregoing,
and all rights and goodwill associated therewith (“Marks”); (iv) domain names and social media accounts and handles;
(v) Software; (vi) proprietary information, know-how, trade secrets and other confidential information (“Trade Secrets”);
(vii) rights in data and databases; and (viii) any similar, corresponding or equivalent rights to any of the foregoing anywhere
in the world.

(uu)         “International
Trade Laws” means all applicable Laws relating to the import, export, re-export, deemed export, deemed re-export, or transfer
of information, data, goods, and technology, including the Export Administration Regulations administered by the U.S. Department of Commerce,
the International Traffic in Arms Regulations administered by the U.S. Department of State, customs and import Laws administered by U.S.
Customs and Border Protection, any other export or import controls administered by an agency of the U.S. government, the anti-boycott
regulations administered by the U.S. Department of Commerce and the U.S. Department of the Treasury, and other applicable Laws adopted
by Governmental Authorities of other countries relating to the same subject matter as the U.S. Laws described above.

(vv)         “Intervening
Event” means an Effect that first occurs after the date of this Agreement that has materially affected or materially affects,
or would be reasonably likely to materially affect, (A) the business, financial condition or results of operations of the Company
and its Subsidiaries, taken as a whole, and (B) to the extent required by Delaware law as applicable to the Company as a public
benefit corporation or the Company Board in the context of a sale of control of the Company, the outcome of the Company Board’s
balancing of (1) pecuniary interests of the Company Stockholders, (2) best interests of those materially affected by the Company’s
conduct and (3) Company’s Public Benefit Purpose, for purposes of making the Company Board Recommendation, in each case, that
(i) is not known by the Company Board as of the date of this Agreement or that was not reasonably foreseeable to the Company Board
as of the date of this Agreement and (ii) does not relate to any Acquisition Proposal; provided, that in no event shall the
following constitute, or be taken into account in determining the existence of an Intervening Event: (Y) the fact alone that the
Company or Parent meets, fails to meet or exceeds any internal or published forecasts or projections for any period (however, the underlying
reasons for such events may constitute an Intervening Event), or (Z) changes in the market price or trading volume of Company Common
Stock or Parent Class A Common Stock, in and of itself, after the date hereof (however, the underlying reasons for such events may
constitute an Intervening Event).

(ww)        “IRS”
means the United States Internal Revenue Service or any successor thereto.

(xx)           “Knowledge”
of the Company, with respect to any matter in question, means the actual knowledge of the individuals listed in Section 1.1(xx) of
the Company Disclosure Letter, after reasonable inquiry of such individual’s direct reports. “Knowledge” of
Parent and Merger Sub, with respect to any matter in question, means the actual knowledge, after reasonable inquiry, of the individuals
listed in Section 1.1(xx) of the Parent Disclosure Letter, after reasonable inquiry of such individual’s direct
reports.

(yy)         “Law”
means any federal, national, state, county, municipal, provincial, local, foreign or multinational, statute, constitution, common law,
ordinance, code, decree, order, judgment, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented
or otherwise put into effect by or under the authority of any Governmental Authority or any self-regulatory organization and any award,
order or decision of an arbitrator or arbitration panel with jurisdiction over the parties and subject matter of the dispute.

(zz)           “Legal
Proceeding” means any claim, action, charge, cause of action, proceeding, lawsuit, litigation, audit, investigation, arbitration,
mediation or other similarly formal legal proceeding brought by or pending before any Governmental Authority, arbitrator, mediator or
other tribunal.

(aaa)        “Legal
Proceedings Development” means, with respect to the Specified Legal Proceedings (and any Legal Proceedings relating to or arising
out of the facts and circumstances of such Specified Legal Proceedings that may be initiated by the SEC or other Governmental Authority,
including any U.S. Attorney’s Office or the U.S. Department of Justice (a “Governmental Proceeding”)), a material
and adverse development in such Legal Proceeding that was not disclosed or made available to Parent prior to the date hereof (where “material”
in this definition will be determined in reference to the impact of the expected outcome of such Legal Proceeding on the Company), including
the filing of a criminal charging document against the Company or the individuals set forth in Section 1.1(aaa)(i) of
the Company Disclosure Letter, the filing of a complaint alleging securities fraud by the SEC against the Company or the individuals
set forth in Section 1.1(aaa)(i) of the Company Disclosure Letter, or the discovery of credible evidence of knowing
or intentional misconduct or securities fraud on the part of the Company or the individuals set forth in Section 1.1(aaa)(i) of
the Company Disclosure Letter; provided, however, that any development described on Section 1.1(aaa)(ii) of
the Company Disclosure Letter will not be a Legal Proceedings Development.

(bbb)       “Lien”
means with respect to any property or asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind.

(ccc)        “Material
Contract” means any of the following Contracts (excluding purchase orders, statements of work and similar commercial documents
issued in the ordinary course under the applicable Contract) to which either the Company or any of its Subsidiaries is a party or bound
other than each Contract solely among the Company and its wholly owned Subsidiaries:

(i)            any
“material contract” (as defined in Item 601(b)(10) of Regulation S-K promulgated by the SEC);

(ii)           (A) any
Contract entered into with a Material Customer or (B) any Contract entered into with any customer that cannot be terminated by the
Company upon thirty (30) days’ notice or less without incurring any material liability;

(iii)          any
Contract entered into with a Material Supplier;

(iv)          any
Contract containing any covenant (A) prohibiting, limiting, curtailing or restricting, or purporting to prohibit, limit, curtail
or restrict, the Company or any of its Affiliates from engaging in any material line of business or levying a fine, charge or other payment
for doing so, competing with any Person in any material line of business or from purchasing, selling, supplying or distributing any material
product, asset or service, in each case, in any geographic area, (B) materially limiting the right of the Company or any of its
Subsidiaries pursuant to any “most favored nation” or “exclusivity” provisions or (C) granting any rights
of first refusal to any Person, rights of first offer to any Person, rights of first notice in connection with a sale to any Person,
or any puts, calls or similar rights, with respect to any assets material to the Company and its Subsidiaries, taken as a whole, or equity
interests of any of the Company or any of its Subsidiaries, in each case of this clause (iv) other than any such Contracts that
may be cancelled without material liability to the Company or its Subsidiaries upon notice of 60 days or less;

(v)           any
Contract (A) entered into within the two (2) year period prior to the date hereof relating to the disposition or acquisition
of tangible assets by the Company or any of its Subsidiaries with a value greater than $10,000,000 after the date of this Agreement other
than in the ordinary course of business, (B) entered into within the two (2) year period prior to the date hereof pursuant
to which the Company or any of its Subsidiaries acquired any material ownership interest in any other Person or other business enterprise
other than any Subsidiary of the Company with a value greater than $5,000,000 or (C) relating to the acquisition or disposition
of any tangible assets, any other Person or other business enterprise that contains material indemnities, “earn-out” or other
contingent payment obligations by the Company or any of its Subsidiaries in favor of a third party that remain outstanding;

(vi)          any
mortgages, indentures, guarantees, loans or credit agreements, security agreements or other Contracts relating to the borrowing of money
or extension of credit, in each case in excess of $1,000,000 other than (A) accounts receivables and payables in the ordinary course
of business and (B) loans to Subsidiaries of the Company in the ordinary course of business;

(vii)         any
Lease or Sublease required to be set forth on Section 3.16(b) of the Company Disclosure Letter;

(viii)        any
Contract with any Governmental Authority in each case under which the Company or any of its Subsidiaries has any material outstanding
rights or obligations;

(ix)          any
Contract providing for severance, retention or other payment, increase or vesting of any benefits or compensation that would become payable
by reason of the Merger (other than Contracts evidencing Company Equity Awards);

(x)           any
Contract providing for the employment or engagement of any Person on a full-time, part-time, independent contractor, temporary or other
basis or otherwise providing compensation or other benefits to any officer, director, employee or independent contractor, other than
Contracts terminable by the Company for any reason upon thirty (30) days’ notice or less without incurring any liability;

(xi)          any
Collective Bargaining Agreement;

(xii)          each
material Contract to which the Company or any of its Subsidiaries is a party entered into in connection with the settlement or other
resolution of any actual or threatened Legal Proceeding, in each case under which the Company or any of its Subsidiaries has any material
outstanding rights or obligations;

(xiii)        any
Contract that provides for indemnification by the Company or any of its Subsidiaries of any officer, director or employee of the Company
or any of its Subsidiaries;

(xiv)        any
Contract between the Company or any of its Subsidiaries, on the one hand, and any Affiliate of the Company, any director or officer of
the Company or any of its Subsidiaries or any Person beneficially owning 5% or more of the outstanding shares of Company Common Stock,
on the other hand, in each case except (A) as contemplated by this Agreement, and (B) any Contracts relating to awards granted
pursuant to the Company Stock Plans;

(xv)         limits
or restricts the ability of the Company or any of its Subsidiaries to declare or pay dividends or make distributions in respect of their
capital stock, partner interests, membership interests or other equity interests;

(xvi)        (i) each
Contract under which the Company or any of its Subsidiaries (A) grants to any third party any license under any Company Owned Intellectual
Property or Intellectual Property used or held for use by the Company or its Subsidiaries that, in each case, is material to the business
of the Company and its Subsidiaries, taken as a whole, or (B) receives a license under any third party’s Intellectual Property
that is material to the business of the Company and its Subsidiaries, taken as a whole, and (ii) each Contract (including settlement
agreements, coexistence agreements and consent agreements) pursuant to which the Company is restricted from using, registering, or enforcing
Company Owned Intellectual Property or Intellectual Property used or held for use by the Company or its Subsidiaries that, in each case,
is material to the business of the Company and its Subsidiaries, taken as a whole, in each case, other than (x) non-exclusive commercially
available off-the-shelf-software and software-based technology with a total annual license, maintenance, support and other fees not in
excess of $500,000 in the aggregate per vendor and Public Software, (y) non-disclosure agreements, and (z) materials transfer
agreements, evaluation agreements, and licenses granted to or by customers or vendors, in each case, that permits the intended consumption
of the specific goods or services sold with no additional rights granted (e.g., no research, development, manufacturing or commercialization
rights); or

(xvii)        any
material Contract that involves a joint venture, collaboration, partnership, development, co-development or similar profit-sharing Contract.

(ddd)       “Merger
Consideration Value” means an amount (rounded down to the nearest whole cent) equal to the product of (x) Merger Consideration
and (y) the Parent Class A Common Stock Price.

(eee)        “Nasdaq”
means The Nasdaq Global Select Market and any successor stock exchange or inter-dealer quotation system operated by The Nasdaq Stock
Market, LLC or any successor thereto.

(fff)          “NYSE”
means The New York Stock Exchange and any successor stock exchange or inter-dealer quotation system operated by New York Stock Exchange
LLC or any successor thereto.

(ggg)       “Organizational
Documents” means the articles of incorporation, certificate of incorporation, memorandum of association, charter, bylaws, articles
of formation, certificate of formation, operating agreement, certificate of limited partnership, partnership agreement, limited liability
company agreement and all other similar documents, instruments or certificates executed, adopted or filed in connection with the creation,
formation or organization of a Person, including any amendments thereto.

(hhh)       “Parent
Class A Common Stock” means the Class A common stock, par value $0.0001 per share, of Parent.

(iii)           “Parent
Class A Common Stock Price” means the volume weighted average of the trading prices, rounded to four decimal points, of
Parent Class A Common Stock on the NYSE during normal trading hours (as reported on Bloomberg L.P. under the function “VWAP”)
for the five (5) consecutive trading days ended on (and including) the trading day that is two (2) full trading days prior
to the Closing Date.

(jjj)           “Parent
Class B Common Stock” means the Class B common stock, par value $0.0001 per share, of Parent.

(kkk)        “Parent
Class C Common Stock” means the Class C common stock, par value $0.0001 per share, of Parent.

(lll)           “Parent
Common Stock” means Parent Class A Common Stock, Parent Class B Common Stock and Parent Class C Common Stock,
as applicable.

(mmm)     “Parent
Material Adverse Effect” means any Effect that, individually or in the aggregate, (x) has had or would reasonably be expected
to have a material adverse effect on the business, assets, liabilities, condition (financial or otherwise) or results of operations of
Parent and its Subsidiaries, taken as a whole, or (y) prevents or materially impairs or delays, or would reasonably be expected
to prevent or materially impair or delay, the ability of Parent or Merger Sub to consummate the Merger; provided, however,
that, solely with respect to clause (x), none of the following, and no Effects to the extent arising out of or resulting from the following
(in each case, by itself or when aggregated) will be deemed to be or constitute a Parent Material Adverse Effect or will be taken into
account when determining whether a Parent Material Adverse Effect has occurred or may, would or could occur (subject to the limitations
set forth below):

(i)            changes
in general economic conditions, or changes or prospective changes in conditions in the global, international or regional economy generally;

(v)           changes
in conditions in the industries in which Parent and its Subsidiaries conduct material business or in labor markets for employees in such
industries;

(vi)          changes
in regulatory, legislative or political conditions, including any trade wars or tariffs and any change in applicable Law, in each case
after the date hereof;

(vii)          any
actual or threatened geopolitical conditions, outbreak of hostilities, acts of war, sabotage, cyberterrorism (including by means of cyber-attack
by or sponsored by a Governmental Authority), terrorism or military actions (including any escalation or general worsening of any such
hostilities, acts of war, sabotage, cyberterrorism, terrorism or military actions);

(ix)          any
Effect resulting from the negotiation, execution, delivery or performance of this Agreement or the announcement of this Agreement or
the pendency of the Merger, including the impact thereof on the relationships, contractual or otherwise, of Parent and its Subsidiaries
with employees, suppliers, lessors, customers, partners, vendors, regulators, Governmental Authorities, or any other third Person (it
being understood and agreed that this clause (ix) will not apply with respect to any representation or warranty the purpose of which
is to address the consequences of the execution and delivery of this Agreement, the consummation of the transactions contemplated hereby
or the performance of obligations of Parent hereunder);

(xi)          any
action taken or refrained from being taken, in each case at the written request of the Company or to which the Company has expressly
approved or consented to following the date of this Agreement;

(xii)         any
change in, or any action taken for the purpose of complying with any change in, GAAP (or authoritative interpretations of GAAP) after
the date hereof;

(xiii)         changes
in the price or trading volume of the Parent Class A Common Stock, in and of itself (it being understood that the facts or causes
underlying or contributing to any such change may be considered in determining whether a Parent Material Adverse Effect has occurred
so long as they are not otherwise excluded by this definition);

(xiv)        any
failure, in and of itself, by Parent and its Subsidiaries to meet (A) any public estimates or expectations of Parent’s revenue,
earnings or other financial performance or results of operations for any period; or (B) any internal budgets, plans, projections
or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that the facts or
causes underlying or contributing to any such failure may be considered in determining whether a Parent Material Adverse Effect has occurred
so long as they are not otherwise excluded by this definition);

(xv)         any
Transaction Litigation; or

(xvi)        any
breach by the Company of this Agreement;

except, in each case of clauses (i),
(ii), (iii), (iv), (v), (vi), (vii), (viii) and (xii), to the extent that such Effect has had a materially disproportionate adverse
effect on Parent relative to other companies operating in the industries in which Parent and its Subsidiaries conduct business, in which
case only the incremental disproportionate adverse impact may be taken into account in determining whether a Parent Material Adverse
Effect has occurred.

(nnn)       “Parent
Options” means any options to purchase shares of Parent Common Stock.

(ooo)       “Parent
Preferred Stock” means the preferred stock, par value $0.0001 per share, of Parent.

(ppp)       “Parent
RSUs” means all Parent restricted share units subject to time-vesting and/or performance-vesting conditions.

(qqq)       “Parent
Stock Plan” means the Parent 2021 Incentive Award Plan, as in effect on the date hereof.

(rrr)          “Parent
Termination Fee” means a fee equal to $10,000,000.

(sss)        “Permitted
Action” means any such commercially reasonable action or inaction taken in good faith (i) required by COVID-19 Measures,
whether or not in the ordinary course of business, or (ii) that is reasonably necessary or prudent for the Company or any of its
Subsidiaries to take or abstain from taking, to protect the health or safety of natural Persons employed by the Company or any of its
Subsidiaries solely in connection with COVID-19 or the COVID-19 Measures.

(ttt)          “Permitted
Liens” means any of the following: (i) liens for Taxes, assessments and governmental charges or levies arising in the
ordinary course of business that are either not yet delinquent or that are being contested in good faith by appropriate proceedings and
for which appropriate reserves have been established in accordance with GAAP; (ii) mechanics, carriers’, workmen’s,
warehouseman’s, repairmen’s, materialmen’s or other similar liens or security interests on real or tangible property
arising in the ordinary course of business that are not yet due or that are being contested in good faith by appropriate proceedings
and for which appropriate reserves have been reflected in accordance with GAAP; (iii) leases, subleases, non-exclusive licenses
and non-exclusive sublicenses (other than capital leases that are not Leases and leases underlying sale and leaseback transactions);
(iv) liens imposed by applicable Law (other than Laws in respect of Tax); (v) pledges or deposits to secure obligations pursuant
to workers’ compensation Laws or similar legislation or to secure public or statutory obligations; (vi) pledges and deposits
to secure the performance of bids, trade contracts, leases, surety and appeal bonds, performance bonds and other obligations of a similar
nature, in each case in the ordinary course of business; (vii) defects, imperfections or irregularities in title, easements, covenants
and rights of way (unrecorded and of record) and other similar liens (or other encumbrances of any type) (in each case, on real or tangible
property), and zoning, building and other similar codes or restrictions, in each case that do not adversely affect in any material respect
the current use of the applicable property owned, leased, used or held for use by the Company or any of its Subsidiaries; (viii) liens
the existence of which are disclosed in the notes to the consolidated financial statements of the Company included in the Company SEC
Reports prior to the date hereof; (ix) non-exclusive licenses of Intellectual Property granted in the ordinary course of business;
(x) statutory, common law or contractual liens (or other encumbrances of any type) of landlords or liens against the interests of
the landlord or owner of any Leased Real Property unless caused by the Company or any of its Subsidiaries; or (xi) liens (or other
encumbrances of any type) that do not materially and adversely affect the use or operation of the asset subject thereto.

(uuu)       “Person”
means any individual, corporation (including any public benefit corporation and any non-profit corporation), limited liability company,
joint stock company, general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, firm, Union,
Governmental Authority, Group or other enterprise, association, organization or entity.

(vvv)       “Personal
Information” means any information in any media that, alone or in combination with other information held by the Company, allows
the identification of a natural person, or a browser or device associated with an identified or identifiable natural person, or contact
with a natural person or can be used to identify a natural person and any other information that constitutes personal data or personal
information under any applicable Privacy Obligations.

(www)     “Privacy
Obligations” means applicable Laws, contractual obligations, self-regulatory standards that are legally binding on the Company,
written policies or notices or terms of use of the Company that are related to privacy, information security, data protection or the
Processing of Sensitive Data in each case as and to the extent applicable to the operation of the Company.

(xxx)         “Process”
or “Processing” means any operation or set of operations which is performed on data, including Personal Information
or sets of Personal Information, whether or not by automated means, such as the receipt, access, acquisition, collection, recording,
organization, compilation, structuring, storage, processing, adaptation or alteration, retrieval, consultation, use, disclosure by transfer,
transmission, dissemination or otherwise making available, alignment or combination, restriction, safeguarding, security, disposal, erasure
or destruction.

(yyy)       “Proxy
Statement/Prospectus” means the proxy statement/prospectus to be sent to the Company Stockholders in connection with the Company
Stockholder Meeting.

(zzz)         “Public
Benefit Purpose” means the specific public benefit to be promoted by the Company as set forth in the Company’s certificate
of incorporation as of the date hereof.

(aaaa)      “Public
Software” means any Software that is distributed (i) as “free software” (as defined by the Free Software Foundation)
or “open source software” (meaning Software distributed under any licensed approved by the Open Source Initiative as set
forth at www.opensource.org); (ii) under a license or other agreement commonly referred to as an open source, free software,
copyleft or community source code license (including any code or library licensed under the GNU General Public License, GNU Lesser General
Public License, BSD License, Apache License, or any other public source code license arrangement); or (iii) any other license or
other agreement that requires, as a condition of the use, modification or distribution of software subject to such license or agreement,
that such software or other software linked with, called by, combined or distributed with such software be (A) disclosed, distributed,
made available, offered, licensed or delivered in source code form; (B) licensed for the purpose of making derivative works; (C) licensed
under terms that allow reverse engineering, reverse assembly, or disassembly of any kind of any products or services; or (D) redistributable
at no charge.

(bbbb)     “Registration
Statement” means the registration statement on Form S-4, including any pre-effective or post-effective amendments or supplements
thereto, filed with the SEC by Parent under the Securities Act registering the shares of Parent Class A Common Stock to be issued
in connection with the Merger.

(cccc)      “Representatives”
of a Person means, collectively, the Affiliates, directors, officers, employees, consultants, agents, representatives and advisors of
such Person.

(dddd)     “Sanctioned
Country” means a country or territory which is itself the subject or target of a general export, import, financial or investment
embargo under Sanctions Laws in effect at the relevant time (at the time of this Agreement, the Crimea region, the separatist-controlled
portions of the Donetsk and Luhansk regions of Ukraine, Cuba, Iran, North Korea and Syria).

(eeee)      “Sanctioned
Person” means (i) any Person identified in any sanctions-related list of designated Persons maintained by (A) the
U.S. Department of the Treasury’s Office of Foreign Assets Control, the U.S. Department of Commerce’s Bureau of Industry
and Security, or the U.S. Department of State, (B) Her Majesty’s Treasury of the United Kingdom, (C) any committee of
the United Nations Security Council or (D) the European Union, (ii) any Person that is a Governmental Authority or government
instrumentality of any Sanctioned Country, (iii) any Person directly or indirectly owned or controlled by, or acting for the benefit
or on behalf of, any Person described in the foregoing clause (i) or (ii), either individually or in the aggregate, or (iv) any
Person organized or resident in a Sanctioned Country.

(ffff)         “Sanctions
Laws” means those trade, economic and financial sanctions Laws administered, enacted or enforced from time to time by (i) the
United States (including the Department of the Treasury’s Office of Foreign Assets Control), (ii) the European Union and enforced
by its member states, (iii) the United Nations or (iv) Her Majesty’s Treasury of the United Kingdom.

(gggg)     “Sarbanes-Oxley
Act” means the Sarbanes-Oxley Act of 2002.

(hhhh)     “SEC”
means the United States Securities and Exchange Commission or any successor thereto.

(iiii)          “Securities
Act” means the Securities Act of 1933.

(jjjj)          “Security
Breach” means any (i) unauthorized acquisition of, access to, loss of, or misuse (by any means) of Sensitive Data; (ii) unauthorized
or unlawful Processing, sale, or rental of Sensitive Data; (iii) phishing, ransomware, denial of service (DoS) or other cyberattack
that results in a material monetary loss or a business disruption; or (iv) other act or omission that compromises the security,
availability, integrity, or confidentiality of Sensitive Data.

(kkkk)      “Sensitive
Data” means (i) all Personal Information and (ii) other confidential or proprietary business information or trade
secret information maintained by or on behalf of the Company

(llll)          “Software”
means all computer software, applications and code, including APIs, interfaces, program files, firmware, operating systems, specifications
and algorithms, whether in object code, source code or any other form and all related documentation and manuals thereto.

(mmmm)  “Subsidiary”
means, with respect to any Person, any other Person (other than a natural Person) of which securities or other ownership interests (i) having
ordinary voting power to elect a majority of the board of directors or other persons performing similar functions or (ii) representing
more than 50% such securities or ownership interests, in each case, are at the time directly or indirectly owned by such first Person.

(nnnn)     “Superior
Proposal” means any unsolicited bona fide written Acquisition Proposal made after the date of this Agreement on terms
that the Company Board (or a committee thereof), after (i) considering each of (A) the Company Stockholders’ pecuniary
(financial) interests, (B) the best interests of those materially affected by the Company’s conduct (including customers,
employees, partners and the communities in which it operates) and (C) the Company’s Public Benefit Purpose and (ii) engaging
in the balancing required by the DGCL, has determined in good faith (after consultation with its outside legal counsel and financial
advisor) would be more favorable than the Merger (taking into account any legal, regulatory, financial, timing, public benefit, financing
and other aspects of such proposal that the Company Board (or a committee thereof) considers relevant and any revisions to this Agreement
made or offered in writing by Parent prior to the time of such determination). For purposes of the reference to an “Acquisition
Proposal” in this definition, all references to “20%” in clause (i) and clause (iii) of the definition of
“Acquisition Transaction” will be deemed to be references to “50%” and all references to “more than 20%”
in clause (ii) of the definition of “Acquisition Transaction” will be deemed to be references to “all or substantially
all”. For the avoidance of doubt, an Acquisition Proposal for an Acquisition Transaction involving the Company’s automation
business alone would not constitute a Superior Proposal.

(oooo)     “Systems”
means all networks, servers, switches, endpoints, Software, platforms, electronics, websites, storage, firmware, hardware, and related
information technology or outsourced services, and all electronic connections between them, that are owned, operated, or used by the
Company, including in connection with their products or services.

(pppp)     “Tax”
means any United States federal, state, local and non-United States taxes, including taxes based upon or measured by gross receipts,
income, profits, sales, use and occupation and value added taxes, ad valorem taxes, transfer taxes, franchise taxes, withholding taxes,
payroll taxes, employment taxes, excise and property taxes, or other charge of any kind whatsoever in the nature of a tax imposed by
a Governmental Authority, together with all interest, penalties and additions imposed with respect to such amounts, in each case whether
disputed or not.

(qqqq)     “Tax
Return” means any return, declaration, election, disclosure, report, claim for refund, statement or information report or filing
with respect to Taxes, including any schedules attached thereto and including any amendment thereof.

(rrrr)         “Termination
Date” means the Initial Termination Date, as it may be extended from time to time in accordance with the terms of this Agreement.

(ssss)      “Transaction
Litigation” means any Legal Proceeding (other than any Legal Proceeding brought by a Governmental Authority under the HSR Act
or any other Antitrust Law applicable to this Agreement or the Merger) commenced or threatened against a Party or any of its Subsidiaries
or Affiliates or otherwise relating to, involving or affecting such Party or any of its Subsidiaries or Affiliates, in each case in connection
with, arising from or otherwise relating to the Merger or any other transaction contemplated by this Agreement, other than any Legal
Proceedings among the Parties related to this Agreement.

(tttt)         “Treasury
Regulations” means regulations promulgated under the Code by the United States Treasury Department.

(uuuu)     “Union”
means any labor union, works council, trade union or other employee representative body.

(vvvv)     “WARN”
means the United States Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar foreign, state or local
Law.

(wwww)  “Willful
and Material Breach” shall mean a material breach of any representation, warranty, covenant or agreement set forth in this
Agreement that is a consequence of an act or failure to act by a Party with the actual knowledge that the taking of such act or failure
to act would cause, or would reasonably be expected to result in, a material breach; it being acknowledged and agreed, without limitation,
that any failure by a Party to close the transactions contemplated hereby, including the Merger, after the applicable conditions thereto
have been satisfied or waived shall constitute a Willful and Material Breach of this Agreement.

1.2            Index
of Defined Terms. The following capitalized terms have the respective meanings given to them in the respective Sections of this Agreement
set forth opposite each of the capitalized terms below:

Term	Section Reference

“Agreement”	Preamble
“Alternative Acquisition Agreement”	5.4(a)
“Company Capitalization Date”	3.8(a)
“Certificate of Merger”	2.2
“Certificates”	2.9(c)
“Chosen Courts”	9.10
“Closing”	2.3
“Closing Date”	2.3
“Collective Bargaining Agreement”	3.21(a)
“Company”	Preamble
“Company Board Recommendation”	3.3(a)
“Company Board Recommendation Change”	5.4(c)(i)
“Company Breach Notice Period”	8.1(e)
“Company Disclosure Letter”	Article III
“Company Related Parties”	8.3(f)
“Company Registered Intellectual Property”	3.18(a)
“Company SEC Reports”	3.10
“Company Securities”	3.8(c)
“Company Stockholder Meeting”	6.4(a)
“Confidentiality Agreement”	9.4
“Continuation Period”	6.9(c)
“D&O Insurance”	6.8(c)
“DGCL”	Recitals
“DTC”	2.9(d)
“Effective Time”	2.2
“Electronic Delivery”	9.14
“Employee Plan”	3.20(a)

“ERISA Affiliate”	3.20(a)
“ESPP Offering Period”	2.8(c)
“Exchange Agent”	2.9(a)
“Exchange Fund”	2.9(b)
“Exchange Ratio”	2.7(a)(ii)
“Excluded Benefits”	6.9(c)
“Export Approvals”	3.23(d)(i)
“Financial Advisor”	3.3(b)
“First Extended Termination Date”	8.1(c)
“Indemnified Persons”	6.8(a)
“Initial Termination Date”	8.1(c)
“Integration Committee”	6.6(b)
“Integration Plan”	6.6(b)
“Intended Tax Treatment”	6.17
“IT Systems”	3.18(j)
“Lease”	3.16(b)
“Leased Real Property”	3.16(b)
“Material Customers”	3.15
“Material Suppliers”	3.15
“Maximum Annual Premium”	6.8(c)
“Merger”	Recitals
“Merger Consideration”	2.7(a)(ii)
“Merger Sub”	Preamble
“Midco”	Recitals
“New Plans”	6.9(d)
“Non-U.S. Employee Plan”	3.20(j)
“Old Plans”	6.9(d)
“Option Consideration”	2.8(a)
“Option Consideration Value”	2.8(a)
“Other Required Filing”	6.3(b)
“Owned Company Shares”	2.7(a)(iii)
“Parent”	Preamble
“Parent Breach Notice Period”	8.1(g)
“Parent Capitalization Date”	4.15(a)
“Parent Disclosure Letter”	Article IV
“Parent Financial Statements”	4.17(a)
“Parent Recent SEC Reports”	Article IV
“Parent Related Parties”	8.3(g)
“Parent SEC Reports”	4.16
“Parent Securities”	4.15(c)
“Party”	Preamble
“Prior Parent SEC Reports”	4.16
“Real Estate Plan”	6.18
“Recent SEC Reports”	Article III
“Requisite Stockholder Approval”	3.5
“Specified Legal Proceedings”	6.16
“Sublease”	3.16(b)
“Surviving Corporation”	2.1
“Takeover Laws”	3.3(c)
“Uncertificated Shares”	2.9(c)
“Withholding Agent”	2.13
“Voting Agreement”	Recitals

1.3            Certain
Interpretations.

(a)            When
a reference is made in this Agreement to an Article or a Section, such reference is to an Article or a Section of this
Agreement unless otherwise indicated. When a reference is made in this Agreement to a Section of the Company Disclosure Letter or
the Parent Disclosure Letter or an Exhibit, such reference is to a Section of the Company Disclosure Letter or the Parent Disclosure
Letter or Exhibit to this Agreement, as applicable, unless otherwise indicated.

(b)            When
used herein, (i) the words “hereof,” “herein” and “herewith” and words of similar import will,
unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; and
(ii) the words “include,” “includes” and “including” will be deemed in each case to be followed
by the words “without limitation.”

(d)            The
word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and does
not simply mean “if.”

(e)            When
used in this Agreement, references to “$” or “Dollars” are references to U.S. dollars.

(f)             The
meaning assigned to each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural
forms of such term, and words denoting any gender include all genders. Where a word or phrase is defined in this Agreement, each of its
other grammatical forms has a corresponding meaning.

(g)            When
reference is made to any Party to this Agreement or any other agreement or document, such reference includes such Party’s successors
and permitted assigns. References to any Person include the successors and permitted assigns of that Person.

(h)            Unless
the context otherwise requires, all references in this Agreement to the Subsidiaries of a Person will be deemed to include all direct
and indirect Subsidiaries of such Person.

(i)             Any
Contract or Law defined or referred to herein or in any agreement or instrument that is referred to herein means such Contract (including
any schedules and exhibits thereto) or Law, in each case, as from time to time amended, modified or supplemented, including (x) in
the case of Laws, any re-enactment or succession of comparable successor statutes or substitution therefor and all rules, regulations
and statutory instruments issued thereunder or pursuant thereto and (y) in the case of Contracts, by waiver or consent, provided however that, for purposes of any representations and warranties in this Agreement that are made as a specific date, references to any specific
Law will be deemed to refer to such legislation or provision (and all rules, regulations and statutory instruments issued thereunder
or pursuant thereto) as of such date.

(j)            All
accounting terms used herein will be interpreted, and all accounting determinations hereunder will be made, in accordance with GAAP.

(k)            The
table of contents and headings set forth in this Agreement are for convenience of reference purposes only and will not affect or be deemed
to affect in any way the meaning or interpretation of this Agreement or any term or provision hereof.

(l)             The
measure of a period of one (1) month or year for purposes of this Agreement will be the date of the following month or year corresponding
to the starting date. If no corresponding date exists, then the end date of such period being measured will be the next actual date of
the following month or year (for example, one (1) month following February 18 is March 18 and one (1) month following
March 31 is May 1).

(m)            The
Parties agree that they have been represented by legal counsel during the negotiation, execution and delivery of this Agreement and therefore
waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other
document will be construed against the Party drafting such agreement or document.

(n)            No
summary of this Agreement or summary of any Exhibit or schedule delivered herewith prepared by or on behalf of any Party will affect
the meaning or interpretation of this Agreement, the Company Disclosure Letter, the Parent Disclosure Letter or any Exhibit to this
Agreement.

(o)            The
information contained in this Agreement and in the Company Disclosure Letter is disclosed solely for purposes of this Agreement, and
no information contained herein or therein will be deemed to be an admission by any Party to any third Person of any matter whatsoever,
including (i) any violation of Law or breach of Contract; or (ii) that such information is material or that such information
is required to be referred to or disclosed under this Agreement.

(p)            The
representations and warranties in this Agreement are the product of negotiations among the Parties and are for the sole benefit of the
Parties. Any inaccuracies in such representations and warranties are subject to waiver by the Parties in accordance with Section 8.5 without notice or liability to any other Person. In some instances, the representations and warranties in this Agreement may represent
an allocation among the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently,
Persons other than the Parties may not rely on the representations and warranties in this Agreement as characterizations of actual facts
or circumstances as of the date of this Agreement or as of any other date.

(q)            Documents
or other information or materials will be deemed to have been “made available” by the Company if such documents, information
or materials have been (i) posted to a virtual data room managed by the Company at https://americas.datasite.com, (ii) provided
directly (including through email) in written form to Parent or any of its Representatives or (iii) that are publicly available
in the Electronic Data Gathering, Analysis and Retrieval (EDGAR) database of the SEC, in each case, prior to 7:00 p.m., New York City
time on July 23, 2022.

(r)             Documents
or other information or materials will be deemed to have been “made available” by Parent if such documents, information or
materials have been (i) provided directly (including through email or secure file transfer) in written form to the Company or any
of its Representatives or (ii) that are publicly available in the Electronic Data Gathering, Analysis and Retrieval (EDGAR) database
of the SEC, in each case, prior to 7:00 p.m., New York City time on July 23, 2022.

(s)            All
references to time shall refer to New York City time unless otherwise specified.

(t)             The
phrase “ordinary course of business” means, with respect to an action taken by any Person, an action that is consistent with
the past practices of such Person or that is otherwise taken in the ordinary course of the normal day-to-day operations of the business
of such Person.

Article II
THE MERGER

2.1            The
Merger. Upon the terms and subject to the conditions set forth in this Agreement and the applicable provisions of the DGCL, on the
Closing Date, (a) Merger Sub will be merged with and into the Company; (b) the separate corporate existence of Merger Sub will
thereupon cease; and (c) the Company will continue as the surviving corporation of the Merger and as an indirect wholly-owned Subsidiary
of Parent. The Company, as the surviving corporation of the Merger, is sometimes referred to herein as the “Surviving Corporation.”

2.2            The
Effective Time. Upon the terms and subject to the conditions set forth in this Agreement, on the Closing Date, Parent, Merger Sub
and the Company shall cause the Merger to be consummated pursuant to the DGCL by filing a certificate of merger in customary form and
substance (the “Certificate of Merger”) with the Secretary of State of the State of Delaware in accordance with the
applicable provisions of the DGCL (the time of such filing and acceptance for record by the Secretary of State of the State of Delaware,
or such later time as may be agreed in writing by Parent, Merger Sub and the Company and specified in the Certificate of Merger, being
referred to herein as the “Effective Time”).

2.3            The
Closing. The consummation of the Merger will take place at a closing (the “Closing”) to occur at (a) 9:00
a.m., New York City time, remotely via the electronic exchange of documents and signatures, on the second (2nd) Business Day after the
satisfaction or waiver (to the extent permitted hereunder) of the last to be satisfied or waived of the conditions set forth in Article VII (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to
the extent permitted hereunder) of such conditions); or (b) such other time, location and date as Parent, Merger Sub and the Company
mutually agree in writing. The date on which the Closing actually occurs is referred to as the “Closing Date.”

2.4            Effect
of the Merger. At the Effective Time, the effect of the Merger will be as provided in this Agreement and the applicable provisions
of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time all (a) of the property,
rights, privileges, powers and franchises of the Company and Merger Sub will vest in the Surviving Corporation; and (b) debts, liabilities
and duties of the Company and Merger Sub will become the debts, liabilities and duties of the Surviving Corporation.

2.5            Certificate
of Incorporation and Bylaws.

(a)            Certificate
of Incorporation. At the Effective Time, the certificate of incorporation of the Company shall be amended and restated in its entirety
to read as set forth in Exhibit A attached hereto and, as so amended and restated, shall be the certificate of incorporation
of the Surviving Corporation until thereafter amended as provided by the DGCL and such certificate of incorporation (subject to Section 6.8(a)).

(b)            Bylaws.
At the Effective Time, the bylaws of Merger Sub as in effect immediately prior to the Effective Time shall become the bylaws of the Surviving
Corporation, except that all references to Merger Sub shall be automatically amended and shall become references to the Surviving Corporation,
until thereafter amended as provided by the DGCL, the certificate of incorporation and such bylaws (subject to Section 6.8(a)).

2.6            Directors
and Officers.

(a)            Directors.
At the Effective Time, the directors of the Surviving Corporation will be the directors of Merger Sub as of immediately prior to the
Effective Time, each to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation until
their respective successors are duly elected or appointed and qualified.

(b)            Officers.
At the Effective Time, the officers of the Surviving Corporation will be the officers of the Company as of immediately prior to the Effective
Time, each to hold office in accordance with the Organizational Documents of the Surviving Corporation until their respective successors
are duly appointed.

2.7            Effect
on Capital Stock.

(a)            Capital
Stock. Upon the terms and subject to the conditions set forth in this Agreement, at the Effective Time, by virtue of the Merger and
without any action on the part of Parent, Merger Sub, the Company or the holders of any of the securities described in this Section 2.7,
the following will occur:

(i)            each
share of common stock, par value $0.0001 per share, of Merger Sub that is issued and outstanding as of immediately prior to the Effective
Time will automatically be cancelled and converted into one validly issued, fully paid and nonassessable share of common stock of the
Surviving Corporation and thereupon each certificate representing ownership of such shares of common stock of Merger Sub will thereafter
represent ownership of shares of common stock of the Surviving Corporation;

(ii)           each
share of Company Common Stock that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company
Shares) will be automatically cancelled, extinguished and converted into the right to receive 0.9179 (the “Exchange Ratio”)
of a share of Parent Class A Common Stock (the “Merger Consideration”), subject to Section 2.7(c) with
respect to fractional shares of Parent Class A Common Stock, in accordance with the provisions of Section 2.9 (or in
the case of a lost, stolen or destroyed certificate, upon delivery of an affidavit (and bond, if required) in accordance with the provisions
of Section 2.11); and

(iii)          each
share of Company Common Stock that is (A) held by the Company as treasury stock; (B) owned by Parent or Merger Sub; or (C) owned
by any direct or indirect wholly-owned Subsidiary of Parent or Merger Sub as of immediately prior to the Effective Time (collectively,
the “Owned Company Shares”) will automatically be cancelled and extinguished without any conversion thereof or consideration
paid therefor.

(b)            Adjustment
to the Merger Consideration. If on or after the date of this Agreement and prior to the Effective Time any change in the outstanding
Company Common Stock or outstanding Parent Class A Common Stock shall occur as a result of any stock split, reverse stock split,
cash or stock dividend (including any dividend of securities convertible into Company Common Stock) with a record date during such period,
reorganization, recapitalization, reclassification, combination, exchange of shares or other similar change with respect to the Company
Common Stock or Parent Class A Common Stock occurring, then the Exchange Ratio and the Merger Consideration will be adjusted appropriately
and equitably to provide to holders of Company Common Stock and/or Company Equity Awards the same economic effect as contemplated by
this Agreement prior to such event; provided, however, that nothing in this Section 2.7(b) shall be construed
to permit (i) the Company or any of its Subsidiaries to take any action that is otherwise prohibited by Section 5.1
or Section 5.2, as applicable, or (ii) Parent or any of its Subsidiaries to take any action that is otherwise prohibited
by Section 5.3.

(c)            No
Fractional Shares. Notwithstanding anything to the contrary set forth in this Agreement, no fraction of a share of Parent Class A
Common Stock will be issued by virtue of the Merger, and in lieu thereof, each holder of record of shares of Company Common Stock who
would otherwise be entitled to a fraction of a share of Parent Class A Common Stock pursuant to this Article II (after
aggregating all fractional shares of Parent Class A Common Stock that otherwise would be received by such holder of record) shall
instead receive an amount of cash (rounded down to the nearest whole cent), without interest, representing such holder’s proportionate
interest in the net proceeds from the sale by the Exchange Agent, on behalf of all such holders, of shares of Parent Class A Common
Stock that would otherwise be issued. The Parties acknowledge that payment of the cash consideration in lieu of issuing fractional shares
of Parent Class A Common Stock was not separately bargained-for consideration but merely represents a mechanical rounding off for
purposes of avoiding the expense and inconvenience that would otherwise be caused by the issuance of fractional shares of Parent Class A
Common Stock.

2.8            Equity
Awards.

(a)            Company
Options. At the Effective Time each Company Option outstanding as of immediately prior to the Effective Time, whether vested or unvested,
will, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will
become a right to receive a number of shares of Parent Class A Common Stock equal to the Option Consideration Value with respect
such Company Option divided by the Parent Class A Common Stock Price, subject to Section 2.7(c) with respect
to any fractional shares (the “Option Consideration”); provided that, notwithstanding anything to the contrary
in this Agreement, each Company Option with an exercise price per share equal to or greater than the Merger Consideration Value will
be cancelled without any payment in respect thereof. With respect to any Company Option, the “Option Consideration Value”
is an amount, without interest, equal to (i) (A) the excess of the Merger Consideration Value over (B) the exercise price
per share of such Company Option, multiplied by (ii) the total number of shares of Company Common Stock issuable upon exercise
in full of such Company Option. Parent shall deliver the Option Consideration to holders of such Company Options as soon as practicable
following the Closing Date, but in any event no later than three (3) Business Days following the Closing Date.

(b)            Company
RSUs.

(i)            At
the Effective Time, each Company RSU outstanding as of immediately prior to the Effective Time that is vested (including after giving
effect to any acceleration of vesting to which such Company RSU is entitled as of immediately prior to the Effective Time as contemplated
by Section 2.8 of the Company Disclosure Letter) will, without any action on the part of Parent, Merger Sub, the Company
or the holder thereof, be cancelled and converted into and will become a right to receive the Merger Consideration, subject to Section 2.7(c) with
respect to fractional shares. Parent shall deliver the Merger Consideration to the holders of such Company RSUs as soon as practicable
following the Closing Date, but in any event no later than three (3) Business Days following the Closing Date.

(ii)           At
the Effective Time, each Company RSU outstanding as of immediately prior to the Effective Time that is unvested will, without any action
on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into a Parent RSU award with respect
to the number of shares of Parent Class A Common Stock that is equal to the product of (A) the number of shares of Company
Common Stock subject to such unvested Company RSU as of immediately prior to the Effective Time multiplied by (B) the Merger Consideration,
rounded down to the nearest whole share, which such Parent RSU award shall be subject to the same vesting terms and conditions applicable
to the Company RSU to which it relates as of immediately prior to the Effective Time, including any applicable vesting acceleration provisions
in connection with such holder’s termination of employment or service but otherwise shall be subject to the terms and conditions
of the Parent Stock Plan. On the Closing Date, Parent shall file with the SEC a registration statement on Form S-8 registering the
Parent RSUs.

(c)            Company
ESPP. As soon as practicable following the date hereof, the Company shall take all actions with respect to the Company ESPP that
are necessary to provide that (i) with respect to the offering period under the Company ESPP in effect as of the date hereof, if
any (the “ESPP Offering Period”), no individual who was not a participant in the Company ESPP as of the date hereof
may enroll in the Company ESPP with respect to such ESPP Offering Period and no participant may increase the percentage amount of his
or her payroll deduction election from that in effect on the date hereof for such ESPP Offering Period, (ii) no new offering period
shall be commenced under the Company ESPP prior to the Effective Time, (iii) immediately prior to the Effective Time, the Company
ESPP shall terminate and (iv) if the applicable purchase date or exercise date with respect to the ESPP Offering Period would otherwise
occur on or after the Effective Time, then the ESPP Offering Period will be shortened and the applicable purchase date or exercise date
with respect to the ESPP Offering Period will occur on the day immediately preceding the date on which the Effective Time occurs.

(d)            Further
Actions. As of immediately prior to the Effective Time, the Company will terminate the Company Stock Plans and all rights thereunder,
including in respect of the Company Options and the Company RSUs, will be cancelled, in each case, without liability to the Company,
Parent, the Surviving Corporation or any of their respective Affiliates or Subsidiaries, other than the obligation to provide the amounts
described in this Section 2.8. The Company will take all actions reasonably necessary to effect the cancellation of the Company
Stock Plans and the Company Equity Awards as of immediately prior to, or upon, as applicable, the Effective Time, to terminate the Company
ESPP effective immediately prior to the Effective Time, and to give effect to this Section 2.8 (including the satisfaction
of the requirements of Rule 16b-3(e) promulgated under the Exchange Act). As soon as reasonably practicable, but in no event
later than ten (10) Business Days prior to the Closing Date, the Company shall provide Parent with drafts of all notices, resolutions,
consents and other written actions as may be required to effectuate the provisions of this Section 2.8 for Parent’s
reasonable review and comment.

2.9            Exchange
Procedures.

(a)            Exchange
Agent. Prior to the Closing, Parent shall (i) select a nationally recognized bank or trust company reasonably acceptable to
the Company to act as the exchange agent for the Merger (the “Exchange Agent”); and (ii) enter into an exchange
agent agreement, in form and substance reasonably acceptable to the Company, with such Exchange Agent.

(b)            Exchange
Fund. At or prior to the Closing, Parent shall deposit (or cause to be deposited) with the Exchange Agent, the shares of Parent Class A
Common Stock in book entry form issuable pursuant to Section 2.7 in exchange for the aggregate shares of Company Common Stock
(such shares, the “Exchange Fund”).

(c)            Exchange
Procedures. Promptly following the Effective Time (and in any event within three (3) Business Days), Parent and the Surviving
Corporation shall cause the Exchange Agent to mail to each holder of record as of immediately prior to the Effective Time (other than
Owned Company Shares) of one or more certificates that immediately prior to the Effective Time represented issued and outstanding shares
of Company Common Stock (other than Owned Company Shares) (the “Certificates” (if any)) (i) a letter of transmittal
in customary form (which will specify that delivery will be effected, and risk of loss and title to the Certificates will pass, only
upon delivery of the Certificates to the Exchange Agent), and (ii) instructions for effecting the surrender of the Certificates
in exchange for the Merger Consideration payable with respect to the shares of Company Common Stock formerly represented thereby pursuant
to Section 2.7. Upon surrender of Certificates for cancellation to the Exchange Agent, together with such letter of transmittal,
duly completed and validly executed in accordance with the instructions thereto, the holders of such Certificates will be entitled to
receive in exchange therefor the Merger Consideration, as determined pursuant to Section 2.7, and the Certificates so surrendered
will forthwith be cancelled. Notwithstanding anything to the contrary in this Agreement, no record holder of uncertificated shares of
Company Common Stock (other than Owned Company Shares) (the “Uncertificated Shares”) will be required to deliver a
Certificate or an executed letter of transmittal to the Exchange Agent in order to receive the payment that such holder is entitled to
receive pursuant to Section 2.7 with respect of such Uncertificated Shares. In lieu thereof, such record holder, upon receipt
of such evidence, if any, of transfer as the Exchange Agent may reasonably request, will be entitled to receive in exchange therefor
the Merger Consideration for such Uncertificated Shares, as determined pursuant to Section 2.7, and the transferred Uncertificated
Shares will be cancelled. No interest will be paid or accrued for the benefit of holders of the Certificates and Uncertificated Shares
on the Merger Consideration payable upon the surrender of such Certificates and transfer of Uncertificated Shares pursuant to this Section 2.9(c).
Until so surrendered or transferred, outstanding Certificates and Uncertificated Shares will be deemed from and after the Effective Time
to evidence only the right to receive the Merger Consideration payable in respect thereof pursuant to Section 2.7.

(d)            DTC
Payment. Prior to the Effective Time, Parent and the Company shall cooperate to establish procedures with the Exchange Agent and
the Depository Trust Company (“DTC”) with the objective that the Exchange Agent shall transmit to DTC or its nominee
on the Closing Date the Merger Consideration with respect to the shares of Company Common Stock (other than Owned Company Shares) held
of record by DTC or such nominee immediately prior to the Effective Time, upon the surrender of such shares held of record by DTC or
its nominees in accordance with DTC’s customary surrender procedures, as determined pursuant to Section 2.7.

(e)            Transfers
of Ownership. If payment of the Merger Consideration is to be made to a Person other than the Person in whose name the surrendered
Certificate or transferred Uncertificated Share in exchange therefor is registered, it shall be a condition of payment that (i) the
Person requesting such exchange present proper evidence of transfer or shall otherwise be in proper form for transfer and (ii) the
Person requesting such payment shall have paid any transfer Taxes required by reason of the payment of the Merger Consideration to a
Person other than the registered holder of such Certificate or Uncertificated Share surrendered or shall have established to the reasonable
satisfaction of the Surviving Corporation or the Exchange Agent that such Tax either has been paid or is not applicable.

(f)             No
Liability. Notwithstanding anything to the contrary set forth in this Agreement, none of the Exchange Agent, Parent, the Surviving
Corporation or any other Party will be liable to a holder of shares of Company Common Stock for any amount properly paid to a public
official pursuant to any applicable abandoned property, escheat or similar Law.

(g)            Distribution
of Exchange Fund to Parent. Any portion of the Exchange Fund that remains undistributed to the holders of the Certificates or Uncertificated
Shares on the date that is one (1) year after the Effective Time will be delivered to Parent (or the Surviving Corporation as directed
by Parent) upon demand, and any holders of shares of Company Common Stock that were issued and outstanding as of immediately prior to
the Merger who have not theretofore surrendered or transferred their Certificates or Uncertificated Shares representing such shares of
Company Common Stock for exchange pursuant to this Section 2.9 shall thereafter look for payment of the Merger Consideration
payable in respect of the shares of Company Common Stock represented by such Certificates or Uncertificated Shares solely to Parent (subject
to abandoned property, escheat or similar Laws), as general creditors thereof, for any claim to the Merger Consideration to which such
holders may be entitled pursuant to Section 2.7. Any amounts remaining unclaimed by holders of any such Certificates or Uncertificated
Shares five (5) years after the Effective Time, or at such earlier date as is immediately prior to the time at which such amounts
would otherwise escheat to, or become property of, any Governmental Authority, will, to the extent permitted by applicable Law, become
the property of the Surviving Corporation free and clear of any claims or interest of any such holders (and their successors, assigns
or personal representatives) previously entitled thereto.

2.10          No
Further Ownership Rights in Company Common Stock. From and after the Effective Time, (a) all shares of Company Common Stock
will no longer be outstanding and will automatically be cancelled, retired and cease to exist; and (b) each holder of a Certificate
or Uncertificated Shares theretofore representing any shares of Company Common Stock will cease to have any rights with respect thereto,
except the right to receive the Merger Consideration payable therefor in accordance with Section 2.7. The Merger Consideration
paid in accordance with the terms of this Article II will be deemed to have been paid in full satisfaction of all rights
pertaining to such shares of Company Common Stock. From and after the Effective Time, there will be no further registration of transfers
on the records of the Surviving Corporation of shares of Company Common Stock that were issued and outstanding immediately prior to the
Effective Time, other than transfers to reflect, in accordance with customary settlement procedures, trades effected prior to the Effective
Time. If, after the Effective Time, Certificates or Uncertificated Shares are presented to the Surviving Corporation for any reason,
they will (subject to compliance with the exchange procedures of Section 2.9(c)) be cancelled and exchanged as provided in
this Article II.

2.11          Lost,
Stolen or Destroyed Certificates. In the event that any Certificates have been lost, stolen or destroyed, the Exchange Agent shall
issue in exchange therefor, upon the making of an affidavit of that fact by the holder thereof, the Merger Consideration payable in respect
thereof pursuant to Section 2.7. Parent or the Exchange Agent may, in its reasonable discretion and as a condition precedent
to the payment of such Merger Consideration, require the owners of such lost, stolen or destroyed Certificates to deliver a bond in such
reasonable amount as it may direct as indemnity against any claim that may be made against Parent, the Surviving Corporation or the Exchange
Agent with respect to the Certificates alleged to have been lost, stolen or destroyed.

2.12          FIRPTA
Certificates. On or prior to the Closing, the Company shall deliver to Parent a properly executed certification that the shares of
Company Common Stock are not “United States real property interests” in accordance with the Treasury Regulations under Sections
897 and 1445 of the Code, together with a notice to the IRS (which shall be filed by Parent with the IRS following the Closing) in accordance
with the provisions of Section 1.897-2(h)(2) of the Treasury Regulations.

2.13          Required
Withholding. Each of the Exchange Agent, Parent, the Company and the Surviving Corporation and any other applicable withholding agent
(each a “Withholding Agent”) will be entitled to deduct and withhold from the consideration otherwise payable pursuant
to this Agreement to any holder or former holder of shares of Company Common Stock, Company Equity Awards, or any other payee as contemplated
by this Agreement such amounts as are required to be deducted or withheld therefrom pursuant to any Tax Laws; provided, that if
any Withholding Agent determines that an amount is required to be deducted or withheld, such Withholding Agent shall use commercially
reasonable efforts to (i) at least five (5) Business Days prior to the payment of such amount, provide the Person in respect
of whom such withholding or deduction would apply with written notice of its intent to deduct and withhold (ii) cooperate in good
faith with such Person to reduce or eliminate the deduction or withholding of such amount (including cooperation in seeking refunds of
any amounts withheld), and (iii) provide such Person a reasonable opportunity to provide forms or other documentation that would
reduce or exempt such amounts from withholding. Notwithstanding anything to the contrary herein, (a) no such written notice shall
be required for any compensatory amounts payable pursuant to or as contemplated by this Agreement, and (b) all compensatory amounts
payable pursuant to or as contemplated by this Agreement shall be remitted to the Company or a Subsidiary of the Company for payment
in accordance with applicable payroll procedures after applicable withholding. To the extent that such amounts are so deducted or withheld
and paid over to the appropriate Governmental Authority, such amounts will be treated for all purposes of this Agreement as having been
paid to the Person to whom such amounts would otherwise have been paid.

Article III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

With respect to any Section of
this Article III, except (a) as disclosed in the reports, statements and other documents filed by the Company with the
SEC or furnished by the Company to the SEC on or after April 21, 2021 and at least one (1) Business Day prior to the date of
this Agreement (excluding any predictive or cautionary disclosures (other than statements of historical fact) contained or referenced
therein, including under the captions “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk”
or in any “forward-looking statements” disclaimer) (the “Recent SEC Reports”) (it being agreed and understood
that any matter disclosed in the Recent SEC Reports shall not be deemed disclosed for purposes of Section 3.1, Section 3.2,
Section 3.3, Section 3.4, Section 3.5, Section 3.8 and the first sentence of Section 3.13),
and (b) subject to the terms of Section 9.13, as set forth in the disclosure letter delivered by the Company to Parent
and Merger Sub on the date of this Agreement (the “Company Disclosure Letter”), the Company hereby represents and
warrants to Parent and Merger Sub as follows:

3.1            Organization;
Good Standing. The Company is a public benefit corporation duly organized, validly existing and in good standing pursuant to the
DGCL. The Company has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own,
lease or operate its properties and assets, except where the failure to have such power or authority would not reasonably be expected
to have a Company Material Adverse Effect. The Company is duly qualified to do business and is in good standing in each jurisdiction
where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect
to jurisdictions that recognize the concept of good standing), except where the failure to be so qualified or in good standing would
not reasonably be expected to have a Company Material Adverse Effect.

3.2            Corporate
Power; Enforceability. The Company has the requisite corporate power and authority to (a) execute and deliver this Agreement;
(b) perform its covenants and obligations hereunder; and (c) subject to receiving the Requisite Stockholder Approval, consummate
the Merger. The execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and obligations
hereunder, and the consummation of the Merger have been duly authorized and approved by all necessary corporate action on the part of
the Company and no additional corporate actions on the part of the Company are necessary to authorize (i) the execution and delivery
of this Agreement by the Company; (ii) the performance by the Company of its covenants and obligations hereunder; or (iii) subject
to the receipt of the Requisite Stockholder Approval, the consummation of the Merger. This Agreement has been duly executed and delivered
by the Company and, assuming the due authorization, execution and delivery by Parent and Merger Sub, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability (A) may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors’
rights generally; and (B) is subject to general principles of equity.

3.3            Company
Board Approval; Opinion of Financial Advisor; Anti-Takeover Laws.

(a)            Company
Board Approval. At a meeting called and held prior to the execution and delivery of this Agreement, the Company Board has unanimously
(i) considered each of (A) the Company Stockholders’ pecuniary (financial) interests, (B) the best interests of
those materially affected by the Company’s conduct (including customers, employees, partners and the communities in which it operates)
and (C) the Company’s Public Benefit Purpose, engaged in the balancing required by the DGCL, and declared it advisable, to
enter into this Agreement and consummate the Merger upon the terms and subject to the conditions set forth herein and determined that
the Merger is fair and in the best interests of the Company, the Company Stockholders and those materially affected by the Company’s
conduct, and promotes the Public Benefit Purpose; (ii) approved the execution and delivery of this Agreement by the Company, the
performance by the Company of its covenants and other obligations hereunder, and the consummation of the Merger upon the terms and conditions
set forth herein; and (iii) resolved to recommend that the Company Stockholders adopt this Agreement in accordance with the DGCL
(collectively, the “Company Board Recommendation”), which resolutions have not been subsequently modified, rescinded
or withdrawn as of the date hereof.

(b)            Opinion
of Financial Advisor. The Company Board has received the written opinion (or an oral opinion to be confirmed in writing) of Cowen
and Company, LLC (the “Financial Advisor”), to the effect that, as of the date of such opinion and based upon and
subject to the various assumptions, qualifications, limitations and other matters set forth therein, the Merger Consideration to be received
by the holders of shares of Company Common Stock (other than Owned Company Shares) in the Merger is fair to such holders from a financial
point of view. As of the date of this Agreement, such opinion has not been withdrawn, revoked or modified. The Company shall, following
the date hereof, furnish to Parent, solely for informational purposes, a written copy of such opinion (it being understood and agreed
that such written opinion is for the benefit of the Company Board and any committee thereof and may not be relied upon by Parent or Merger
Sub).

(c)            Anti-Takeover
Laws. Assuming that the representations of Parent and Merger Sub set forth in Section 4.8 are true and correct, the Company
Board has taken all necessary actions so that the restrictions on business combinations set forth in any “moratorium,” “control
share acquisition,” “business combination,” “fair price” “supermajority,” “affiliate
transactions” or other form of anti-takeover laws and regulations, including Section 203 of the DGCL or any restrictive provision
of any applicable anti-takeover provision in applicable Organizational Documents (collectively, “Takeover Laws”) of
the Company will not be applicable to the Merger.

3.4            Brokers.
Other than the Financial Advisor, there is no financial advisor, investment banker, broker, finder, agent or other similar Person that
has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who is entitled to any financial advisor’s,
investment banking, brokerage, finder’s or other similar fee or commission in connection with the Merger. The Company has heretofore
made available to Parent a true and complete copy of the Company’s engagement letter with the Financial Advisor.

3.5            Requisite
Stockholder Approval. The affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled
to vote on the Merger (the “Requisite Stockholder Approval”) is the only vote of holders of any class or series of
Company capital stock that is necessary to approve or adopt, as applicable, this Agreement and consummate the Merger pursuant to applicable
Law and the Company’s Organizational Documents.

3.6            Non-Contravention.
The execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and obligations hereunder,
and the consummation of the Merger do not (a) violate or conflict with any provision of the Company’s Organizational Documents;
(b) violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of time or both,
would become a default) pursuant to, result in the termination of, accelerate the performance required by, or result in a right of termination
or acceleration pursuant to the terms, conditions or provisions of any Material Contract to which the Company or any of its Subsidiaries
is a party or by which the Company or any of its Subsidiaries or any of their properties or assets may be bound; (c) assuming compliance
with the matters referred to in Section 3.7 and, in the case of the consummation of the Merger, subject to obtaining the
Requisite Stockholder Approval, violate or conflict with any Law or order applicable to the Company or any of its Subsidiaries or by
which any of their respective properties or assets are bound; or (d) result in the creation of any Lien (other than Permitted Liens)
upon any of the properties or assets of the Company or any of its Subsidiaries, except in the case of each of clauses (b), (c) and
(d) for such violations, conflicts, breaches, defaults, terminations, accelerations or Liens that would not reasonably be expected
to have a Company Material Adverse Effect.

3.7            Requisite
Governmental Approvals.

(a)            No
Governmental Authorization is required on the part of the Company (a) in connection with the execution and delivery of this Agreement
by the Company; (b) the performance by the Company of its covenants and obligations pursuant to this Agreement; or (c) the
consummation of the Merger, except for (i) the filing of the Certificate of Merger and related documentation with the Secretary
of State of the State of Delaware and such filings with Governmental Authorities to satisfy the applicable Laws of states in which the
Company and its Subsidiaries are qualified to do business; (ii) such filings and approvals as may be required by any applicable
federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act; (iii) compliance with
any applicable requirements of the HSR Act and any other applicable Antitrust Laws; (iv) compliance with Section 203 of the
DGCL and any other similar applicable Takeover Law; and (v) such other Governmental Authorizations the failure of which to obtain
would not reasonably be expected to have a Company Material Adverse Effect.

(b)            The
Company does not engage in any of the activities listed on Section 3.7(b) of the Company Disclosure Letter in the jurisdiction
specified therein.

3.8            Company
Capitalization.

(a)            Capital
Stock. The authorized capital stock of the Company consists of (i) 1,500,000,000 shares of Company Common Stock and (ii) 170,000,000
shares of Company Preferred Stock. As of 5:00 p.m., New York City time, on July 19, 2022 (such time and date, the “Company
Capitalization Date”), (A) 104,098,538 shares of Company Common Stock were issued and outstanding; and (B) no shares
of Company Preferred Stock were issued and outstanding. All outstanding shares of Company Common Stock are validly issued, fully paid,
nonassessable and free of any preemptive rights. From the close of business on the Company Capitalization Date to the date of this Agreement,
the Company has not issued or granted any Company Common Stock or Company Equity Awards other than pursuant to the exercise of Company
Options, the settlement of Company RSUs and/or the exercise of purchase rights under the Company ESPP, in each case, granted prior to
the date of this Agreement.

(b)            Stock
Reservation. As of the Company Capitalization Date, the Company has reserved 20,731,643 shares of Company Common Stock for issuance
pursuant to the Company Stock Plans (other than the Company ESPP) and 2,758,864 shares of Company Common Stock for issuance pursuant
to the Company ESPP. As of the Company Capitalization Date, there were outstanding (i) Company Options to acquire 6,753,525 shares
of Company Common Stock, of which 202,596 Company Option to acquire 202,596 shares of Company Common Stock have an exercise price per
share less than the Merger Consideration Value, (ii) Company RSUs that may be settled into 7,826,295 shares of Company Common Stock
and (iii) outstanding rights to purchase a maximum 51,321 shares of Company Common Stock under the Company ESPP, based on accumulated
payroll deductions and outstanding elections, assuming the “Fair Market Value” (as defined in the Company ESPP) of a share
of Company Common Stock on the date any such shares are purchased is equal to the Merger Consideration Value; provided that for
purposes of clause (i) and (iii) of this Section 3.8(b), the Merger Consideration Value shall be determined assuming
a Parent Class A Common Stock Price of $2.94.

(c)            Company
Securities. Except as set forth in Section 3.8(a), as of the Company Capitalization Date, there were (i) no issued
and outstanding shares of capital stock of, or other equity or voting interest in, the Company; (ii) no outstanding securities of
the Company convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, the Company; (iii) no
outstanding options, warrants or other rights or binding arrangements to acquire from the Company, or that obligate the Company to issue,
any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable for shares of capital
stock of, or other equity or voting interest in, the Company; (iv) no obligations of the Company to grant, extend or enter into
any subscription, warrant, right, convertible or exchangeable security, or other similar Contract relating to any capital stock of, or
other equity or voting interest (including any voting debt) in, the Company; (v) no outstanding restricted shares, restricted share
units, stock appreciation rights, profits interests, profit participation, performance shares, contingent value rights, “phantom”
stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value
or price of, any capital stock of, or other securities or ownership interests in, the Company (the items in clauses (i), (ii), (iii),
(iv) and (v), collectively with the Company Common Stock and Company Preferred Stock, the “Company Securities”);
(vi) voting trusts, proxies or similar arrangements or understandings to which the Company is a party or by which the Company is
bound with respect to the voting of any shares of capital stock of, or other equity or voting interest in, the Company; (vii) obligations
or binding commitments of any character restricting the transfer of any shares of capital stock of, or other equity or voting interest
in, the Company to which the Company is a party or by which it is bound; and (viii) no other obligations by the Company to make
any payments based on the price or value of any Company Securities. The Company is not a party to any Contract that obligates it to repurchase,
redeem or otherwise acquire any Company Securities. There are no accrued and unpaid dividends with respect to any outstanding shares
of Company Common Stock. The Company does not have a stockholder rights plan in effect. Each Company Option (A) has at all times
been exempt from the requirements of Section 409A of the Code and has otherwise complied in all material respects with all other
applicable Laws and all of the terms and conditions of the applicable Company Stock Plan, and (B) has an exercise price that is
equal or greater than the fair market value of the underlying share of Company Common Stock on the date of grant. Each Company RSU has
at all times been exempt from the requirements of Section 409A of the Code and has otherwise complied with all other applicable
Laws and all of the terms and conditions of the applicable Company Stock Plan. Section 3.8(c) of the Company Disclosure
Letter sets forth, with respect to each Company Option and Company RSU, as of the Company Capitalization Date, (1) the name of the
holder, (2) the grant date, (3) the type of award and the number of shares of Company Common Stock underlying such award, (4) the
vesting schedule (including any accelerated vesting by reason of the transactions contemplated by this Agreement), (5) the exercise
price, as applicable, and (6) the expiration date. The Company has the requisite power and authority, in accordance with the applicable
Company Stock Plan, the applicable award agreements and any other applicable contract, to take the actions contemplated by Section 2.8,
including the treatment of Company Options and Company RSUs as described in Section 2.8.

(d)            Other
Rights. Except as contemplated by this Agreement, as of the date of this Agreement, the Company is not a party to any Contract relating
to the voting of, requiring registration of, or granting any preemptive rights, anti-dilutive rights or rights of first refusal or other
similar rights with respect to any Company Securities. As of the date of this Agreement, there are not any bonds, debentures, notes or
other indebtedness of the Company outstanding having the right to vote (or convertible into, exchangeable for, securities having the
right to vote) on any matters on which holders of Company Common Stock may vote.

3.9            Subsidiaries.

(a)            Subsidiaries.
Section 3.9(a) of the Company Disclosure Letter sets forth a true, correct and complete list of all of the Subsidiaries
of the Company, and for each Subsidiary of the Company, the state or country of formation. Each Subsidiary of the Company (i) is
duly organized, validly existing and in good standing pursuant to the Laws of its jurisdiction of organization (to the extent that the
concept of “good standing” is applicable in any jurisdiction outside of Delaware); and (ii) has the requisite power
and authority to conduct its business as it is presently being conducted and to own, lease or operate its respective properties and assets,
except where the failure to be in good standing would not reasonably be expected to have a Company Material Adverse Effect. Each Subsidiary
of the Company is duly qualified to do business and is in good standing in each jurisdiction where the character of its properties owned
or leased or the nature of its activities make such qualification necessary, except where the failure to be so qualified or in good standing
would not reasonably be expected to have a Company Material Adverse Effect. As of the date of this Agreement, the Company has made available
true and complete copies of the Organizational Documents of each Subsidiary of the Company. No Subsidiary of the Company is in violation
of its Organizational Documents, except for such violations that have not had, and would not reasonably be expected to have a Company
Material Adverse Effect.

(b)            Capital
Stock of Subsidiaries. All of the outstanding capital stock of or other voting securities of, or ownership interests in, each Subsidiary
of the Company is owned by the Company, directly or indirectly, free and clear of all Liens (other than liens imposed by this Agreement,
the Organizational Documents of the Company or its Subsidiaries or applicable securities laws) and transfer restrictions, except for
such liens and transfer restrictions of general applicability as may be provided under the Securities Act or other applicable securities
Laws.

(c)            Other
Securities of Subsidiaries. There are no outstanding (i) securities convertible into or exchangeable for shares of capital stock
of, or other equity or voting interest in, any Subsidiary of the Company; (ii) options, warrants or other rights or arrangements
obligating the Company or any of its Subsidiaries to acquire from any Subsidiary of the Company, or that obligate any Subsidiary of the
Company to issue, any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable for,
shares of capital stock of, or other equity or voting interest in, any Subsidiary of the Company; (iii) obligations of any Subsidiary
of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security, or other similar
Contract relating to any capital stock of, or other equity or voting interest (including any voting debt) in, such Subsidiary to any
Person other than the Company or one of its Subsidiaries; or (iv) restricted shares, restricted share units, stock appreciation
rights, profits interests, profit participation, performance shares, contingent value rights, “phantom” stock or similar
securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any
capital stock of, or other securities or ownership interests in, any Subsidiary of the Company. As of the date of this Agreement, neither
the Company, nor any of its Subsidiaries, owns directly or indirectly, any capital stock or other securities in any Person other than
the Company’s Subsidiaries.

3.10         Company
SEC Reports. Since April 21, 2021 and through the date of this Agreement, the Company has timely filed with, or furnished to,
the SEC all forms, reports and documents that have been required to be filed or furnished by it pursuant to applicable Laws (the “Company
SEC Reports”). Each Company SEC Report complied, as of its filing date (or, if amended or superseded by a filing prior to the
date of this Agreement, on the date of such amended or superseded filing), in all material respects with the applicable requirements
of the Securities Act or the Exchange Act, as the case may be, each as in effect on the date that such Company SEC Report was filed.
As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseded
filing), each Company SEC Report did not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. Since April 21,
2021, the Company has been in compliance in all material respects with the applicable listing and corporate governance rules and
regulations of Nasdaq. As of the date of this Agreement, to the Knowledge of the Company there are no outstanding or unresolved comments
received from the SEC staff with respect to the Company SEC Reports. To the Knowledge of the Company, as of the date of this Agreement,
none of the Company SEC Reports is the subject of ongoing SEC review or investigation. None of the Company’s Subsidiaries is required
to file periodic reports with the SEC pursuant to the Exchange Act.

3.11          Company
Financial Statements; Internal Controls.

(a)            Company
Financial Statements. The consolidated financial statements (including any related notes and schedules) of the Company filed with
the Company SEC Reports (i) were prepared in accordance with GAAP (except as may be indicated in the notes thereto or as otherwise
permitted by Form 10-Q with respect to any financial statements filed on Form 10-Q); (ii) comply as to form in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto; and (iii) fairly
present, in all material respects, the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates
thereof and the consolidated results of operations and cash flows for the periods then ended (subject, in the case of the unaudited financial
statements, to normal and recurring year-end adjustments and to any other adjustment described therein). There are no “off balance
sheet arrangements” of the Company that have not been disclosed in the Company SEC Reports where the result, purpose or effect
of such off balance sheet arrangements is to avoid disclosure of any material transaction involving, or material liabilities of, the
Company or any of its Subsidiaries in the Company SEC Reports. Since April 21, 2021, there has been no material change in the Company’s
accounting methods or principles that would be required to be disclosed in the Company’s financial statements in accordance with
GAAP, except as described in the Company SEC Reports.

(b)            Disclosure
Controls and Procedures. The Company has established and maintains “disclosure controls and procedures” and “internal
control over financial reporting” (in each case as defined pursuant to Rule 13a-15 and Rule 15d-15 promulgated under
the Exchange Act). The Company’s disclosure controls and procedures are reasonably designed to ensure that all (i) material
information required to be disclosed by the Company in the reports and other documents that it files or furnishes pursuant to the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC; and (ii) such
material information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding
required disclosure and to make the certifications required pursuant to Section 302 and 906 of the Sarbanes-Oxley Act. Since April 21,
2021, (i) the Company has been and is an “emerging growth company” as defined in Section 2(a) of the Securities
Act and (ii) the principal executive officer and principal financial officer of the Company have made all certifications required
by the Sarbanes-Oxley Act. Neither the Company nor its principal executive officer or principal financial officer has received notice
from any Governmental Authority challenging or questioning the accuracy, completeness, form or manner of filing of such certifications.

(c)            Internal
Controls. Since April 21, 2021, neither the Company nor, to the Knowledge of the Company, the Company’s independent registered
public accounting firm has identified or been made aware of (A) any significant deficiency or material weakness in the system of
internal control over financial reporting used by the Company and its Subsidiaries that has not been subsequently remediated; or (B) any
fraud that involves the Company’s management or other employees who have a role in the preparation of financial statements or the
internal control over financial reporting utilized by the Company and its Subsidiaries.

3.12          No
Undisclosed Liabilities. Neither the Company nor any of its Subsidiaries has any liabilities or obligations of any nature (whether
accrued, contingent, absolute, determined, determinable or otherwise), other than liabilities or obligations (a) reflected or otherwise
reserved against in the Audited Company Balance Sheet or in the consolidated financial statements of the Company and its Subsidiaries
(including the notes thereto) included in the Company SEC Reports; (b) arising pursuant to this Agreement or incurred in connection
with the Merger; (c) incurred in the ordinary course of business since the date of the Audited Company Balance Sheet (other than
liabilities resulting from breach of contract, tort, or violation of Law); or (d) that would not reasonably be expected to have
a Company Material Adverse Effect.

3.13          Absence
of Certain Changes. Since the date of the Audited Company Balance Sheet through the date of this Agreement, the business of the Company
and its Subsidiaries has been conducted in the ordinary course of business in all material respects. Since the date of the Audited Company
Balance Sheet through the date of this Agreement, there has not occurred a Company Material Adverse Effect. Since the date of the Audited
Company Balance Sheet through the date of this Agreement, neither the Company nor any of its Subsidiaries has taken any action that,
if it had been taken or occurred after the execution of this Agreement, would have required the consent of Parent pursuant to Sections
5.2(a), 5.2(b), 5.2(c) (other than in the ordinary course of business), 5.2(d), 5.2(e), 5.2(i),
5.2(k), 5.2(o), 5.2(p), 5.2(q), 5.2(r) or 5.2(s) (as it relates to the foregoing
clauses of Section 5.2). Since March 31, 2022 through the date of this Agreement, neither the Company nor any of its
Subsidiaries has taken any action that, if it had been taken or occurred after the execution of this Agreement, would have required the
consent of Parent pursuant to Section 5.2(g) (other than immaterial actions).

3.14          Material
Contracts; Government Contracts.

(a)            List
of Material Contracts. Section 3.14(a) of the Company Disclosure Letter contains a true, correct and complete list
of all Material Contracts, as in effect as of the date of this Agreement, to which the Company or any of its Subsidiaries is a party
or is bound (other than any Material Contracts contemplated by clause (i) of the definition of Material Contract), each of
which has been made available by the Company to Parent prior to the date hereof.

(b)           Validity.
Each Material Contract (other than any Material Contract that has expired in accordance with its terms) is valid and binding on the Company
or each such Subsidiary of the Company party thereto and is in full force and effect, and none of the Company, any of its Subsidiaries
party thereto or, to the Knowledge of the Company, any other party thereto is in breach of or default pursuant to any such Material Contract,
except for such failures to be in full force and effect would not reasonably be expected to have a Company Material Adverse Effect. No
event has occurred that, with notice or lapse of time or both, would constitute such a breach or default pursuant to any Material Contract
by the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any other party thereto, except for such breaches and
defaults that would not reasonably be expected to have, a Company Material Adverse Effect. The Company and/or the applicable Subsidiary
of the Company and, to the Knowledge of the Company, each other party thereto, has performed all obligations required to be performed
by it under each Material Contract, except where such nonperformance has not had, or would not reasonably be expected to have a Company
Material Adverse Effect.

(c)            Government
Contracts. As of the date of this Agreement, there are no Government Contracts with respect to which the Company or any of its Subsidiaries
has any outstanding liabilities or obligations, except as would not reasonably be expected to be material to the Company and its Subsidiaries,
taken as a whole. As of the date of this Agreement, there are no disputes or Legal Proceedings pending or, to the Knowledge of the Company,
threatened against or affecting the Company or any of its Subsidiaries in connection with any Government Contract. As of the date of
this Agreement, there are no Government Proposals or teaming or other agreements that would obligate the Company or any of its Subsidiary
to submit Government Proposals.

3.15         Customers
and Suppliers. Section 3.15 of the Company Disclosure Letter sets forth true, correct and complete lists of (a) the
five (5) largest customers of the Company and its Subsidiaries based on the aggregate payments received or expected as of the date
hereof to be received by the Company and its Subsidiaries, taken as a whole, for the fiscal year ended December 31, 2022 (the “Material
Customers”) and (b) the ten (10) largest suppliers of the Company and its Subsidiaries based on aggregate payments
made or expected to be made as of the date hereof by the Company and its Subsidiaries, taken as a whole, for the fiscal year ended December 31,
2022 (the “Material Suppliers”). To the Knowledge of the Company, and, as of the date hereof, no Material Customer
or Material Supplier has terminated, or threatened in writing to terminate, its relationship with the Company or its Subsidiaries.

3.16          Property.

(a)            Owned
Real Property. Neither the Company nor any Subsidiary owns any real property.

(b)            Leased
Real Property. Section 3.16(b) of the Company Disclosure Letter contains a true, correct and complete list, as of
the date of this Agreement, of all of the existing leases, subleases, licenses or other agreements pursuant to which the Company or any
of its Subsidiaries uses or occupies, or has the right to use or occupy, any real property (such property, the “Leased Real
Property,” and each such lease, sublease, license or other agreement, a “Lease”) for which annual base rent
exceeds $500,000. With respect to each Lease and except as would not reasonably be expected to have, a Company Material Adverse Effect,
(i) the Company or one of its Subsidiaries has not collaterally assigned or granted any other security interest in such Lease or
any interest therein; and (ii) there are no Liens (other than Permitted Liens) on the estate or interest created by such Lease.
The Company or one of its Subsidiaries has valid leasehold estates in the Leased Real Property, free and clear of all Liens (other than
Permitted Liens). To the Knowledge of the Company, neither the Company nor any of its Subsidiaries is in material breach of or default
pursuant to any Lease. There are no subleases, licenses or similar agreements (each, a “Sublease”) granting to any
Person, other than the Company or any of its Subsidiaries, any right to use or occupy the Leased Real Property for which annual base
rent exceeds $500,000.

(c)            Equipment
and Other Tangible Property. Except as would not reasonably be expected to have a Company
Material Adverse Effect, the Company or one of its Subsidiaries has good title to, or has valid leasehold interests in or valid rights
under Contract to use, all machinery, equipment and other tangible property that are material to the respective businesses of the Company
and its Subsidiaries free and clear of all Liens (other than Permitted Liens).

3.17          Environmental
Matters. The Company and each of its Subsidiaries is and since December 31, 2019 has been in compliance with all Environmental
Laws applicable to the Company and its Subsidiaries or to the conduct of the business or operations of the Company and its Subsidiaries
(which compliance includes the possession of, and compliance with, all material permits required under Environmental Law for the operation
of the Company and its Subsidiaries), except for any such non-compliance that would not reasonably be expected to be material to the
Company and its Subsidiaries, taken as a whole. Other than matters that have been resolved, neither the Company nor any of its Subsidiaries
has received any written notice from any Governmental Authority or other Person alleging that the Company or any Subsidiary has violated
or has any liability under any Environmental Law (the substance of which has not been resolved). Neither the Company nor any of its Subsidiaries,
or, to the Knowledge of the Company, any third party, has released or disposed of any Hazardous Substances on, into, or from the Leased
Real Property or any other real property currently or formerly owned, leased, or operated by the Company or any Subsidiary, in any case
in a manner that would reasonably be expected to result in liability for the Company under Environmental Law, except for any such release
or disposition that would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. There are
no Legal Proceedings pending or, to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries
(i) alleging the noncompliance by the Company or any of its Subsidiaries with any Environmental Law; or (ii) seeking to impose
any financial responsibility for any investigation, cleanup, removal or remediation pursuant to any Environmental Law, except for any
such Legal Proceedings that that would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole.
The Company has made available to Parent copies of all material environmental assessments, reports or other similar studies in the Company’s
possession, that relate to the compliance of the Company or its Subsidiaries with Environmental Law, or to the environmental condition
of the Leased Real Property or any other real property currently or formerly owned, leased or operated by the Company.

3.18          Intellectual
Property; Privacy Matters.

(a)            Section 3.18(a) of
the Company Disclosure Letter sets forth a list as of the date of this Agreement of all Company Owned Intellectual Property that consists
of (i) issued Patents and Patent applications; (ii) registered Marks and applications to register Marks; (iii) all registered
Copyrights and applications to register Copyrights; and (iv) all domain name registrations and social media accounts and handles
(“Company Registered Intellectual Property”). The Company has maintained all Company Registered Intellectual Property
in the ordinary course consistent with reasonable business practices. The Company and/or one of its Subsidiaries is the sole and exclusive
owner of all rights, title and interests in and to the Company Registered Intellectual Property, free and clear of any Liens other than
Permitted Liens. All registrations of the foregoing are subsisting, and to the Knowledge of the Company, valid, and enforceable, in each
case, except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect.

(b)            To
the Knowledge of the Company, the Company or one of its Subsidiaries of the Company owns, is licensed to use or otherwise has the right
to use and, as of the Closing, will have the right to use all Intellectual Property that is necessary or used in the business of the
Company and its Subsidiaries in the manner as such Intellectual Property is used in the conduct of the business of the Company and its
Subsidiaries as currently conducted.

(c)            As
of the date of this Agreement, to the Knowledge of the Company, neither the Company nor any of its Subsidiaries has received any notice,
claim or demand by any Person (i) alleging infringement, misappropriation or other violation by the Company or any of its Subsidiaries
of any Intellectual Property rights of such Person or alleging that the exploitation of a Company Product or practice of any Company
Owned Intellectual Property or Intellectual Property used or held for use by the Company or its Subsidiaries in the business of the Company
or its Subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property rights of such Person or (ii) challenging
the ownership, validity or enforceability of any Company Owned Intellectual Property. Neither the Company nor any of its Subsidiaries
has brought any claim or sent any notice alleging any infringement, misappropriation or violation of any Company Owned Intellectual Property
or Intellectual Property used or held for use by the Company or its Subsidiaries in the business of the Company or its Subsidiaries and,
to the Knowledge of the Company, no Person is infringing, misappropriating or otherwise violating any Company Owned Intellectual Property
or Intellectual Property used or held for use by the Company or its Subsidiaries, in each case, that is material to the business of the
Company and its Subsidiaries when taken as a whole.

(d)            To
the Knowledge of the Company, (i) neither the practice of the business of the Company or its Subsidiaries, (ii) the exploitation
of any Company Product nor (iii) the practice of any Company Owned Intellectual Property or Intellectual Property used or held for
use by the Company or its Subsidiaries, in each case under this clause (iii) that is material to the business of the Company and
its Subsidiaries, infringes, misappropriates or otherwise violates any Intellectual Property rights of any Person. No item of Company
Registered Intellectual Property that is material to the business of the Company and its Subsidiaries when taken as a whole as presently
conducted on the date hereof has been or is involved in any Legal Proceeding, including any interference, reissue, reexamination, opposition,
invalidation or cancellation proceeding, and to the Knowledge of the Company, no such Legal Proceeding is threatened.

(e)            To
the Knowledge of the Company, all current and former employees, consultants and independent contractors of the Company and its Subsidiaries,
who conceived or developed any material Intellectual Property on behalf of the Company or its Subsidiaries have executed and delivered
to the Company an enforceable written agreement irrevocably assigning to the Company all of such Person’s right, title and interest
in and to such Intellectual Property. To the Knowledge of the Company, no Person has violated any term of such agreement and there is
no threatened claim by any Person, including any founder, or former or current employee or contractor of the Company or its Subsidiaries,
asserting that such founder, employee or independent contractor has any ownership or other right or interest in any such Intellectual
Property, in each case, in a manner that would be material to the business of the Company and its Subsidiaries when taken as a whole.

(f)             No
funding or facilities of a university, college, other educational institution, Governmental Authority or research center was used in
the development of any Company Owned Intellectual Property that is material to the business of the Company and its Subsidiaries when
taken as a whole and no university, college, other educational institution, Governmental Authority or research center has any right to,
or right to royalties for, or right to impose any requirement on the manufacture or commercialization of any product incorporating, any
Company Owned Intellectual Property. Except as would not reasonably be expected to have a Company Material Adverse Effect, the Company
and its Subsidiaries have complied with any and all obligations to the extent applicable pursuant to the Bayh-Dole Act, 35 U.S.C. §200–212,
with respect to any Patents that are part of the Company Registered Intellectual Property and are practiced by a Company Product.

(g)            The
Company and its Subsidiaries have taken reasonable steps to protect and maintain the secrecy of all material Trade Secrets included in
the Company Owned Intellectual Property or otherwise possessed by the Company or its Subsidiaries on behalf of third parties.

(h)            Except
as would not reasonably be expected to have a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has used
any Public Software or other software, software development toolkits, databases, libraries, scripts, or other, similar modules of software
that are subject to “open source” or similar license terms in a manner that subjects any Company Software to any copy-left
license, that requires or purports to require the Company to grant any license with respect to any Trade Secret of the Company, that
requires any Trade Secret of the Company to be disclosed or distributed in source code form, or licensed for the purpose of making derivative
works. Except as would not reasonably be expected to have a Company Material Adverse Effect, the Company is or will be in compliance
with all applicable Public Software license agreements, and similar licenses, including with respect to notice and attribution requirements
under such agreements.

(i)             Except
as would not reasonably be expected to have a Company Material Adverse Effect, (i) neither the Company nor its Subsidiaries have
disclosed any source code for Company Software that is not Public Software to third parties, except for employees and independent contractors
pursuant to written confidentiality terms that reasonably protect the rights in such Software; and (ii) no Company Software has
been placed in escrow or is subject to an obligation to be placed into escrow whereby a third party has access to or the right to access
the source code for the Company Software due to the consummation of the transactions contemplated by this Agreement.

(j)             Except
as would not reasonably be expected to have a Company Material Adverse Effect, the Company Software does not contain any Contaminants
and the Company and its Subsidiaries have taken customary measures to protect in all respects the Systems used in connection with the
business of the Company (“IT Systems”), including from Contaminants. Except as would not reasonably be expected to
be material to the Company and its Subsidiaries, taken as a whole, the Company and its Subsidiaries own, lease, license or otherwise
have the right to use the IT Systems and the IT Systems are reasonably adequate to conduct the business of the Company and its Subsidiaries
as currently conducted. Except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole,
the Company and its Subsidiaries have implemented and maintain organizational, administrative, physical and technical safeguards that
are commercially reasonably necessary to: (i) protect the confidentiality, integrity, operation and security of the IT Systems (and
all information and transactions stored or contained therein or transmitted thereby) against any unauthorized use, access, interruption,
modification, corruption or vulnerability; (ii) defend the IT Systems against denial of service attacks, distributed denial of service
attacks, hacking attempts and like attacks and activities by any other Person; and (iii) maintain the continued operation of IT
Systems, including deployment of commercially reasonably security, maintenance, disaster recovery, redundancy, backup, archiving and
virus or malicious device scanning/protection measures.

(k)            Except
as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, the Company and its Subsidiaries
(i) comply with applicable Privacy Obligations; (ii) adopted and published complete and accurate privacy notices and policies,
and are in compliance with those notices and policies; and (iii) have not discovered or been notified of any Security Breach.

(l)             The
Company and its Subsidiaries have implemented and maintained a written information security program comprising reasonable administrative,
physical, and technical safeguards that are consistent with the Company’s Privacy Obligations.

(m)           Except
as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, the Company and its Subsidiaries
have contractually obligated all third party service providers, outsourcers, processors, or other third parties Processing Sensitive
Data, in each case on behalf of the Company, to terms that comply with applicable Privacy Obligations.

3.19          Tax
Matters.

(a)            the
Company and each of its Subsidiaries have (i) timely filed all income and other material Tax Returns required to be filed by any
of them; and (ii) paid, or have adequately reserved or accrued (in accordance with GAAP) for the payment of, all income and other
material Taxes that are required to be paid;

(b)            the
most recent financial statements contained in the Company SEC Reports reflect an adequate reserve (in accordance with GAAP) for all Taxes
accrued but not then payable by the Company and its Subsidiaries through the date of such financial statements;

(c)            neither
the Company nor any of its Subsidiaries has executed or is the beneficiary of any waiver, except in connection with any ongoing Tax examination,
of any statute of limitations on, or extended the period for the assessment or collection of, any Tax, in each case that has not since
expired (other than pursuant to automatic extensions of time to file);

(d)            no
material audits or other examinations with respect to Taxes of the Company or any of its Subsidiaries are presently in progress or have
been asserted or proposed in writing;

(e)            neither
the Company nor any of its Subsidiaries has engaged in a “listed transaction” as set forth in Treasury Regulation §
1.6011-4(b)(2);

(f)             neither
the Company nor any of its Subsidiaries (i) is a party to or bound by, or currently has any material liability pursuant to, any
Tax sharing, allocation or indemnification agreement or obligation, other than any such agreement or obligation (x) entered into
in the ordinary course of business the primary purpose of which is unrelated to Taxes or (y) solely among the Company and its Subsidiaries;
or (ii) has any material liability for the Taxes of any Person other than the Company and its Subsidiaries pursuant to Treasury
Regulation § 1.1502-6 (or any similar provision of state, local or non-United States Law), as a transferee or successor, or otherwise
by operation of Law; and

(g)            neither
the Company nor any of its Subsidiaries has within the last two (2) years distributed stock of another person, or has had its stock
distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Section 355
or Section 361 of the Code.

3.20          Employee
Plans.

(a)            Employee
Plans. Section 3.20(a) of the Company Disclosure Letter contains a true and complete list of all material Employee
Plans. For purposes of this Agreement, “Employee Plan” means each (i) “employee benefit plan” (as
defined in Section 3(3) of ERISA); and (ii) each employment, individual independent contractor, bonus, commission, incentive,
stock option, stock purchase, restricted stock, stock appreciation, phantom equity, other equity or equity-based, benefit, incentive
compensation, profit sharing, savings, retirement, pension, supplemental retirement, profit sharing, employee loan, health, dental, vision,
life insurance, disability, insurance, paid time off, vacation, cafeteria, deferred compensation, severance, termination, retention,
change of control and each other fringe, welfare or other employee benefit plan, program, agreement, Contract, policy or arrangement,
in each case, whether or not subject to ERISA and whether written or unwritten, that is maintained, sponsored, contributed to, or required
to be contributed to for the benefit of any current or former employee, officer, director or individual independent contractor of the
Company, any of its Subsidiaries or any other trade or business (whether or not incorporated) that would be treated as a single employer
with the Company or any of its Subsidiaries pursuant to Section 414 of the Code (an “ERISA Affiliate”) or their
dependents or beneficiaries, or with respect to which the Company or any of its Subsidiaries has any liability, contingent or otherwise,
or to which the Company or any of its Subsidiaries is a party. With respect to each material Employee Plan, to the extent applicable,
the Company has made available to Parent a copy of (A) the current plan documents and all amendments thereto (or, if the plan has
not been reduced to writing, a written summary of the material terms) and the most recent summary plan descriptions and material modifications
thereto; (B) any related trust agreements, insurance Contracts, insurance policies or other documents of any funding arrangements;
(C) the most recent annual report on Form 5500 (with schedules and attachments); (D) the most recent financial statements
and actuarial report; (E) the most recent determination, opinion or advisory letter received from the IRS; (F) the most recent
results of any discrimination testing; (G) the Forms 1094-C and a representative sample of Forms 1095-C for 2015 to 2021 for each
employing entity during such period; and (H) any notices or other correspondence (other than routine non-material correspondence)
to or from the IRS or any office or representative of the United States Department of Labor or any other Governmental Authority within
the past six (6) years.

(b)            Absence
of Certain Plans. Neither the Company nor any of its ERISA Affiliates maintains, sponsors, participates in, contributes to or is
required to contributed to or has, at any time during the past six years, maintained, sponsored or participated in, or contributed to,
or been required to contribute to (i) a “multiemployer plan” (as defined in Section 3(37) or 4001(a)(3) of
ERISA); (ii) a “multiple employer plan” (as defined in Section 4063 or Section 4064 of ERISA); (iii) a
plan that is subject to Section 302 of Title I of ERISA, Section 412 of the Code or Title IV of ERISA; or (iv) any “multiple
employer welfare arrangement” within the meaning of Section 3(40) of ERISA, and neither the Company nor any of its ERISA Affiliates
could reasonably be expected to have any liability (contingent or otherwise) with respect to any such plans.

(c)            Compliance.
Each Employee Plan has been established, maintained, funded, operated and administered in all material respects in accordance with its
terms and with all applicable Law, including the applicable provisions of ERISA and the Code. All contributions, premiums or payments
required to be made with respect to each Employee Plan have been made in all material respects on or before their due dates (including
any extensions) and within the applicable time required by the Employee Plan and applicable Law.

(d)            Employee
Plan Legal Proceedings. There are no material Legal Proceedings pending or, to the Knowledge of the Company, threatened on behalf
of, against, or with respect to any Employee Plan, the assets of any trust pursuant to any Employee Plan, or the plan sponsor, plan administrator
or any fiduciary or any Employee Plan with respect to the administration or operation of such plans, other than routine claims for benefits,
and to the Knowledge of the Company, no fact or circumstance exists that would be reasonably likely to give rise to any such Legal Proceeding.
No Employee Plan is or has been within the past six (6) years, the subject of an application or filing under a government sponsored
amnesty, voluntary compliance, or similar program, or been the subject of any self-correction under any such program. Each Employee Plan
that is intended to be qualified under Section 401(a) of the Code has received a determination or opinion letter from the IRS
that it is so qualified and each related trust that is intended to be exempt from federal income taxation under Section 501(a) of
the Code has received a determination or opinion letter from the IRS that it is so exempt and, to the Knowledge of the Company, no fact
or event has occurred since the date of such letter or letters from the IRS that would reasonably be expected to adversely affect the
qualified status of any such Employee Plan or the exempt status of any such trust or otherwise result in material liability to the Company
or any of its Subsidiaries.

(e)            No
Prohibited Transactions. None of the Company, any of its Subsidiaries, or, to the Knowledge of the Company, any of their respective
directors, officers, employees or agents has, with respect to any Employee Plan, engaged in or been a party to any non-exempt “prohibited
transaction” (as defined in Section 4975 of the Code or Section 406 of ERISA) that could reasonably be expected to result
in the imposition of a material penalty assessed pursuant to Section 502(i) of ERISA or a material Tax imposed by Section 4975
of the Code, in each case applicable to the Company, any of its Subsidiaries or any Employee Plan.

(f)             No
Welfare Benefit Plan. No Employee Plan provides, and neither the Company nor any of its Subsidiaries has an obligation to provide,
post-termination or retiree life insurance, health or other welfare benefits to any person, except as may be required by Section 4980B
of the Code or any similar Law at the participant’s sole expense.

(g)            Section 280G.
No payment or benefit that will be made by the Company or any ERISA Affiliate in connection with the transactions contemplated by this
Agreement (whether alone or in combination with any other event) will be characterized as a parachute payment within the meaning of Section 280G
of the Code.

(h)            No
Gross-Ups. The Company is not a party to nor does it have any agreement to compensate any Person for excise Taxes payable pursuant
to Section 4999 of the Code or for additional Taxes payable pursuant to Section 409A(a)(1)(B) of the Code.

(i)             Transaction
Payments; Acceleration. Neither the execution and delivery of this Agreement nor the consummation of the transactions will (whether
alone or in combination with any other event), (i) result in any payment, compensation or benefits becoming due or an increase in
any such payment, compensation or benefits due to any current or former employee, officer, director or individual independent contractor
of the Company or its Subsidiaries, (ii) increase any payments or benefits otherwise payable under any Employee Plan, (iii) require
a contribution or funding by the Company or any of its Subsidiaries to an Employee Plan or the transfer or setting aside of assets to
fund any benefits under an Employee Plan, (iv) result in any forgiveness of indebtedness of any current or former employee, officer,
director or individual independent contractor of the Company or its Subsidiaries, (v) limit or restrict the right to merge, amend,
terminate or transfer the assets of any Employee Plan following the Effective Time, or (vi) result in any acceleration of the time
of payment, funding or vesting of any such benefits for any current or former employee, officer, director or individual independent contractor
of the Company or its Subsidiaries.

(j)             Non-U.S.
Employee Plans. With respect to each Employee Plan that is mandated by a government other than the United States, subject to the
Laws of a jurisdiction outside of the United States or maintained for the benefit of any current or former employee, officer, director
or individual independent contractor who performs services for the Company or any of its Subsidiaries outside of the United States (each,
a “Non-U.S. Employee Plan”), such Non-U.S. Employee Plan (i) has been maintained and operated in all material
respects in accordance with the applicable plan document and all applicable Laws and other requirements, (ii) if required to be
funded, book-reserved or secured by an insurance policy, is funded, book-reserved, or secured by such an insurance policy, as applicable,
based on reasonable and appropriate actuarial assumptions in accordance with applicable accounting principles and applicable Laws, and
(iii) if required to be registered or intended to qualify for special tax treatment, satisfies all registration requirements or
other requirements for such treatment. No Non-U.S. Employee Plan provides for benefits that exceed the statutory minimum benefits required
to be provided by the Company or any of its Subsidiaries to such Person by the applicable jurisdiction outside of the United States.
There is no Non-U.S. Employee Plan in the nature of a defined benefit plan or multiemployer plan.

3.21          Labor
Matters.

(a)            Union
Activities. (i) No employee of the Company or any of its Subsidiaries is represented by a Union; (ii) neither the Company
nor any of its Subsidiaries is party to, or otherwise subject to, any collective bargaining agreement, labor union contract, trade union
agreement or other Contract with a Union (each, a “Collective Bargaining Agreement”); (iii) to the Knowledge
of the Company, there are, and for the past three (3) years, have been no activities or proceedings of any Union to organize any
employees of the Company or any of its Subsidiaries with regard to their employment with the Company or any of its Subsidiaries; (iv) no
Collective Bargaining Agreement is currently being negotiated by the Company or any of its Subsidiaries; (v) there are no pending
or, to the Knowledge of the Company, threatened organized labor disruptions or activities (including any strike, lockout, slowdown, or
work stoppage, demand or petition for recognition, labor organizing effort or drive, handbilling, or picketing) against or affecting
the Company or any of its Subsidiaries, and there have been no such disruptions or activities for the past three years; and (vi) there
are and have been no Legal Proceedings pending or, to the Knowledge of the Company, threatened by or before any Governmental Authority
against or affecting the Company or any of its Subsidiaries concerning employment-related matters (including any labor grievances or
unfair labor practice charges) or brought by or on behalf of any current or former applicant, employee or independent contractor of the
Company or any of its Subsidiaries in the past four years.

(b)            Employment
Law Compliance. Since December 31, 2019, the Company and its Subsidiaries have complied with all applicable Laws with respect
to employment and employment practices and terms and conditions of employment (including applicable Laws regarding wage and hour requirements,
the classification and compensation of employees and independent contractors, minimum wage, overtime, meal and rest breaks, vacation
time, sick leave and work-related expense reimbursement, child labor, withholdings and deductions, background checks and drug testing,
immigration status, pay equity, discrimination, harassment and retaliation in employment, disability rights, family and medical leave,
employee occupational health and safety (including any guidance published by any Governmental Authority related to COVID-19), workers’
compensation, plant closings and mass layoffs and collective bargaining), except for such noncompliance that would not reasonably be
expected to be material to the Company and its Subsidiaries, taken as a whole.

(c)            Employment
Matters. True and complete information as to all persons who are employees of the Company and its Subsidiaries as of the date hereof
has been provided to Parent including, for each such individual, the following: (i) name; (ii) title or position (including
whether full or part time and whether treated as an employee or independent contractor); (iii) employing entity; (iv) hire
date; (v) work location; (vi) current annual base compensation rate or hourly rate, as applicable; (vii) classification
as exempt or non-exempt; (viii) target annual commission, bonus or other incentive-based compensation; (ix) leave status (and,
if on leave, the anticipated return date, if known); and (x) visa status (if applicable). No employee of the Company or any of its
Subsidiaries at the level of Vice President or above or group of employees of the Company or any of its Subsidiaries, to the Knowledge
of the Company, has given notice that such employee or group of employees intends to terminate employment with the Company or any of
its Subsidiaries prior to the Closing or during the twelve (12)-month period following the Closing. No executive officer or employee
of the Company or any of its Subsidiaries at the level of Vice President and above is employed under a non-immigrant work visa or other
work authorization that is limited in duration. To the Knowledge of the Company, no employee of the Company or any of its Subsidiaries
at the level of Vice President and above has been the subject of any sexual harassment, sexual assault, sexual discrimination or sexual
misconduct allegations during his or her tenure at the Company or any of its Subsidiaries.

3.22          Regulatory
Matters.

(a)            Since
December 31, 2019, the Company and its Subsidiaries have been in compliance with all Laws applicable to the research, development,
testing, manufacture, marketing, distribution or promotion of the Company Products, including all applicable Laws administered and enforced
by the U.S. Food and Drug Administration and the U.S. Department of Agriculture, except for such non-compliance that would not reasonably
be expected to be material to the Company and its Subsidiaries, taken as a whole.

(b)            The
Company and its Subsidiaries (i) do not and have never conducted, overseen, or been engaged in any animal or human subjects research
activities; and (ii) do not and have not generated, used, accessed, or otherwise processed any data originating from any animal
or human research subject in the conduct of its/their business or operations.

(c)            Except
for such non-compliance that would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, (i) any
preclinical or clinical studies, trials, research, and/or other similar testing being conducted, overseen, or otherwise supported by
or on behalf of the Company and/or any of its Subsidiaries are being conducted, and since December 31, 2019 have been conducted,
in compliance with applicable Laws; (ii) since December 31, 2019, no studies conducted by or on behalf of the Company or any
of its Subsidiaries have been placed on clinical hold or terminated or suspended prior to completion; and (iii) since December 31,
2019, neither the Company nor any of its Subsidiaries has received any notice, correspondence or other communication from any Governmental
Authority, any institutional review board (as defined in 21 C.F.R. Part 50.3(i)) or similar ethical body, or investigator alleging
a lack of compliance with any Laws or requiring the termination, suspension or modification of any ongoing studies conducted by or on
behalf of the Company or any of its Subsidiaries.

3.23          Compliance
with Laws.

(a)            Compliance
with Laws. The Company and each of its Subsidiaries is in, and has since December 31, 2019 been in, compliance with all Laws
that are applicable to the Company and its Subsidiaries or to the conduct of the business or operations of the Company and its Subsidiaries,
in each case, except for any such non-compliance that would not reasonably be expected to be material to the Company and its Subsidiaries,
taken as a whole.

(b)            Governmental
Authorizations. Except for as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole,
(i) The Company and its Subsidiaries have all Governmental Authorizations necessary for the ownership and operation of its business
as presently conducted, including all such Governmental Authorizations required by Governmental Authorities engaged in the regulation
of drugs, pharmaceuticals or biohazardous materials, and each such Governmental Authorization is in full force and effect; (ii) the
Company and its Subsidiaries are, and since December 31, 2019 have been, in compliance with the terms of all Governmental Authorizations
necessary for the ownership and operation of its businesses; and (iii) since December 31, 2019 to the date of this Agreement,
neither the Company nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any conflict with
or breach of any such Governmental Authorization, the substance of which has not been resolved.

(i)            To
the Knowledge of the Company, for the past five (5) years, none of the Company, any of its Subsidiaries or their respective directors
or officers while acting on behalf of the Company or any of its Subsidiaries or any employee or agent acting on behalf of the Company
or any of its Subsidiaries has corruptly offered or given anything of value to: (A) any official or employee of a Governmental Authority,
any political party or official thereof or any candidate for political office or (B) any other Person, in any such case while knowing
or being aware of a high probability that all or a portion of such money or thing of value will be offered, given or promised, directly
or indirectly, to any official or employee of a Governmental Authority or candidate for political office, in each case in violation of
applicable Anti-Bribery Laws in any material respect.

(ii)           To
the Knowledge of the Company, as of the date hereof, there are no current or pending internal investigations, third-party investigations
(including by any Governmental Authority) or internal or external audits that address any material allegations or information concerning
possible violations of applicable Anti-Bribery Laws or Anti-Money Laundering Laws related to the Company or any of its Subsidiaries in
any material respect. To the Knowledge of the Company, for the past five years, the Company, its Subsidiaries and their respective directors,
officers, and agents while acting on behalf of the Company or any of its Subsidiaries have been in compliance with all applicable Anti-Money
Laundering Laws in all material respects.

(d)            Sanctions
and International Trade Compliance.

(i)            To
the Knowledge of the Company, the Company, its Subsidiaries and their respective directors, officers, and agents while acting on behalf
of the Company (A) are, and have been for the past five years, in compliance in all material respects with all applicable International
Trade Laws and Sanctions Laws, and (B) have obtained all required licenses, consents, notices, waivers, approvals, orders, registrations,
declarations, or other authorizations from, and have made any material filings with, any applicable Governmental Authority for the import,
export, re-export, deemed export, deemed re-export, or transfer required under applicable International Trade Laws and Sanctions Laws
(the “Export Approvals”). There are no pending or, to the Knowledge of the Company, threatened, claims, complaints,
charges, investigations, voluntary disclosures or Legal Proceedings against the Company or any of the Company’s Subsidiaries concerning
possible violations of applicable International Trade Laws or Sanctions Laws, or possible noncompliance with required Export Approvals.

(ii)            None
of the Company or any of its Subsidiaries or any of their respective directors or officers or, to the Knowledge of the Company, any of
the Company’s or any of its Subsidiaries’ respective employees, agents, representatives or other Persons acting on behalf
of the Company or any of its Subsidiaries (A) is, or has been during the past five years, a Sanctioned Person, or (B) has transacted
business, related to the Company or any of its Subsidiaries, directly or knowingly indirectly with any Sanctioned Person or in any Sanctioned
Country in violation of applicable Sanctions Laws.

3.24          Legal
Proceedings; Orders.

(a)            No
Legal Proceedings. As of the date of this Agreement, except as would not reasonably be expected to be material to the Company and
its Subsidiaries, taken as a whole, there are no Legal Proceedings pending or, to the Knowledge of the Company, threatened against or
affecting the Company or any of its Subsidiaries, any of their respective properties or any of their respective officers or directors.

(b)            No
Orders. Except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, neither
the Company nor any of its Subsidiaries is subject to any order of any kind or nature.

3.25          Insurance.
As of the date of this Agreement, the Company and its Subsidiaries have all material policies of insurance covering the Company and its
Subsidiaries and any of their respective employees, properties or assets, including policies of life, property, fire, workers’
compensation, products liability, directors’ and officers’ liability and other casualty and liability insurance, that is
customarily carried by Persons conducting business similar to that of the Company and its Subsidiaries. As of the date of this Agreement,
all such insurance policies are in full force and effect, no notice of cancellation has been received and there is no existing default
or event that, with notice or lapse of time or both, would constitute a default by any insured thereunder, except for such defaults that
have not had, and would not reasonably be expected to have a Company Material Adverse Effect.

3.26          Information
Supplied. None of the information supplied or to be supplied by the Company for inclusion or incorporation by reference in (a) the
Registration Statement (or any amendment or supplement thereto) will, at the time the Registration Statement (or any amendment or supplement
thereto) is filed with the SEC or at the time it becomes effective under the Securities Act, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, at the time
and in light of the circumstances under which they were made, not false or misleading, and (b) the Proxy Statement/Prospectus (in
each case, including any amendments or supplements thereto) will, at the date it is first published, mailed or given to the Company Stockholders,
on the date of any amendment or supplement thereto or at the time of the Company Stockholder Meeting, contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they are made, not misleading. Notwithstanding anything to the contrary in this Agreement,
no representation or warranty is made by the Company with respect to any statements or disclosures about Parent or Merger Sub in the
Proxy Statement/Prospectus or the Registration Statement that are based on statements or information supplied, drafted or reviewed by
Parent or Merger Sub (or their respective Representatives) (including by incorporation by reference) expressly for inclusion or incorporation
by reference in the Proxy Statement/Prospectus or the Registration Statement.

3.27          Related
Person Transactions. Except for compensation or other employment arrangements in the ordinary course of business, there are no Contracts,
transactions, arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any Affiliate (including
any director or officer) thereof, but not including any wholly-owned Subsidiary of the Company, on the other hand, that would be required
to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC in the Company’s Form 10-K or proxy statement
pertaining to an annual meeting of stockholders.

3.28          No
Other Representations or Warranties.

(a)            No
Other Representations and Warranties of the Company. Except for the representations and warranties expressly made by the Company
in this Article III or in any certificate delivered pursuant to this Agreement, neither the Company nor any other Person
makes any representation or warranty of any kind whatsoever, express or implied, at Law or in equity, with respect to the Company, any
of its Subsidiaries or their respective business, operations, assets, liabilities, condition (financial or otherwise) or the transactions
contemplated hereby, notwithstanding any other statements made or the delivery or disclosure to the Parent and Merger Sub or any of their
respective Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing.

(b)            No
Other Representations and Warranties of Parent and Merger Sub. The Company, on behalf of itself and its Subsidiaries, acknowledges
and agrees that, except for the representations and warranties expressly set forth in Article IV:

(i)            Neither
Parent nor any of its Subsidiaries (or any other Person) makes, or has made, any representation or warranty relating to the Company,
its Subsidiaries or any of their businesses, operations or otherwise in connection with this Agreement or the Merger;

(ii)            no
Person has been authorized by Parent, any of its Subsidiaries or any of its or their respective Representatives to make any representation
or warranty relating to Parent, its Subsidiaries or any of their businesses or operations or otherwise in connection with this Agreement
or the Merger, and if made, such representation or warranty must not be relied upon by the Company or any of its Representatives as having
been authorized by Parent, any of its Subsidiaries or any of its or their respective Representatives (or any other Person); and

(iii)          the
representations and warranties made by Parent and Merger Sub in this Agreement are in lieu of and are exclusive of all other representations
and warranties, including any express or implied or as to merchantability or fitness for a particular purpose, and Parent and Merger
Sub hereby disclaim any other or implied representations or warranties, notwithstanding the delivery or disclosure to the Company or
any of their respective Representatives of any documentation or other information (including any financial information, supplemental
data or financial projections or other forward-looking statements).

(c)            No
Reliance. The Company, on behalf of itself and its Subsidiaries, acknowledges and agrees that, (x) it has had reasonable access
to, and has been afforded the opportunity to request and review, the books and records of Parent and its Subsidiaries (including in the
possession of the Parent’s Representatives) and (y) except for the representations and warranties expressly set forth in Article IV,
it is not acting (including, as applicable, by entering into this Agreement or consummating the Merger) in reliance on:

(i)            any
representation or warranty, express or implied;

(ii)           any
estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information provided or
addressed to the Company or any of its Representatives, including any materials or information made available in the electronic data
room hosted by or on behalf of Parent in connection with the Merger, in connection with presentations by the Parent’s management
or in any other forum or setting; or

(iii)          the
accuracy or completeness of any other representation, warranty, estimate, projection, prediction, data, financial information, memorandum,
presentation or other materials or information.

Article IV
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

With respect to any Section of
this Article IV, except (a) as disclosed in the reports, statements and other documents filed by Parent with the SEC
or furnished by Parent to the SEC on or after September 17, 2021 and at least one (1) Business Day prior to the date of this
Agreement (excluding any predictive or cautionary disclosures (other than statements of historical fact) contained or referenced therein,
under the captions “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk” or in any
“forward-looking statements” disclaimer) (the “Parent Recent SEC Reports”) (it being agreed and understood
that any matter disclosed in the Parent Recent SEC Reports shall not be deemed disclosed for purposes of Section 4.1, Section 4.2,
Section 4.11, Section 4.15 and the first sentence of Section 4.19), and (b) subject to the terms of
Section 9.13, as set forth in the disclosure letter delivered by Parent to the Company on the date of this Agreement (the
“Parent Disclosure Letter”), Parent and Merger Sub hereby represent and warrant to the Company as follows:

4.1            Organization;
Good Standing; Anti-Takeover Laws.

(a)            Parent.
Each of Parent and its Subsidiaries (i) is duly organized, validly existing and in good standing pursuant to the Laws of its jurisdiction
of organization; and (ii) has the requisite power and authority to conduct its business as it is presently being conducted and to
own, lease or operate its properties and assets, except where the failure to have such power or authority would not reasonably be expected
to have a Parent Material Adverse Effect. Each of Parent and its Subsidiaries is duly qualified to do business and is in good standing
in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary
(with respect to jurisdictions that recognize the concept of good standing), except where the failure to be so qualified or in good standing
would not reasonably be expected to have a Parent Material Adverse Effect.

(b)            Merger
Sub. Merger Sub (i) is a corporation duly organized, validly existing and in good standing pursuant to the DGCL; and (ii) has
the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its
properties and assets.

(c)            Organizational
Documents. Parent has made available to the Company true, correct and complete copies of the Organizational Documents of Parent and
Merger Sub, each as amended to date. None of Parent, Merger Sub or Parent’s “significant subsidiaries” (as such term
is defined in Regulation S-X promulgated by the SEC) is in violation of its Organizational Documents, except for such violations that
have not had, and would not reasonably be expected to have a Parent Material Adverse Effect.

(d)            Anti-Takeover
Laws. There are no Takeover Laws with respect to Parent or Merger Sub applicable to the Merger.

4.2            Power;
Enforceability. Each of Parent and Merger Sub has the requisite power and authority to (a) execute and deliver this Agreement;
(b) perform its covenants and obligations hereunder; and (c) consummate the Merger. The execution and delivery of this Agreement
by each of Parent and Merger Sub, the performance by each of Parent and Merger Sub of its respective covenants and obligations hereunder
and the consummation of the Merger have been duly authorized and approved by all necessary action on the part of each of Parent and Merger
Sub and no additional actions on the part of Parent or Merger Sub are necessary to authorize (i) the execution and delivery of this
Agreement by each of Parent and Merger Sub; (ii) the performance by each of Parent and Merger Sub of its respective covenants and
obligations hereunder; or (iii) the consummation of the Merger. This Agreement has been duly executed and delivered by each of Parent
and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes a legal, valid and binding obligation
of each of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its terms, except as such enforceability
(A) may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating
to creditors’ rights generally; and (B) is subject to general principles of equity.

4.3            Non-Contravention.
The execution and delivery of this Agreement by each of Parent and Merger Sub, the performance by each of Parent and Merger Sub of their
respective covenants and obligations hereunder, and the consummation of the Merger do not (a) violate or conflict with any provision
of the Organizational Documents of Parent or Merger Sub; (b) violate, conflict with, result in the breach of, constitute a default
(or an event that, with notice or lapse of time or both, would become a default) pursuant to, result in the termination of, accelerate
the performance required by, or result in a right of termination or acceleration pursuant to the terms, conditions or provisions of any
material Contract to which Parent or any of its Subsidiaries is a party or by which Parent or any of its Subsidiaries, or any of their
respective properties or assets may be bound; (c) assuming compliance with the matters referred to in Section 4.5, violate
or conflict with any Law or order applicable to Parent, Merger Sub or any other Subsidiary of Parent, or by which any of their respective
properties or assets are bound; or (d) result in the creation of any Lien (other than Permitted Liens) upon any of the properties
or assets of Parent or any of its Subsidiaries, except in the case of each of clauses (b), (c) and (d) for such violations,
conflicts, breaches, defaults, terminations, accelerations or Liens that would not reasonably be expected to have a Parent Material Adverse
Effect.

4.4            Foreign
Persons. Neither Parent nor Merger Sub is a “foreign person” as defined in 31 C.F.R. § 800.224 of the regulations
of the Committee on Foreign Investment in the United States.

4.5            Requisite
Governmental Approvals. No Governmental Authorization is required on the part of Parent or Merger Sub or any of their Subsidiaries
(a) in connection with the execution and delivery of this Agreement by each of Parent and Merger Sub; (b) the performance by
each of Parent and Merger Sub of their respective covenants and obligations pursuant to this Agreement; or (c) the consummation
of the Merger, except for (i) the filing of the Certificate of Merger and related documentation with the Secretary of State of the
State of Delaware and such filings with Governmental Authorities to satisfy the applicable Laws of states in which the Company and its
Subsidiaries are qualified to do business; (ii) such filings and approvals as may be required by any applicable federal or state
securities Laws, including compliance with any applicable requirements of the Exchange Act; (iii) compliance with any applicable
requirements of the HSR Act and any other applicable Antitrust Laws; (iv) compliance with Section 203 of the DGCL and any other
similar applicable Takeover Law; and (v) such other Governmental Authorizations the failure of which to obtain would not reasonably
be expected to have a Parent Material Adverse Effect.

4.6            Compliance
with Laws.

(a)            Compliance
with Laws. Parent and each of its Subsidiaries is in, and has since December 31, 2019 been in, compliance with all Laws that
are applicable to Parent and its Subsidiaries or to the conduct of the business or operations of Parent and its Subsidiaries, in each
case, except for any such non-compliance that would not reasonably be expected to be material to Parent and its Subsidiaries, taken as
a whole.

(b)            Governmental
Authorizations. Except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole, (i) Parent
and its Subsidiaries have all Governmental Authorizations necessary for the ownership and operation of its business as presently conducted,
including all such Governmental Authorizations required by Governmental Authorities engaged in the regulation of drugs, pharmaceuticals
or biohazardous materials, and each such Governmental Authorization is in full force and effect; (ii) Parent and its Subsidiaries
are, and since December 31, 2019 have been, in compliance with the terms of all Governmental Authorizations necessary for the ownership
and operation of its businesses; and (iii) since December 31, 2019 to the date of this Agreement, neither Parent nor any of
its Subsidiaries has received written notice from any Governmental Authority alleging any conflict with or breach of any such Governmental
Authorization, the substance of which has not been resolved.

(i)            To
the Knowledge of Parent, for the past five (5) years, none of Parent, any of its Subsidiaries or their respective directors or officers
while acting on behalf of Parent or any of its Subsidiaries or any employee or agent acting on behalf of Parent or any of its Subsidiaries
has corruptly offered or given anything of value to: (A) any official or employee of a Governmental Authority, any political party
or official thereof or any candidate for political office or (B) any other Person, in any such case while knowing or being aware
of a high probability that all or a portion of such money or thing of value will be offered, given or promised, directly or indirectly,
to any official or employee of a Governmental Authority or candidate for political office, in each case in violation of applicable Anti-Bribery
Laws in any material respect.

(ii)           To
the Knowledge of Parent, as of the date hereof, there are no current or pending internal investigations, third-party investigations (including
by any Governmental Authority) or internal or external audits that address any material allegations or information concerning possible
violations of applicable Anti-Bribery Laws or Anti-Money Laundering Laws related to Parent or any of its Subsidiaries in any material
respect. To the Knowledge of Parent, for the past five years, Parent, its Subsidiaries and their respective directors, officers, and
agents while acting on behalf of Parent or any of its Subsidiaries have been in compliance with all applicable Anti-Money Laundering
Laws in all material respects.

(d)            Sanctions
and International Trade Compliance.

(i)            To
the Knowledge of Parent, Parent and its Subsidiaries (A) are, and have been for the past five years, in compliance in all material
respects with all applicable International Trade Laws and Sanctions Laws, and (B) have obtained all Export Approvals. There are
no pending or, to the Knowledge of Parent, threatened, claims, complaints, charges, investigations, voluntary disclosures or Legal Proceedings
against Parent or any of Parent’s Subsidiaries concerning possible violations of applicable International Trade Laws or Sanctions
Laws, or possible noncompliance with required Export Approvals.

(ii)           None
of Parent or any of its Subsidiaries or any of their respective directors or officers or, to the Knowledge of Parent, any of Parent’s
or any of its Subsidiaries’ respective employees, agents, representatives or other Persons acting on behalf of Parent or any of
its Subsidiaries (A) is, or has been during the past five years, a Sanctioned Person, or (B) has transacted business, related
to Parent or any of its Subsidiaries, directly or knowingly indirectly with any Sanctioned Person or in any Sanctioned Country in violation
of applicable Sanctions Laws.

4.7            Legal
Proceedings; Orders.

(a)            No
Legal Proceedings. As of the date of this Agreement, except as would not reasonably be expected to be material to Parent and its
Subsidiaries, taken as a whole, there are no Legal Proceedings pending or, to the Knowledge of Parent, threatened against Parent or any
of its Subsidiaries, any of their respective properties or assets, or any of their respective officers or directors.

(b)            No
Orders. Except as would not reasonably be expected to be material to Parent and its Subsidiaries, taken as a whole, neither Parent
nor any of its Subsidiaries is subject to any order of any kind or nature.

4.8            Ownership
of Company Common Stock. None of Parent, Merger Sub or, to the Knowledge of Parent, any directors, officers, or controlled Affiliates
of Parent or Merger Sub (a) has owned any shares of Company Common Stock or (b) has been an “interested stockholder”
(as defined in Section 203 of the DGCL) of the Company, in each case during the three (3) years prior to the date of this Agreement.

4.9            Brokers.
There is no financial advisor, investment banker, broker, finder, agent or other similar Person that has been retained by or is authorized
to act on behalf of Parent, Merger Sub or any of their Affiliates who is entitled to any financial advisor’s, investment banking,
brokerage, finder’s or other similar fee or commission in connection with the Merger for which the Company or any of its Subsidiaries
could be liable.

4.10          Ownership
of Merger Sub. Parent or one of its wholly-owned Subsidiaries owns beneficially and of record all of the outstanding capital stock,
and other equity and voting interest in, Merger Sub free and clear of all liens, except for such liens and transfer restrictions of general
applicability as may be provided under the Securities Act or other applicable securities Laws.

4.11          No
Parent Vote or Approval Required. No vote or consent of the holders of any capital stock of, or other equity or voting interest in,
Parent is necessary to approve this Agreement, the Merger or the other transactions contemplated hereby. The vote or consent of Parent,
as the sole stockholder of Merger Sub, is the only vote or consent of the capital stock of, or other equity interest in, Merger Sub necessary
under applicable Law or its Organizational Documents to approve or authorize this Agreement, the Merger and the other transactions contemplated
hereby.

4.12          Availability
of Funds. Parent currently has, and as of any date the Closing could occur Parent will have available funds (including cash, cash
equivalents, available lines of credit or other sources of immediately available funds) sufficient to (a) make all payments contemplated
by this Agreement in connection with the Merger (including the payment of all amounts payable pursuant to Article II in connection
with or as a result of the Merger); and (b) pay all fees and expenses required to be paid at the Closing by the Company, Parent
or Merger Sub in connection with the Merger and the other transactions contemplated hereby.

4.13          Stockholder
and Management Arrangements. As of the date hereof, other than the Voting Agreements, neither Parent or Merger Sub nor any of their
respective Affiliates is a party to any Contract, or has authorized, made or entered into, or committed or agreed to enter into, any
formal or informal arrangements or other understandings (whether or not binding) with any stockholder, director, officer, employee or
other Affiliate of the Company or any of its Subsidiaries (a) relating to (i) this Agreement or the Merger; (ii) the Company
or (iii) the Surviving Corporation or any of its Subsidiaries, businesses or operations (including as to continuing employment)
from and after the Effective Time; or (b) pursuant to which (i) any such holder of shares of Company Common Stock would be
entitled to receive consideration of a different amount or nature than the Merger Consideration in respect of such holder’s shares
of Company Common Stock; (ii) such holder of shares of Company Common Stock has agreed to approve this Agreement or vote against
any Superior Proposal; or (iii) any Person (including any stockholder, director, officer, employee or other Affiliate of the Company)
has agreed to provide, directly or indirectly, equity investment to Parent, Merger Sub or the Company to finance any portion of the Merger.

4.14          No
Other Negotiations. As of the date of this Agreement, none of Parent, Merger Sub or any of their respective Affiliates are involved
in substantive negotiations with respect to or have entered into any agreements with respect to the acquisition of any business that
would reasonably be expected to materially impair or delay the ability of Parent to consummate the transactions contemplated hereby.

4.15          Parent
Capitalization.

(a)            Capital
Stock. The authorized capital stock of Parent consists of (i) 10,500,000,000 shares of Parent Class A Common Stock, (ii) 4,500,000,000
shares of Parent Class B Common Stock, (iii) 800,000,000 shares of Parent Class C Common Stock and (iv) 200,000,000
shares of Parent Preferred Stock. As of 5:00 p.m., New York City time, on July 15, 2022 (such time and date, the “Parent
Capitalization Date”), (A) 1,097,858,130 shares of Parent Class A Common Stock were issued and outstanding; (B) 396,498,686
shares of Parent Class B Common Stock were issued and outstanding; (C) 288,000,000 shares of Parent Class C Common Stock
were issued and outstanding (in each case of (A), (B) and (C), which includes shares underlying Parent restricted stock); (D) no
shares of Parent Preferred Stock were issued and outstanding; and (E) no shares of Parent Class A Common Stock were held by
Parent as treasury shares. All outstanding shares of Parent Common Stock are validly issued, fully paid, nonassessable and free of any
preemptive rights. From the close of business on the Parent Capitalization Date to the date of this Agreement, Parent has not issued
or granted any Parent Common Stock other than pursuant to the exercise of Parent Options and/or the settlement of Parent RSUs, in each
case, granted prior to the date of this Agreement.

(b)            Stock
Reservation. As of the Parent Capitalization Date, Parent has reserved for future issuance shares of Parent Class A Common Stock
and Parent Class B Common Stock as follows: (i) 21,878,554 shares for issuance pursuant to issued and outstanding Parent Options;
(ii) 214,219,535 shares for issuance pursuant to outstanding Parent RSUs; (iii) 207,250,245 shares available for grant under
the Parent Stock Plan; (iv) 36,909,908 shares available for grant under the Parent 2021 Employee Stock Purchase Plan; and (v) 51,824,895
shares for issuance pursuant to outstanding warrants to purchase shares of Parent Class A Common Stock.

(c)            Parent
Securities. Except as set forth in this Section 4.15, as of the Parent Capitalization Date, there were (i) no issued
and outstanding shares of capital stock of, or other equity or voting interest in, Parent; (ii) no outstanding securities of Parent
convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, Parent; (iii) no outstanding
options, warrants or other rights or binding arrangements to acquire from Parent, or that obligate Parent to issue, any capital stock
of, or other equity or voting interest in, or any securities convertible into or exchangeable for shares of capital stock of, or other
equity or voting interest in, Parent; (iv) no obligations of Parent to grant, extend or enter into any subscription, warrant, right,
convertible or exchangeable security, or other similar Contract relating to any capital stock of, or other equity or voting interest
(including any voting debt) in, Parent; (v) no outstanding restricted shares, restricted share units, stock appreciation rights,
profits interests, profit participation, performance shares, contingent value rights, “phantom” stock or similar securities
or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock
of, or other securities or ownership interests in, Parent (the items in clauses (i), (ii), (iii), (iv) and (v), collectively with
Parent Common Stock and Parent Preferred Stock, the “Parent Securities”); (vi) voting trusts, proxies or similar
arrangements or understandings to which Parent is a party or by which Parent is bound with respect to the voting of any shares of capital
stock of, or other equity or voting interest in, Parent; (vii) obligations or binding commitments of any character restricting the
transfer of any shares of capital stock of, or other equity or voting interest in, Parent to which Parent is a party or by which it is
bound; and (viii) no other obligations by Parent to make any payments based on the price or value of any Parent Securities. Parent
is not a party to any Contract that obligates it to repurchase, redeem or otherwise acquire any Parent Securities. There are no accrued
and unpaid dividends with respect to any outstanding shares of Parent Class A Common Stock. Parent does not have a stockholder rights
plan in effect.

(d)            Other
Rights. As of the date of this Agreement, Parent is not a party to any Contract relating to the voting of, requiring registration
of, or granting any preemptive rights, anti-dilutive rights or rights of first refusal or other similar rights with respect to any Parent
Securities. As of the date of this Agreement, there are not any bonds, debentures, notes or other indebtedness of Parent outstanding
having the right to vote (or convertible into, exchangeable for, securities having the right to vote) on any matters on which holders
of Parent Class A Common Stock may vote.

4.16          Parent
SEC Reports. Since September 17, 2021 and through the date of this Agreement, Parent has timely filed with, or furnished to,
the SEC all forms, reports and documents that have been required to be filed or furnished by it pursuant to applicable Laws (the “Parent
SEC Reports”) and, to the Knowledge of Parent and except where such failure would not reasonably be expected to be material
to Parent and its Subsidiaries taken as a whole, from February 23, 2021 through September 16, 2021, Parent timely filed with,
or furnished to, the SEC all forms, reports and documents that have been required to be filed or furnished by it pursuant to applicable
Laws (the “Prior Parent SEC Reports”). Each Parent SEC Report and, to the Knowledge of Parent and except where such
failure would not reasonably be expected to be material to Parent and its Subsidiaries taken as a whole, each Prior Parent SEC Report,
complied, as of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended
or superseded filing), in all material respects with the applicable requirements of the Securities Act or the Exchange Act, as the case
may be, each as in effect on the date that such Parent SEC Report or Prior Parent SEC Report, as applicable, was filed. As of its filing
date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseded filing),
each Parent SEC Report and, to the Knowledge of Parent and except as would not reasonably be expected to be material to Parent and its
Subsidiaries taken as a whole, each Prior Parent SEC Report, did not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. Since September 17, 2021 and, to the Knowledge of Parent and except as would not reasonably be expected to be material
to Parent and its Subsidiaries taken as a whole, from February 23, 2021 through September 16, 2021, Parent has been in compliance
in all material respects with the applicable listing and corporate governance rules and regulations of NYSE. As of the date of this
Agreement, to the Knowledge of Parent, there are no outstanding or unresolved comments received from the SEC staff with respect to the
Parent SEC Reports or, except as would not reasonably be expected to be material to Parent and its Subsidiaries taken as a whole, the
Prior Parent SEC Reports. To the Knowledge of Parent, as of the date of this Agreement, none of the Parent SEC Reports or, except as
would not reasonably be expected to be material to Parent and its Subsidiaries taken as a whole, Prior Parent SEC Reports, is the subject
of ongoing SEC review or investigation. None of Parent’s Subsidiaries is required to file periodic reports with the SEC pursuant
to the Exchange Act.

4.17          Parent
Financial Statements; Internal Controls.

(a)            Parent
Financial Statements. The consolidated financial statements (including any related notes and schedules) of Parent filed with the
Parent SEC Reports (the “Parent Financial Statements”) (i) were prepared in accordance with GAAP (except as may
be indicated in the notes thereto or as otherwise permitted by Form 10-Q with respect to any financial statements filed on Form 10-Q);
(ii) comply as to form in all material respects with applicable accounting requirements and the published rules and regulations
of the SEC with respect thereto; and (iii) fairly present, in all material respects, the consolidated financial position of Parent
and its consolidated Subsidiaries as of the dates thereof and the consolidated results of operations and cash flows for the periods then
ended (subject, in the case of the unaudited financial statements, to normal and recurring year-end adjustments and to any other adjustment
described therein). There are no “off balance sheet arrangements” of Parent that have not been disclosed in the Parent SEC
Reports where the result, purpose or effect of such off balance sheet arrangements is to avoid disclosure of any material transaction
involving, or material liabilities of, Parent or any of its Subsidiaries in the Parent SEC Reports. Since September 17, 2021 and,
to the Knowledge of Parent and except as would not reasonably be expected to be material to Parent and its Subsidiaries taken as a whole,
from February 23, 2021 through September 16, 2021, there has been no material change in Parent’s accounting methods or
principles that would be required to be disclosed in Parent’s financial statements in accordance with GAAP, except as described
in the notes thereto.

(b)            Disclosure
Controls and Procedures. Parent has established and maintains “disclosure controls and procedures” and “internal
control over financial reporting” (in each case as defined pursuant to Rule 13a-15 and Rule 15d-15 promulgated under
the Exchange Act). Parent’s disclosure controls and procedures are reasonably designed to ensure that all (i) material information
required to be disclosed by Parent in the reports and other documents that it files or furnishes pursuant to the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the rules and forms of the SEC; and (ii) such material
information is accumulated and communicated to the Parent’s management as appropriate to allow timely decisions regarding required
disclosure and to make the certifications required pursuant to Section 302 and 906 of the Sarbanes-Oxley Act. Since September 17,
2021, and, to the Knowledge of Parent and except as would not reasonably be expected to be material to Parent and its Subsidiaries taken
as a whole, from February 23, 2021 through September 16, 2021, (A) Parent has been and, as of the date hereof, is an “emerging
growth company” as defined in Section 2(a) of the Securities Act and (B) the principal executive officer and principal
financial officer of Parent have made all certifications required by the Sarbanes-Oxley Act. Neither Parent nor its principal executive
officer or principal financial officer has received notice from any Governmental Authority challenging or questioning the accuracy, completeness,
form or manner of filing of such certifications.

(c)            Internal
Controls. Since January 1, 2022, neither Parent nor, to the Knowledge of Parent, Parent’s independent registered public
accounting firm has identified or been made aware of (i) any significant deficiency or material weakness in the system of internal
control over financial reporting used by Parent and its Subsidiaries that has not been subsequently remediated; or (ii) any fraud
that involves Parent’s management or other employees who have a role in the preparation of financial statements or the internal
control over financial reporting utilized by Parent and its Subsidiaries.

4.18          No
Undisclosed Liabilities. Neither Parent nor any of its Subsidiaries has any liabilities or obligations of any nature (whether accrued,
contingent, absolute, determined, determinable or otherwise), other than liabilities or obligations (a) reflected or otherwise reserved
against in the Audited Parent Balance Sheet or in the consolidated financial statements of Parent and its Subsidiaries (including the
notes thereto) included in the Parent SEC Reports; (b) arising pursuant to this Agreement or incurred in connection with the Merger;
(c) incurred in the ordinary course of business since the date of the Audited Parent Balance Sheet (other than liabilities resulting
from breach of contract, tort, or violation of Law); or (d) that would not reasonably be expected to have a Parent Material Adverse
Effect.

4.19          Absence
of Certain Changes. Since the date of the Audited Parent Balance Sheet through the date of this Agreement, the business of Parent
and its Subsidiaries has been conducted in the ordinary course of business in all material respects. Since the date of the Audited Parent
Balance Sheet through the date of this Agreement, there has not occurred a Parent Material Adverse Effect. Since the date of the Audited
Parent Balance Sheet, through the date of this Agreement, neither Parent nor any of its Subsidiaries has taken any action that, if it
had been taken or occurred after the execution of this Agreement, would have required the consent of the Company pursuant to Sections
5.3(a), 5.3(b), 5.3(c) or 5.3(d) (as it relates to the foregoing clauses of Section 5.3).

4.20          Information
Supplied. None of the information supplied or to be supplied by Parent or Merger Sub for inclusion or incorporation by reference
in (a) the Registration Statement (or any amendment or supplement thereto) will, at the time the Registration Statement (or any
amendment or supplement thereto) is filed with the SEC or at the time it becomes effective under the Securities Act, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, at the time and in light of the circumstances under which they were made, not false or misleading, and (b) the Proxy Statement/Prospectus
(in each case, including any amendments or supplements thereto) will, at the date it is first published, mailed or given to the Company
Stockholders, on the date of any amendment or supplement thereto or at the time of the Company Stockholder Meeting, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they are made, not misleading. Notwithstanding anything to the contrary in this
Agreement, no representation or warranty is made by Parent or Merger Sub with respect to any statements or disclosures about the Company
in the Proxy Statement/Prospectus or the Registration Statement that are based on statements or information supplied, drafted or reviewed
by the Company (or its Representatives) (including by incorporation by reference) expressly for inclusion or incorporation by reference
in the Proxy Statement/Prospectus or the Registration Statement.

4.21          Tax
Matters.

(a)            Parent
and each of its Subsidiaries have (i) timely filed all income and other material Tax Returns required to be filed by any of them;
and (ii) paid, or have adequately reserved or accrued (in accordance with GAAP) for the payment of, all income and other material
Taxes that are required to be paid;

(b)            the
most recent Parent Financial Statements reflect an adequate reserve (in accordance with GAAP) for all Taxes accrued but not then payable
by Parent and its Subsidiaries through the date of such financial statements;

(c)            neither
Parent nor any of its Subsidiaries has executed or is the beneficiary of any waiver, except in connection with any ongoing Tax examination,
of any statute of limitations on, or extended the period for the assessment or collection of, any Tax, in each case that has not since
expired (other than pursuant to automatic extensions of time to file);

(d)            no
material audits or other examinations with respect to Taxes of Parent or any of its Subsidiaries are presently in progress or have been
asserted or proposed in writing;

(e)            neither
Parent nor any of its Subsidiaries has engaged in a “listed transaction” as set forth in Treasury Regulation § 1.6011-4(b)(2);

(f)             neither
Parent nor any of its Subsidiaries (i) is a party to or bound by, or currently has any material liability pursuant to, any Tax sharing,
allocation or indemnification agreement or obligation, other than any such agreement or obligation (x) entered into in the ordinary
course of business the primary purpose of which is unrelated to Taxes or (y) solely among Parent and its Subsidiaries; or (ii) has
any material liability for the Taxes of any Person other than Parent and its Subsidiaries pursuant to Treasury Regulation § 1.1502-6
(or any similar provision of state, local or non-United States Law) as a transferee or successor, or otherwise by operation of Law; and

(g)            neither
Parent nor any of its Subsidiaries has within the last two (2) years distributed stock of another person, or has had its stock distributed
by another person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or Section 361
of the Code.

4.22          Exclusivity
of Representations and Warranties.

(a)            No
Other Representations or Warranties of Parent. Except for the representations and warranties expressly made by Parent and Merger
Sub in this Article IV or in any certificate delivered pursuant to this Agreement, none of Parent, Merger Sub nor any other
Person makes any representation or warranty of any kind whatsoever, express or implied, at Law or in equity, with respect to Parent,
any of its Subsidiaries or their respective business, operations, assets, liabilities, condition (financial or otherwise) or the transactions
contemplated hereby, notwithstanding any other statements made or the delivery or disclosure to the Company or any of its Representatives
of any documentation, forecasts or other information with respect to any one or more of the foregoing.

(b)            No
Other Representations and Warranties of the Company. Each of Parent and Merger Sub, on behalf of itself and its Subsidiaries, acknowledges
and agrees that, except for the representations and warranties expressly set forth in Article III:

(i)            neither
the Company nor any of its Subsidiaries (or any other Person) makes, or has made, any representation or warranty relating to the Company,
its Subsidiaries or any of their businesses, operations or otherwise in connection with this Agreement or the Merger;

(ii)           no
Person has been authorized by the Company, any of its Subsidiaries or any of its or their respective Representatives to make any representation
or warranty relating to the Company, its Subsidiaries or any of their businesses or operations or otherwise in connection with this Agreement
or the Merger, and if made, such representation or warranty must not be relied upon by Parent, Merger Sub or any of their respective
Representatives as having been authorized by the Company, any of its Subsidiaries or any of its or their respective Representatives (or
any other Person); and

(iii)          the
representations and warranties made by the Company in this Agreement are in lieu of and are exclusive of all other representations and
warranties, including any express or implied or as to merchantability or fitness for a particular purpose, and the Company hereby disclaims
any other or implied representations or warranties, notwithstanding the delivery or disclosure to Parent, Merger Sub or any of their
respective Representatives of any documentation or other information (including any financial information, supplemental data or financial
projections or other forward-looking statements).

(c)            No
Reliance. Each of Parent and Merger Sub, on behalf of itself and its Subsidiaries, acknowledges and agrees that, (x) it has
had reasonable access to, and has been afforded the opportunity to request and review, the books and records of the Company and its Subsidiaries
(including in the possession of the Company’s Representatives) and (y) except for the representations and warranties expressly
set forth in Article III, it is not acting (including, as applicable, by entering into this Agreement or consummating the
Merger) in reliance on:

(i)            any
representation or warranty, express or implied;

(ii)           any
estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information provided or
addressed to Parent, Merger Sub or any of their respective Representatives, including any materials or information made available in
the electronic data room hosted by or on behalf of the Company in connection with the Merger, in connection with presentations by the
Company’s management or in any other forum or setting; or

Article V
INTERIM OPERATIONS

5.1            Company
Affirmative Obligations. Except (a) as expressly permitted or expressly contemplated by this Agreement (including the Real Estate
Plan); (b) as set forth in Section 5.1 or Section 5.2 of the Company Disclosure Letter; (c) as required
by applicable Law; (d) for any Permitted Action, subject to reasonable prior consultation with Parent; or (e) as approved in
writing by Parent (which approval shall not be unreasonably withheld, conditioned or delayed), provided that consent of Parent shall
be deemed to have been given if Parent does not object within five (5) Business Days after a written request for such consent is
provided by the Company to Parent, during the period from the execution and delivery of this Agreement until the earlier to occur of
the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall, and shall cause each
of its Subsidiaries to (i) maintain its existence in good standing pursuant to applicable Law; (ii) conduct its business and
operations in the ordinary course of business; and (iii) to the extent consistent with clause (ii), use its commercially
reasonable efforts to preserve intact, in all material respects, its business organization and existing relationships with its material
suppliers, customers, employees, creditors, lessors, Governmental Authorities and other Persons with whom the Company and its Subsidiaries
have business relations.

5.2            Company
Forbearance Covenants. Except (w) as expressly permitted by this Agreement (including the Real Estate Plan); (x) as set
forth in Section 5.2 of the Company Disclosure Letter; (y) as required by applicable Law; or (z) as approved in
writing by Parent (which approval will not be unreasonably withheld, conditioned or delayed), during the period from the execution and
delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the
Effective Time, the Company shall not, and shall cause each of its Subsidiaries as applicable not to:

(a)            amend
any Organizational Documents of the Company or its Subsidiaries;

(b)            propose
or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;

(c)            issue,
sell, deliver or agree or commit to issue, sell or deliver (whether through the issuance or granting of options, warrants, commitments,
subscriptions, rights to purchase or otherwise) any Company Securities, except in connection with (i) agreements in effect on the
date of this Agreement disclosed on Section 5.2(c)(i) of the Company Disclosure Letter; (ii) the grant of Company
RSUs to newly hired employees who are hired in accordance with Section 5.2(h) below in the ordinary course of business
with respect to up to 300,000 shares of Company Common Stock in the aggregate which grants will have the terms and conditions set forth
on Section 5.2(c)(ii) of the Company Disclosure Letter; (iii) the issuance of any shares of Company Common Stock
upon the exercise of Company Options or the settlement of Company RSUs that are, in each case outstanding as of the date of this Agreement
in accordance with the present terms of such Company Equity Awards or granted following the date of this Agreement as permitted by clause
(ii) in accordance with the terms of such Company Equity Awards; or (iv) the issuance of shares of Company Common Stock upon
the exercise of purchase rights under the Company ESPP in accordance with Section 2.8(c);

(d)            directly
or indirectly acquire, repurchase or redeem any Company Securities, except for (i) repurchases or acquisitions of Company Securities
pursuant to the terms and conditions of Company Equity Awards, or (ii) transactions between the Company and any of its direct or
indirect wholly-owned Subsidiaries;

(e)            (i) adjust,
split, combine or reclassify any shares of capital stock, or issue or authorize or propose the issuance of any other Company Securities
in respect of, in lieu of or in substitution for, shares of its capital stock or other equity or voting interest; (ii) declare,
set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any
shares of capital stock or other equity or voting interest, or make any other actual, constructive or deemed distribution in respect
of the shares of capital stock or other equity or voting interest, except for cash dividends made by any direct or indirect wholly-owned
Subsidiary of the Company to the Company or one of its other wholly-owned Subsidiaries; or (iii) pledge or encumber any shares of
its capital stock or other equity or voting interest;

(f)            (i) incur,
assume or suffer any Indebtedness (other than such items referred to in clauses (iv) and (vi) of such term) or issue any debt
securities, except (1) for trade payables incurred in the ordinary course of business, (2) for loans or advances to wholly-owned
Subsidiaries of the Company, and (3) up to $1,000,000 of additional Indebtedness; (ii) assume, guarantee, endorse or otherwise
become liable or responsible (whether directly, contingently or otherwise) for the obligations of any other Person, except with respect
to obligations of direct or indirect wholly-owned Subsidiaries of the Company; (iii) make any loans, advances or capital contributions
to, or investments in, any other Person, except for extensions of credit to, or receivables payable from, customers, in each case, in
the ordinary course of business; or (iv) mortgage or pledge any assets, tangible or intangible, or create or suffer to exist any
Lien thereupon (other than Permitted Liens);

(g)            (i) enter
into, adopt, amend or modify any Employee Plan or accelerate compensation or benefits provided under any Employee Plan (other than administrative
amendments to, or annual renewals of, Employee Plans that are broad-based health or welfare plans in the ordinary course of business
but only if such amendments or annual renewals result in not more than a de minimis increase in cost for the Company); or (ii) increase
any benefits under any Employee Plan or increase the compensation payable or paid, whether conditionally or otherwise, of any current
or former employee, officer, director or individual independent contractor, pay any special bonus or special remuneration to any current
or former director, officer, employee or individual independent contractor, adopt or enter into any severance or termination pay agreements,
plans, policies or arrangements or pay any benefit not permitted in accordance with the terms of any Employee Plan as in effect as of
the date of this Agreement, except in the case of each of (i) and (ii), (A) as may be required by applicable Law or required
pursuant to the terms of an existing Employee Plan so long as such Employee Plan has been disclosed as of the date of this Agreement
to Parent in Section 5.2(g) of the Company Disclosure Letter; or (B) for increases in compensation adopted in the
ordinary course of business consistent with past practice in respect of any non-officer employee whose annual base compensation does
not exceed $200,000 after giving effect to such increase;

(h)            hire,
engage or terminate (other than a termination for cause) the employment or engagement of any employee or individual independent contractor
who earns or will earn (or prior to such termination, did earn) annual base compensation in excess of $200,000;

(i)             waive,
release, assign (other than to or from a Subsidiary of the Company), compromise or settle any pending or threatened Legal Proceeding,
except for the settlement of any Legal Proceedings (other than Transaction Litigation, which shall be governed by Section 6.12,
and subject to Section 6.16 with respect to the Specified Legal Proceedings) that (i) is for solely monetary payments
of no more than $250,000 individually and $2,000,000 in the aggregate (in excess of amounts funded by an indemnity obligation to, or
an insurance policy of, the Company or any of its Subsidiaries, and excluding ordinary course administrative expenses that may be incurred
in connection therewith) or (ii) is for the settlement of claims of the Company or any of its Subsidiaries that results in no monetary
obligation of the Company or any of its Subsidiaries or that results in the receipt by the Company or any of its Subsidiaries of a payment,
provided that, in each case of the foregoing clauses (i) and (ii), such settlement does not involve any non-de minimis injunctive
or equitable relief or impose non-de minimis restrictions on the business activities of the Company and its Subsidiaries or Parent and
its Subsidiaries or any admission of wrongdoing or criminal act;

(j)             except
as required by applicable Law or GAAP, (i) revalue in any material respect any of its properties or assets, including writing-off
notes or accounts receivable, other than in the ordinary course of business; or (ii) make any material change in any of its accounting
principles or practices;

(k)            (i) make
or change any material Tax election (other than elections the Company is required to make annually that are consistent with past practice);
(ii) settle or compromise any material Tax claim or assessment; (iii) consent to any extension or waiver of any limitation
period with respect to any material Tax claim or assessment (other than the extension of any such period arising as a result of a customary
extension of time to file a Tax Return); (iv) surrender any right to claim a material Tax refund; (v) file any amended Tax
Return; or (vi) enter into any material closing agreement or contractual obligation in respect of Taxes with any Governmental Authority.

(l)             incur
or commit to incur any capital expenditures other than (i) as set forth in the Real Estate Plan, (ii) in accordance with the
capital expenditure budget set forth in Section 5.2(l) of the Company Disclosure Letter and (iii) with respect
to any capital expenditures not addressed by the foregoing clauses (i) and (ii), capital expenditures that do not exceed $1,000,000
in the aggregate;

(m)           enter
into, modify in any material respect, amend in any material respect or terminate (excluding terminations upon expiration of the term
thereof in accordance with the terms thereof) any Material Contract (which for purposes of this Section 5.2(m) will
be deemed to include any project plan, research plan or similar document under any Material Contract), including by amendment of any
Contract that is not a Material Contract such that such Contract becomes a Material Contract;

(n)            maintain
insurance at less than current levels or otherwise in a manner inconsistent with past practice;

(o)            other
than with respect to the matters set forth in Section 5.2(g), engage in any transaction with, or enter into any agreement,
arrangement or understanding with, any Affiliate of the Company or other Person covered by Item 404 of Regulation S-K promulgated by
the SEC that would be required to be disclosed pursuant to Item 404;

(p)            (i) take
any action that would constitute a “plant closing” or “mass layoff” (as defined in WARN) affecting in whole or
in part any site of employment, facility, operating unit or employee or that would otherwise trigger notice requirements or liability
under any foreign, state or local plant closing notice Law, (ii) implement any layoffs affecting, place on unpaid leave or furlough,
or materially reduce the hours or weekly pay of, twenty-five (25) or more employees; or (iii) enter into or modify any Collective
Bargaining Agreement, or recognize any Union as the bargaining representative for any employees;

(q)            enter
into any material new line of business or make any material change in any line of business in which it engages as of the date of this
Agreement;

(r)            (i) merge
or consolidate with any Person; (ii) make any acquisition or disposition of any material assets, securities, property or business
(including by merger, consolidation or acquisition of stock or assets) in a single transaction or series of transactions, except for
(A) any transactions permitted under Section 5.2(l), (B) any disposition of obsolete or worn out equipment, or
(C) non-exclusive licenses under Intellectual Property, in the ordinary course of business or (D) abandonment or allowing to
lapse of Intellectual Property that is not material to the business of the Company and its Subsidiaries; or (iii) enter into any
joint venture, partnership, participation or other similar arrangement, except, with respect to this subclause (iii), in the ordinary
course of business (it being understood and agreed that any Contract proposed to be entered into pursuant to the exception in this Section 5.2(r)(iii) that
would be a Material Contract will be subject to Section 5.2(m)); or

(s)            enter
into a Contract to take, or otherwise agree, resolve or commit to take, any of the actions prohibited by this Section 5.2.

5.3            Parent
and Merger Sub Obligations. Except (w) as expressly permitted by this Agreement; (x) as set forth on Section 5.3 of the Parent Disclosure Letter; (y) as required by applicable Law; or (z) as approved in writing by the Company (which
approval will not be unreasonably withheld, conditioned or delayed), during the period from the execution and delivery of this Agreement
until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, Parent and
Merger Sub shall not, and shall cause its respective Subsidiaries as applicable not to:

(a)            amend
any Organizational Documents in a manner (i) that would be (or would reasonably be expected to be) adverse to the Company Stockholders’
interests as holders of Parent Class A Common Stock following the consummation of the Merger (including relative to the rights and
interests of holders of Parent Class A Common Stock, Parent Class B Common Stock and Parent Class C Common Stock prior
to the consummation of the Merger), and (ii) where such amendment would reasonably be expected to prevent, materially impede or
materially delay the consummation of the Merger and the other transactions contemplated by this Agreement;

(b)            (i) adjust,
split, combine or reclassify any shares of capital stock, or issue or authorize or propose the issuance of any other securities in respect
of, in lieu of or in substitution for, shares of its capital stock in any manner that would have (or would reasonably be expected to
have) a material and adverse impact on the value of the Parent Class A Common Stock, except for issuances made in the ordinary course
of business with respect to the issuance of equity awards by Parent, or (ii) declare, set aside or pay any dividend or other distribution
(whether in cash, shares or property or any combination thereof) in respect of any shares of capital stock or other equity or voting
interest, or make any other actual, constructive or deemed distribution in respect of the shares of capital stock or other equity or
voting interest, except for dividends or other distributions made by any direct or indirect wholly-owned Subsidiary of Parent to Parent
or one of its other wholly-owned Subsidiaries;

(c)            propose
or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization
with respect to Parent or Merger Sub (other than (i) the transactions contemplated hereby, including the Merger, (ii) transactions
among Parent and one or more direct or indirect wholly owned Subsidiaries of Parent or among direct or indirect wholly owned Subsidiaries
of Parent and (iii) transactions that would not reasonably be expected to prevent, materially impede or materially delay the consummation
of the Merger and the other transactions contemplated by this Agreement, in each case, so long as none of the foregoing actions would
reasonably be expected to have any of the adverse effects that are otherwise prohibited by Sections 5.3(a) and 5.3(b));
or

(d)            enter
into a Contract to take, or otherwise agree, resolve or commit to take, any of the actions prohibited by this Section 5.3.

5.4            No
Solicitation; Company Board Recommendation Change.

(a)            No
Solicitation or Negotiation. The Company will, will cause its Subsidiaries and will use reasonable best efforts to cause its Representatives
to, (x) on the date of this Agreement, immediately cease and cause to be terminated any discussions or negotiations with any Person
and its Representatives with respect to any Acquisition Transaction, (y) as promptly as practicable on or following the date of
this Agreement (and in any event within three (3) Business Days following the date of this Agreement) request the return or destruction
of all confidential information previously provided to such parties and (z) promptly prohibit access by any Person (other than Parent,
its Subsidiaries and its and their Representatives) to any physical or electronic data room. Except as expressly permitted by Section 5.4(b),
from the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII
and the Effective Time, the Company and its Subsidiaries will not, and will use reasonable best efforts to cause their respective Representatives
not to, directly or indirectly, (i) solicit, initiate, propose or induce the making, submission or announcement of, or knowingly
encourage, facilitate or assist, any proposal or offer that constitutes or could reasonably be expected to lead to, an Acquisition Proposal;
(ii) furnish to any Person (other than Parent, Merger Sub or any designees of Parent or Merger Sub) any non-public information relating
to the Company or any of its Subsidiaries or afford to any Person access to the business, properties, assets, books, records or other
non-public information, or to any personnel, of the Company or any of its Subsidiaries (other than Parent, Merger Sub or any designees
of Parent or Merger Sub), in any such case with the intent to induce the making, submission or announcement of, or to knowingly encourage,
facilitate or assist, an Acquisition Proposal or any inquiries or the making of any proposal or offer that could reasonably be expected
to lead to an Acquisition Proposal; (iii) participate or engage in discussions or negotiations with any Person with respect to an
Acquisition Proposal in each case other than (A) informing such Persons of the provisions contained in this Section 5.4
or (B) contacting such Person or its Representatives to clarify the terms and conditions of any Acquisition Proposal (or inquiries,
communications, proposals or offers or any other effort or attempt that could reasonably be expected to lead to an Acquisition Proposal);
(iv) approve, endorse or recommend an Acquisition Proposal; (v) enter into any letter of intent, memorandum of understanding,
merger agreement, acquisition agreement or other Contract relating to an Acquisition Transaction, other than an Acceptable Confidentiality
Agreement (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other Contract relating
to an Acquisition Transaction, an “Alternative Acquisition Agreement”); or (vi) resolve, propose or agree to
do any of the foregoing. From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to
Article VIII and the Effective Time, the Company will enforce, and will not waive, modify, amend or terminate, any provision
of any standstill or confidentiality agreement that prohibits or purports to prohibit a proposal being made to the Company Board (or
any committee thereof) and shall enforce, to the fullest extent permitted under applicable Law, the provisions of any such agreements;
provided, that the Company shall be permitted to waive, modify, amend or terminate any provision of any standstill agreement (or
similar agreement) in order to permit a Person to make an Acquisition Proposal, if and only if the Company Board shall have determined
in good faith (after consultation with outside legal counsel) that the failure to so waive, modify, amend or terminate would be reasonably
likely to be inconsistent with the directors’ fiduciary duties under applicable Law.

(b)            Superior
Proposals. Notwithstanding anything to the contrary set forth in this Section 5.4, but subject to Section 5.4(e),
from the date of this Agreement until the Company’s receipt of the Requisite Stockholder Approval, the Company and the Company
Board (or a committee thereof) may, directly or indirectly through one or more of their Representatives, participate or engage in discussions
or negotiations with, furnish any non-public information relating to the Company or any of its Subsidiaries to, or afford access to the
business, properties, assets, books, records or other non-public information, or to any personnel, of the Company or any of its Subsidiaries
pursuant to an Acceptable Confidentiality Agreement to any Person or its Representatives that has made, renewed or delivered to the Company
a bona fide written Acquisition Proposal after the date of this Agreement, and otherwise facilitate such Acquisition Proposal
or assist such Person (and its Representatives) with such Acquisition Proposal if requested by such Person, in each case with respect
to an Acquisition Proposal that was not the result of a material breach of Section 5.4(a); provided, that, the Company
Board may take the foregoing actions only if the Company Board (or a committee thereof) has determined in good faith (after consultation
with its outside legal counsel and financial advisors) (i) such Acquisition Proposal either constitutes a Superior Proposal or would
reasonably be expected to lead to a Superior Proposal and (ii) the failure to take such actions would be reasonably likely to be
inconsistent with the directors’ fiduciary duties under applicable Law; provided, further, that subject to
applicable Law, the Company shall provide to Parent and Merger Sub any non-public information or data that is provided to any Person
given such access that was not previously made available to Parent or Merger Sub prior to or substantially concurrently to (and within
twenty-four (24) hours of) the time it is provided to such Person.

(c)            No
Company Board Recommendation Change or Alternative Acquisition Agreement. Except as permitted by Section 5.4(d), neither
the Company Board nor any committee thereof shall:

(i)            (A) withhold
or withdraw (or amend, qualify or modify in a manner adverse to Parent in any material respect), or publicly propose to withhold or withdraw
(or amend, qualify or modify in a manner adverse to Parent in any material respect), the Company Board Recommendation; (B) fail
to include the Company Board Recommendation in the Proxy Statement/Prospectus; (C) publicly adopt, approve or recommend an Acquisition
Proposal; (D) make any recommendation in support of, or fail to recommend against, a tender or exchange offer that constitutes an
Acquisition Proposal (it being understood that the Company Board (or a committee thereof) may refrain from taking a position with respect
to an Acquisition Proposal until the close of business on the tenth (10^th) Business Day after the commencement of a tender
or exchange offer in connection with such Acquisition Proposal without such action being considered a violation of this Section 5.4(c)(i));
or (E) fail to reaffirm the Company Board Recommendation on or prior to the later of (x) ten (10) Business Days after
an Acquisition Proposal shall have been publicly announced or disclosed and (y) two (2) Business Days following the written
request of Parent after an Acquisition Proposal shall have been publicly announced or disclosed (provided, however, that
Parent may make such request no more than twice after, and in connection with, an Acquisition Proposal that shall have been made; provided,
further, that any material change to the terms of such Acquisition Proposal shall entitle Parent to a further two (2) requests
in connection with such Acquisition Proposal) (any action described in clauses (A), (B), (C), (D) or (E), a “Company Board
Recommendation Change”). For the avoidance of doubt, (1) a “stop, look and listen” communication by the Company
Board (or a committee thereof) to the Company Stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act, (2) the
determination by the Company Board (or a committee thereof) that an Acquisition Proposal constitutes a Superior Proposal as and to the
extent permitted by Section 5.4(d)(ii) or the taking of any other action expressly permitted by Section 5.4(b) or (3) the delivery by the Company of any notice contemplated by Section 5.4(d) or any negotiations during the
applicable three (3) Business Day notice period in respect thereto in compliance with this Agreement will not (in and of itself)
constitute a Company Board Recommendation Change; or

(ii)            cause
or permit the Company or any of its Subsidiaries to enter into an Alternative Acquisition Agreement.

(d)            Company
Board Recommendation Change; Entry into Alternative Acquisition Agreement. Notwithstanding anything to the contrary set forth in
this Agreement, at any time prior to obtaining the Requisite Stockholder Approval:

(i)            the
Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event if the Company
Board (or a committee thereof) determines in good faith (after consultation with its outside legal counsel) that the failure to do so
would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law; provided, however, that the
Company Board (or a committee thereof) shall not effect such a Company Board Recommendation Change unless:

(1)            the
Company has provided prior written notice to Parent at least three (3) Business Days in advance to the effect that the Company Board
(or a committee thereof) intends to effect a Company Board Recommendation Change, which notice shall specify the basis for such Company
Board Recommendation Change, including a reasonably detailed description of the facts and circumstances relating to such Intervening
Event;

(2)            prior
to effecting such Company Board Recommendation Change, during such three (3) Business Day period, the Company has negotiated with
Parent and its Representatives in good faith (to the extent that Parent requested to do so) to allow Parent to offer such adjustments
to the terms and conditions of this Agreement in such a manner that would obviate the need to effect a Company Board Recommendation Change
in response to such Intervening Event; and

(3)            following
such three (3) Business Day period, taking into account such adjustments offered by Parent (if any), the Company Board (or a committee
thereof) determines in good faith (after consultation with its outside legal counsel) that the failure to make such a Company Board Recommendation
Change would continue to reasonably likely be inconsistent with its fiduciary duties under applicable Law (it being understood that in
the event of any material development in the facts and circumstances relating to such Intervening Event, the Company will be required
to deliver a new written notice and a new three (3) Business Day notice period as described in clauses (1) and (2) above
will commence, during which period the Company will be required to comply with the requirements of clause (2) anew); or

(ii)           if
the Company has received a bona fide Acquisition Proposal that does not result from a breach of Section 5.4(a) or
(b) that the Company Board has determined in good faith (after consultation with its financial advisors and outside legal
counsel) constitutes a Superior Proposal, then the Company Board (or a committee thereof) may (A) effect a Company Board Recommendation
Change with respect to such Superior Proposal; or (B) cause the Company to terminate this Agreement pursuant to Section 8.1(h) to
enter into an Alternative Acquisition Agreement with respect to such Superior Proposal substantially concurrently with the termination
of this Agreement; provided, however, that the Company Board (or a committee thereof) shall not effect such a Company Board
Recommendation Change unless:

(1)            the
Company Board (or a committee thereof) determines in good faith (after consultation with its advisors) that the failure to do so would
be reasonably likely to be inconsistent with the directors’ fiduciary duties under applicable Law;

(2)            the
Company has complied in all material respects with its obligations pursuant to this Section 5.4 with respect to such Superior
Proposal; and

(3)            the
Company has provided prior written notice to Parent three (3) Business Days in advance to the effect that the Company Board (or
a committee thereof) (A) has received a Superior Proposal; and (B) intends to effect a Company Board Recommendation Change
or to terminate this Agreement pursuant to Section 8.1(h) absent any revision to the terms and conditions of this Agreement,
which notice will identify the Person or Group making such Superior Proposal and include the material terms thereof and copies of all
material relevant agreements relating to such Superior Proposal;

(4)            during
such three (3) Business Day period, the Company has negotiated with Parent and its Representatives in good faith (to the extent
that Parent has requested to do so) to allow Parent to offer such adjustments to the terms and conditions of this Agreement so that such
Acquisition Proposal ceases to constitute a Superior Proposal; and

(5)            following
such three (3) Business Day period, taking into account such adjustments offered by Parent (if any), the Company Board (or a committee
thereof) determines in good faith (after consultation with its outside legal counsel) that such Acquisition Proposal continues to constitute
a Superior Proposal and that the failure to make such a Company Board Recommendation Change or to so terminate this Agreement to enter
into an Alternative Acquisition Agreement with respect to such Superior Proposal in accordance with Section 8.1(h), as applicable,
would continue to be reasonably likely to be inconsistent with the directors’ fiduciary duties under applicable Law (it being understood
that in the event of any material amendment relating to such Acquisition Proposal, the Company will be required to deliver a new written
notice and a new three (3) Business Day notice period as described in clauses (3) and (4) above will commence, during
which period the Company will be required to comply with the requirements of clause (4) anew).

(e)            Notice.
From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII
and the Effective Time, the Company will as promptly as reasonably practicable (and, in any event, within two (2) calendar days)
notify Parent in writing if any Acquisition Proposal or offers or proposals that could reasonably be expected to lead to an Acquisition
Proposal are received by, any non-public information is requested from, or any discussions or negotiations are sought to be initiated
or continued with, the Company or any of its Representatives. Such notice must include (i) the identity of the Person or Group making
such offers or proposals; (ii) a summary of the material terms and conditions of such offers or proposals; and (iii) copies
of all written materials related thereto sent or provided to the Company or any of its Affiliates that describe any material terms or
conditions of any Acquisition Proposal (as well as written summaries of any material oral communications addressing such matters). Thereafter,
the Company must keep Parent reasonably informed, on a prompt basis, as requested by Parent, of the status and terms of any such offers
or proposals (including any amendments thereto) and the status of any such discussions or negotiations.

(f)            Certain
Disclosures. Nothing contained in this Agreement will prohibit the Company or the Company Board (or a committee thereof) from (i) taking
and disclosing to the Company Stockholders a position contemplated by Rule 14e-2(a) promulgated under the Exchange Act or complying
with Rule 14d-9 promulgated under the Exchange Act, including a “stop, look and listen” communication by the Company
Board (or a committee thereof) to the Company Stockholders pursuant to Rule 14d-9(f) promulgated under the Exchange Act (or
any substantially similar communication); (ii) complying with Item 1012(a) of Regulation M-A promulgated under the Exchange
Act; (iii) informing any Person of the existence of the provisions contained in this Section 5.4; (iv) complying
with the Company’s disclosure obligations under U.S. federal or state Law with regard to an Acquisition Proposal; or (v) making
any disclosure to the Company Stockholders unrelated to an Acquisition Proposal (including regarding the business, financial condition
or results of operations of the Company and its Subsidiaries) that the Company Board (or a committee thereof) has determined to make
in good faith, it being understood that any such statement or disclosure made by the Company Board (or a committee thereof) must be subject
to the terms and conditions of this Agreement; provided, that the Company Board may not make a Company Board Recommendation Change
except in accordance with Section 5.4(d).

5.5            No
Control of the Other Party’s Business. The Parties acknowledge and agree that the restrictions set forth in this Agreement
are not intended to give Parent or Merger Sub, on the one hand, or the Company, on the other hand, directly or indirectly, the right
to control or direct the business or operations of the other at any time prior to the Effective Time. Prior to the Effective Time, each
of Parent, Merger Sub and the Company shall exercise, consistent with the terms, conditions and restrictions of this Agreement, complete
control and supervision over their own business and operations.

Article VI
ADDITIONAL COVENANTS

6.1            Required
Action and Forbearance; Efforts.

(a)            Reasonable
Best Efforts. Upon the terms and subject to the conditions set forth in this Agreement, Parent and Merger Sub (and their respective
Affiliates, if applicable), on the one hand, and the Company, on the other hand, will use their respective reasonable best efforts (A) to
take (or cause to be taken) all actions; (B) do (or cause to be done) all things; and (C) assist and cooperate with the other
Parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable Law or
otherwise to consummate and make effective, as promptly as reasonably practicable, the Merger and the other transactions contemplated
hereby, including by:

(i)            causing
the conditions to the Merger set forth in Article VII to be satisfied;

(ii)            (1) obtaining
all consents, waivers, approvals, orders and authorizations from Governmental Authorities, and (2) making all registrations, declarations
and filings with Governmental Authorities, in each case, that are necessary or advisable to consummate the Merger;

(iii)          obtaining
all consents, waivers and approvals and delivering all notifications pursuant to any Contract to which the Company or any of its Subsidiaries
is a party, including those set forth in Section 6.1(a)(iii) of the Company Disclosure Letter, that are necessary in
connection with this Agreement and the consummation of the Merger; and

(iv)          executing
and delivering any Contracts and other instruments that are in each case reasonably necessary to consummate the Merger.

(b)            No
Failure to Take Necessary Action. In addition to the foregoing, subject to the terms and conditions of this Agreement, neither Parent
or Merger Sub, on the one hand, nor the Company, on the other hand, will take any action, or fail to take any action, that is intended
to or has (or would reasonably be expected to have) the effect of preventing, impairing, materially delaying or otherwise materially
and adversely affecting (i) the consummation of the Merger; or (ii) the ability of such Party to fully perform its obligations
pursuant to this Agreement. For the avoidance of doubt, no action by the Company taken in compliance with Section 5.4 will
be considered a violation of this Section 6.1.

(c)            No
Consent Fee. Notwithstanding anything to the contrary set forth in this Section 6.1 or elsewhere in this Agreement, neither
the Company nor any of its Subsidiaries will be required to agree to (i) the payment of a consent fee, “profit sharing”
payment or other consideration (including increased or accelerated payments); (ii) the provision of additional security (including
a guaranty); or (iii) material conditions or obligations, including amendments to existing material conditions and obligations,
in each case, in connection with the Merger, including in connection with obtaining any consent pursuant to any Material Contract.

(d)            Notification
of Certain Matters. Each of the Company and Parent shall promptly advise the other of (i) any notice or other material communication
from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this
Agreement; (ii) any notice or other communication from any Governmental Authority in connection with the transactions contemplated
by this Agreement; (iii) any Legal Proceedings commenced or, to its Knowledge, threatened against, relating to or involving or otherwise
affecting the Company or any of its Subsidiaries or Parent and any of its Subsidiaries, as the case may be, that, if pending on the date
of this Agreement, would have been required to have been disclosed by the Company pursuant to Section 3.24 or by Parent pursuant
to Section 4.7; (iv) any Effect that would be reasonably likely to have a Company Material Adverse Effect, in the case
of the Company, or a Parent Material Adverse Effect, in the case of Parent; or (v) such party becoming aware of the occurrence of
any Effect that it believes would or would be reasonably likely to prevent or delay beyond the Termination Date the consummation of the
transactions contemplated by this Agreement or that results or would reasonably be expected to result in any of the conditions to the
Merger set forth in Article VII not being satisfied prior to the Termination Date; provided that no such notification
shall affect the representations, warranties, covenants or agreements of the Parties (or remedies with respect thereto) or the conditions
to the obligations of the Parties under this Agreement; provided, further, that a failure to comply with this Section 6.1(d) shall
not constitute the failure of any condition set forth in Article VII to be satisfied unless the underlying change or event
would independently result in the failure of a condition set forth in Article VII to be satisfied.

(e)            Antitrust
Approvals. This Section 6.1 shall not apply to filings or related approvals, reviews, or waiting periods under Antitrust
Laws, which shall be governed by the obligations set forth in Section 6.2.

6.2            Antitrust
Filings.

(a)            Filing
Under the HSR Act. Each of Parent and Merger Sub (and their respective Affiliates, if applicable), on the one hand, and the Company
(and its Subsidiaries, if applicable), on the other hand, shall, (i) within ten (10) Business Days following the date of this
Agreement, file with the FTC and the Antitrust Division of the DOJ a Notification and Report Form relating to this Agreement and
the Merger as required by the HSR Act, which shall request early termination of the HSR Act waiting period; and (ii) as promptly
as reasonably practicable following the date of this Agreement, file comparable pre-merger or post-merger notification filings, forms
and submissions with any Governmental Authority that are required by other applicable Antitrust Laws in connection with the Merger. Each
of Parent and the Company shall use its reasonable best efforts to (A) cooperate and coordinate (and shall cause its respective
Affiliates and Subsidiaries, respectively, to cooperate and coordinate) with the other in the making of such filings; (B) supply
the other (or cause to be supplied) with any information that may be reasonably required in order to make such filings; (C) as promptly
as reasonably practicable supply (or cause the other to be supplied) any additional information that reasonably may be required or requested
by the FTC, the DOJ or the Governmental Authorities of any other applicable jurisdiction in which any such filing is made; and (D) take
(and cause its respective Affiliates or Subsidiaries, respectively, to take) all action necessary, proper or advisable to (1) cause
the expiration or termination of the applicable waiting periods pursuant to the HSR Act and any other Antitrust Laws applicable to this
Agreement or the Merger; and (2) obtain any required approvals or consents pursuant to any Antitrust Laws applicable to this Agreement
or the Merger, in each case as promptly as practicable and in any event prior to the Termination Date. Each of Parent and Merger Sub
shall (and shall cause its respective Affiliates), on the one hand, and the Company shall (and shall cause its Subsidiaries), on the
other hand, promptly inform the other of any material communication from any Governmental Authority regarding the Merger in connection
with such filings. If any Party or any Affiliate thereof receives a request for additional information or documentary material from any
Governmental Authority with respect to the Merger pursuant to the HSR Act or any similar request pursuant to any other Antitrust Laws
applicable to the Merger, then such Party will make (or cause to be made), as promptly as reasonably practicable and after consultation
with the other Parties, an appropriate response in substantial compliance with such request.

(b)            Antitrust
Approvals. In furtherance and not in limitation of the foregoing, if and to the extent advisable and necessary to obtain the expiration
or termination of the waiting period pursuant to the HSR Act and any other Antitrust Laws applicable to the Merger, or to obtain any
consents, clearances or approvals pursuant to applicable Antitrust Laws, each of Parent and Merger Sub shall (and shall cause their respective
Affiliates to) contest, defend and appeal any Legal Proceedings, whether judicial or administrative, challenging this Agreement or the
consummation of the Merger. Notwithstanding the foregoing, nothing in this Section 6.2 or otherwise in this Agreement shall
require Parent, Merger Sub, the Company, or any of their respective Affiliates or Subsidiaries to: offer, negotiate, commit to and effect,
by consent decree, hold separate order or otherwise, (i) the sale, divestiture, license or other disposition of any and all of the
capital stock or other equity or voting interest, assets (whether tangible or intangible), rights, properties, products or businesses
of Parent and Merger Sub (and their respective Affiliates, if applicable), on the one hand, and the Company and its Subsidiaries, on
the other hand; or (ii) any other restrictions on the activities of Parent and Merger Sub (and their respective Affiliates, if applicable),
on the one hand, and the Company and its Subsidiaries, on the other hand; furthermore, neither the Company nor any of its respective
Subsidiaries shall, without Parent’s written consent, in Parent’s sole discretion, offer, negotiate or commit to any divestiture
transaction, or offer, negotiate or commit to alter their businesses or commercial practices in any way, or otherwise take or commit
to take any action that limits Parent’s freedom of action with respect to, or Parent’s ability to retain any of the businesses,
product lines, or assets of, the Company or otherwise receive the full benefits of this Agreement. If, prior to the Closing Date, a merger
control inquiry is initiated or commenced by a Governmental Authority outside of the United States, approval in that jurisdiction will
be deemed a condition to the completion of the Merger under Section 7.1(b).

(c)            Cooperation.
In furtherance and not in limitation of the foregoing, the Company, Parent and Merger Sub shall (and shall cause their respective Affiliates
and Subsidiaries, respectively, to), subject to any restrictions under applicable Laws, keep the other parties apprised of the content
and status of any material communications with or from any Governmental Authority with respect to the Merger, including (i) promptly
notify the Parties of, and, if in writing, furnish the others with copies of (or, in the case of oral communications, advise the others
of the contents of) any material communication received by such Person from a Governmental Authority in connection with the Merger and
permit the other parties to review and discuss in advance (and to consider in good faith any comments made by the other parties in relation
to) any proposed draft notifications, formal notifications, filing, submission or other material written communication (and any analyses,
memoranda, white papers, presentations, correspondence or other documents submitted therewith) made in connection with the Merger to
a Governmental Authority; (ii) keep the Parties reasonably informed with respect to the status of any such submissions and filings
to any Governmental Authority in connection with the Merger and any developments, meetings or discussions with any Governmental Authority
in respect thereof, including with respect to (A) the receipt of any non-action, action, clearance, consent, approval or waiver,
(B) the expiration or termination of any waiting period, (C) the commencement or proposed or threatened commencement of any
investigation, litigation or administrative or judicial action or proceeding under applicable Laws and (D) the nature and status
of any objections raised or proposed or threatened to be raised by any Governmental Authority with respect to the Merger; and (iii) not
independently participate in any substantive meeting (including any timing and/or scheduling meetings), hearing, proceeding or discussions
(whether in person, by telephone or otherwise) with or before any Governmental Authority in respect of the Merger without giving the
other Parties reasonable prior notice of such meeting or substantive discussions and, unless prohibited by such Governmental Authority,
the opportunity to attend or participate. The Parties shall coordinate and cooperate fully with each other in exchanging such information
and providing such assistance as the other Party may reasonably request in connection with the foregoing and in seeking early termination
of any applicable waiting periods, including under the HSR Act. However, each of the Company, Parent and Merger Sub may, as it deems
advisable and necessary, reasonably designate any non-public information provided to any Governmental Authority as restricted to “outside
counsel” only and any such information shall not be shared with employees, officers or directors or their equivalents of the other
Party without approval of the Party providing the non-public information; provided, that each of the Company, Parent and Merger
Sub may redact such information as necessary to (i) remove any valuation and related information, or (ii) address any contractual
arrangements or reasonable attorney-client or other privilege or confidentiality concerns before sharing any information provided to
any Governmental Authority with another Party on an “outside counsel” only basis.

(d)            Other
Actions. Each of Parent and Merger Sub agrees that, between the date hereof and the Closing, it shall not, and shall not permit any
of its controlled Affiliates to, enter into or consummate any Contracts for an acquisition (by stock purchase, merger, consolidation,
purchase of assets, license or otherwise) of any ownership interest, assets or rights of any Person, other than the transactions described
in Section 6.2(d) of the Parent Disclosure Letter, if such ownership interest, assets or rights would reasonably be
expected to result in a material delay in obtaining, or to result in the failure to obtain, any regulatory approvals required in connection
with the Merger, or which would otherwise reasonably be expected to prevent or materially delay consummation of the Merger prior to the
Termination Date.

6.3            Registration
Statement; Proxy Statement/Prospectus and Other Required SEC Filings.

(a)            Registration
Statement and Proxy Statement/Prospectus. As promptly as practical following the date of this Agreement, (i) Parent and the
Company shall jointly prepare and cause to be filed with the SEC, the Proxy Statement/Prospectus and (ii) Parent shall prepare (with
the Company’s reasonable cooperation) and file with the SEC the Registration Statement, which shall include the Proxy Statement/Prospectus.
Each of Parent and the Company shall cooperate with each other and use their respective reasonable best efforts to (i) cause the
Registration Statement and the Proxy Statement/Prospectus, when filed, to comply in all material respects with all legal requirements
applicable thereto, (ii) respond as promptly as reasonably practicable to and resolve all comments received from the SEC or its
staff concerning the Registration Statement and the Proxy Statement/Prospectus, (iii) have the Registration Statement declared effective
under the Securities Act as promptly as practicable after such filing and (iv) keep the Registration Statement effective for so
long as necessary to complete the Merger. No filing of, or amendment or supplement to, the Registration Statement or the Proxy Statement/Prospectus,
or response to SEC comments with respect thereto, will be made by Parent or the Company, as applicable, without the other’s prior
consent (which shall not be unreasonably withheld, conditioned or delayed) and without providing the other Party and its outside counsel
a reasonable opportunity to review and comment thereon, and each Party shall consider in good faith all comments reasonably proposed
by the other Party; provided, however, that the Company, in connection with a Company Board Recommendation Change, may amend or
supplement the Proxy Statement/Prospectus (including by incorporation by reference) to effect such change without Parent’s consent.
Subject to the proviso in the foregoing sentence and Section 5.4, the Company shall include the Company Board Recommendation
in the Proxy Statement/Prospectus.

(b)            Other
Required Filings. If the Company or Parent determines that it is required to file any document other than the Proxy Statement/Prospectus
or the Registration Statement, as applicable, with the SEC in connection with the Merger pursuant to applicable Law (such document, as
amended or supplemented, an “Other Required Filing”), then the applicable Party (with the assistance and cooperation
of the other Parties as reasonably requested by the applicable Party) shall promptly prepare and file such Other Required Filing with
the SEC. Each Party shall use its respective reasonable best efforts to cause the Proxy Statement/Prospectus and any Other Required Filing
to comply as to form in all material respects with the applicable requirements of the Exchange Act and the rules of the SEC and
Nasdaq and Parent shall use its reasonable best efforts to cause the Registration Statement and any Other Required Filing to comply as
to form in all material respects with the applicable requirements of the Exchange Act and the rules of the SEC and NYSE.

(c)            Furnishing
Information. Each of the Company, on the one hand, and Parent and Merger Sub, on the other hand, shall furnish all information concerning
it and its Affiliates, if applicable, as the other Party may reasonably request in connection with the preparation and filing with the
SEC of the Registration Statement, the Proxy Statement/Prospectus and any Other Required Filing. If at any time prior to the Company
Stockholder Meeting any information relating to the Company, Parent, Merger Sub or any of their respective Affiliates should be discovered
by the Company, on the one hand, or Parent or Merger Sub, on the other hand, that should be set forth in an amendment or supplement to
the Registration Statement, the Proxy Statement/Prospectus or any Other Required Filing, as the case may be, so that such filing would
not include any misstatement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, then the Party that discovers such
information shall promptly notify the other, and an appropriate amendment or supplement to such filing describing such information shall
be promptly prepared and filed with the SEC by the appropriate Party and, to the extent required by applicable Law or the SEC or its
staff, disseminated to the Company Stockholders.

(d)            Consultation
Prior to Certain Communications. The Company, on the one hand, and Parent, Merger Sub and their respective Affiliates, on the other
hand, may not communicate in writing with the SEC or its staff with respect to the Registration Statement, Proxy Statement/Prospectus
or any Other Required Filing, as the case may be, without providing the other, to the extent practicable, a reasonable opportunity to
review and comment on such written communication.

(e)            Notices.
The Company, on the one hand, and Parent and Merger Sub, on the other hand, shall advise (and provide copies to) the other, as promptly
as reasonably practicable after it receives notice thereof, of any receipt of a request by the SEC or its staff for (i) any amendment
or revisions to the Registration Statement, Proxy Statement/Prospectus or any Other Required Filing, as the case may be; (ii) any
receipt of comments from the SEC or its staff on the Registration Statement, Proxy Statement/Prospectus or any Other Required Filing,
as the case may be; or (iii) any receipt of a request by the SEC or its staff for additional information in connection therewith.

(f)             Dissemination
of Proxy Statement/Prospectus. Subject to applicable Law, the Company shall use its reasonable best efforts to cause the Proxy Statement/Prospectus
to be disseminated to the Company Stockholders as promptly as reasonably practicable following the later of (i) the filing thereof
with the SEC and confirmation from the SEC that it will not review, or that it has completed its review of, the Proxy Statement/Prospectus
and (ii) the Registration Statement having been declared effective under the Securities Act.

(g)            Blue
Sky Laws. Parent will use reasonable best efforts to take any other action required to be taken under the Securities Act, the Exchange
Act, any applicable foreign or state securities or Blue Sky Laws and the rules and regulations thereunder in order to consummate
the Merger.

(h)            Effectiveness.
Parent will advise the Company, as promptly as reasonably practicable after it receives notice thereof, of the time of effectiveness
of the Registration Statement and the issuance of any stop order relating thereto or the suspension of the qualification of the shares
of Parent Class A Common Stock issuable in connection with the Merger for offering or sale in any jurisdiction, and Parent shall
use reasonable best efforts to take all actions necessary to have any such stop order or suspension lifted, reversed or otherwise terminated.

6.4            Company
Stockholder Meeting.

(a)            Call
of Company Stockholder Meeting. Subject to the provisions of this Agreement, the Company will, in consultation with Parent, take
all action necessary in accordance with all applicable Law (including the DGCL), the Company’s Organizational Documents and the
rules and regulations of the Nasdaq to establish a record date for, duly call, give notice of, convene and hold a meeting of its
stockholders for the purpose of obtaining the Requisite Stockholder Approval (the “Company Stockholder Meeting”) as
promptly as reasonably practicable following the Registration Statement having been declared effective under the Securities Act. The
Company Stockholder Meeting and the record date therefor shall be set at the sole discretion by the Company Board (or committee thereof)
in consultation with Parent, with any views expressed by Parent related to such dates being considered in good faith by the Company Board
(or committee thereof). Notwithstanding anything to the contrary in this Agreement, the Company will not be required to convene and hold
the Company Stockholder Meeting at any time prior to the 20th Business Day following the mailing of the Proxy Statement/Prospectus to
the Company Stockholders. Subject to Section 5.4 and unless there has been a Company Board Recommendation Change, the Company
will use reasonable best efforts to solicit proxies to obtain the Requisite Stockholder Approval. Without limiting the generality of
the foregoing, the Company agrees that in the event that the Company Board makes a Company Board Recommendation Change, the Company will
nevertheless submit this Agreement to the Company Stockholders for the purpose of obtaining the Requisite Stockholder Approval unless
this Agreement shall have been terminated in accordance with its terms prior to the Company Stockholder Meeting. The Company shall use
reasonable best efforts to keep Parent updated with respect to proxy solicitation efforts and tallies as reasonably requested by Parent
or Merger Sub. Without the prior written consent of Parent, the matters contemplated by the Requisite Stockholder Approval shall be the
only matters (other than matters of procedure and matters required by or advisable under applicable law to be voted on by the Company
Stockholders in connection therewith) that the Company shall propose to be voted on by the Company Stockholders at the Company Stockholder
Meeting.

(b)            Adjournment
of Company Stockholder Meeting. Notwithstanding anything to the contrary in this Agreement, nothing will prevent the Company from
postponing or adjourning the Company Stockholder Meeting (i) if, after consultation with Parent, the Company believes in good faith
that such adjournment or postponement is reasonably necessary to allow additional solicitation of votes in order to obtain the Requisite
Stockholder Approval; (ii) if there are holders of an insufficient shares of the Company Common Stock present or represented by
proxy at the Company Stockholder Meeting to constitute a quorum at the Company Stockholder Meeting; (iii) the Company is required
to postpone or adjourn the Company Stockholder Meeting by applicable Law or a request from the SEC or its staff; or (iv) the Company
Board (or a committee thereof) has determined in good faith (after consultation with outside legal counsel) that it is reasonably likely
to be required under applicable Law to postpone or adjourn the Company Stockholder Meeting in order to give the Company Stockholders
sufficient time to evaluate any information or disclosure that the Company has sent to the Company Stockholders or otherwise made available
to the Company Stockholders (including in connection with any Company Board Recommendation Change); provided that, with respect
to postponements or adjournments in accordance with the preceding clauses (i) and (ii), the Company shall not postpone or adjourn
the Company Stockholder Meeting without Parent’s prior written consent for a period of more than ten (10) Business Days after
the date on which the Company Stockholder Meeting was originally scheduled or (y) ten (10) Business Days before the Termination
Date. The Company shall, if requested by Parent (to the extent permitted by Law), adjourn or postpone the Company Stockholder Meeting
for the absence of quorum or to allow additional solicitation of votes in order to obtain the Requisite Stockholder Approval; provided,
that the Company shall not be required pursuant to this sentence to adjourn the Company Stockholder Meeting more than two (2) times
or for more than ten (10) Business Days in the aggregate from the originally scheduled date of the Company Stockholder Meeting.

6.5            Anti-Takeover
Laws. The Company and the Company Board shall use reasonable best efforts to (a) take all necessary actions within their power
to ensure that no Takeover Law is or becomes applicable to the Merger; and (b) if any Takeover Law becomes applicable to the Merger,
take all reasonable action within their power to ensure that the Merger may be consummated as promptly as reasonably practicable on the
terms contemplated by this Agreement and otherwise use reasonable best efforts to minimize the effect of such statute or regulation on
the Merger.

6.6            Access;
Integration Planning.

(a)            Access.
At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur
of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall, and shall cause
each of its Subsidiaries to, (i) afford Parent and its Representatives reasonable access, consistent with applicable Law, during
normal business hours, upon reasonable advance request provided in writing to the Chief Financial Officer of the Company, or another
Person designated in writing by the Company, to the offices, facilities, properties, Contracts, books and records and personnel of the
Company, and (ii) request its Representatives to cooperate with Parent’s investigation (at Parent’s sole expense), except
that the Company may restrict or otherwise prohibit access to any documents or information to the extent that (a) any applicable
Law or Contract requires the Company to restrict or otherwise prohibit access by Parent or its Representatives to such documents or information;
(b) access to such documents or information would give rise to a material risk of waiving any attorney-client privilege, work product
doctrine or other privilege applicable to such documents or information; (c) such disclosure relates to interactions with other
prospective buyers of the Company or the negotiation of this Agreement and the transactions contemplated hereby, or information relating
to the analysis, valuation or consideration of the Merger or the transactions contemplated hereby; (d) access to a Contract to which
the Company or any of its Subsidiaries is a party or otherwise bound would violate or cause a default pursuant to, or give a third Person
the right to terminate or accelerate the rights pursuant to, such Contract; (e) access would result in the disclosure of any trade
secrets of third Persons; or (f) such documents or information are reasonably pertinent to any adverse Legal Proceeding between
the Company and its Affiliates, on the one hand, and Parent and its Affiliates, on the other hand; provided that the Company shall
use reasonable best efforts to communicate to Parent the requested information (or as much of it as possible) in a way that would not
waive any applicable privilege, contravene any applicable Law or Contract or disclose such trade secrets, as applicable. Nothing in this
Section 6.6(a) shall be construed to require the Company, any of its Subsidiaries or any of their respective Representatives
to prepare any reports, analyses, appraisals, opinions or other information that is not already prepared internally in the ordinary course
of business at the time of such request. Any investigation conducted pursuant to the access contemplated by this Section 6.6(a) shall
be conducted in a manner that does not unreasonably (i) interfere or otherwise result in any significant interference with the discharge
by officers, employees and other authorized Representatives of the Company or any of its Subsidiaries of their normal duties, or (ii) create
a material risk of damage or destruction to any property or assets of the Company or its Subsidiaries. Any access to the properties of
the Company and its Subsidiaries will be subject to the Company’s reasonable security measures and insurance requirements and will,
to the extent not prohibited by the applicable Lease, include the right to perform non-invasive assessments of the environmental condition
of the Leased Real Property or of the compliance of the Company’s operations with Environmental Laws, but will not include the
right to perform invasive testing without the Company’s prior written consent. The terms and conditions of the Confidentiality
Agreement will apply to any non-public information disclosed by the Company, its Subsidiaries or its Representatives pursuant to the
access contemplated by this Section 6.6(a). All requests for access pursuant to this Section 6.6(a) must
be directed to the Chief Financial Officer of the Company or another person designated in writing by the Company.

(b)            Integration
Planning. Promptly following the date hereof, Parent and the Company shall establish a transition and integration planning team (the
“Integration Committee”), consisting of two senior executives of Parent designated by the Chief Executive Officer
of Parent and two senior executives of the Company designated by the Chief Executive Officer of the Company. The chair of the Integration
Committee will be designated by the Chief Executive Officer of Parent. Subject to Section 6.6(a), the Integration Committee
shall meet from time to time, as reasonably requested by the Chief Executive Officer of Parent. Subject to applicable Law and Section 6.6(a),
the Integration Committee shall discuss and plan for a transition and integration planning process concerning the combination of the
operations of Parent, the Company and their respective Subsidiaries after the Closing (the “Integration Plan”), which
the Integration Committee shall use its reasonable best efforts to prepare and agree in draft form by the date that is fifteen (15) days
from the date hereof and shall be finalized prior to the Closing.

6.7            Section 16(b) Exemption. Prior
to the Effective Time, the Company shall be permitted to take all such actions as may be reasonably necessary or advisable hereto to
cause the Merger, and any dispositions of equity securities of the Company (including derivative securities) in connection with the Merger
by each individual who is a director or executive officer of the Company, to be exempt pursuant to Rule 16b-3 promulgated under
the Exchange Act.

6.8            Directors’
and Officers’ Exculpation, Indemnification and Insurance.

(a)            Indemnified
Persons. The Surviving Corporation and its Subsidiaries shall, and Parent shall cause the Surviving Corporation and its Subsidiaries
to, honor and fulfill the obligations of the Company and any of its Subsidiaries pursuant to any indemnification agreements in effect
as of the date of this Agreement between the Company and any of its Subsidiaries, on the one hand, and any of their respective current
or former directors, officers or employees (and any person who becomes a director, officer or employee of the Company or any of its Subsidiaries
prior to the Effective Time), on the other hand (collectively, the “Indemnified Persons”). In addition, during the
period commencing at the Effective Time and ending on the sixth (6th) anniversary of the Effective Time, the Surviving Corporation and
its Subsidiaries shall (and Parent shall cause the Surviving Corporation and its Subsidiaries to) cause the Organizational Documents
of the Surviving Corporation and its Subsidiaries to contain provisions with respect to indemnification, exculpation and the advancement
of expenses that are at least as favorable as the indemnification, exculpation and advancement of expenses provisions set forth in the
Organizational Documents of the Subsidiaries of the Company, as applicable, as of the date of this Agreement. During such six-year period,
such provisions may not be repealed, amended or otherwise modified in any manner that would adversely affect the rights of the Indemnified
Persons thereunder except as required by applicable Law.

(b)            Indemnification
Obligation. Without limiting the generality of the provisions of Section 6.8(a), during the period commencing at the
Effective Time and ending on the sixth (6th) anniversary of the Effective Time, the Surviving Corporation shall (and Parent shall cause
the Surviving Corporation to) indemnify and hold harmless, to the fullest extent permitted by applicable Law or pursuant to any indemnification
agreements with the Company and any of its Subsidiaries in effect on the date of this Agreement, each Indemnified Person from and against
any costs, fees and expenses (including attorneys’ fees and investigation expenses), judgments, penalties, fines, losses, claims,
damages, liabilities and amounts paid in settlement or compromise in connection with any Legal Proceeding, whether civil, criminal, administrative
or investigative, to the extent that such Legal Proceeding arises, directly or indirectly, out of or pertains, directly or indirectly,
to (i) the fact that an Indemnified Person is or was a director, officer, employee or agent of the Company or such Subsidiary or
Affiliate; (ii) any action or omission, or alleged action or omission, in such Indemnified Person’s capacity as a director,
officer, employee or agent of the Company or any of its Subsidiaries or other Affiliates, or taken at the request of the Company or such
Subsidiary or Affiliate (including in connection with serving at the request of the Company or such Subsidiary or Affiliate as a director,
officer, employee, agent, trustee or fiduciary of another Person (including any employee benefit plan)), regardless of whether such action
or omission, or alleged action or omission, occurred prior to, at or after the Effective Time; and (iii) the Merger, as well as
any actions taken by the Company, Parent or Merger Sub with respect thereto, except that if, at any time prior to the sixth (6th) anniversary
of the Effective Time, any Indemnified Person delivers to Parent a written notice asserting a claim for indemnification pursuant to this
Section 6.8(b), then the claim asserted in such notice will survive the sixth (6th) anniversary of the Effective Time until
such claim is fully and finally resolved. In the event of any such Legal Proceeding, the Surviving Corporation shall advance all fees
and expenses (including fees and expenses of any counsel) as incurred by an Indemnified Person in the defense of such Legal Proceeding;
provided that advancement of fees expenses shall be made only upon receipt of an undertaking by such person to repay all amounts
advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such person
is not entitled to be indemnified for such expenses under this Section 6.8(b) or otherwise. Notwithstanding anything
to the contrary in this Agreement, none of Parent, the Surviving Corporation nor any of their respective Affiliates shall settle or otherwise
compromise or consent to the entry of any judgment with respect to, or otherwise seek the termination of, any Legal Proceeding for which
indemnification may be sought by an Indemnified Person pursuant to this Agreement (solely as to settlements, compromises, or releases
of claims against such Indemnified Person) unless such settlement, compromise, consent or termination includes an unconditional release
of such Indemnified Person from all liability arising out of such Legal Proceeding. Any determination required to be made with respect
to whether the conduct of any Indemnified Person complies or complied with any applicable standard will be made by independent legal
counsel selected by the Surviving Corporation, the fees and expenses of which shall be paid by the Surviving Corporation.

(c)            D&O
Insurance. During the period commencing at the Effective Time and ending on the sixth (6th) anniversary of the Effective Time, the
Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) maintain in effect the Company’s current directors’
and officers’ liability insurance (“D&O Insurance”) in respect of acts or omissions occurring at or prior
to the Effective Time on terms (including with respect to coverage, conditions, retentions, limits and amounts) that are substantially
equivalent in the aggregate to those of the D&O Insurance. In satisfying its obligations pursuant to this Section 6.8(c),
the Surviving Corporation will not be obligated to pay annual premiums in excess of 300% of the amount paid by the Company for coverage
for its last full fiscal year (such amount, the “Maximum Annual Premium”). If the annual premiums of such insurance
coverage exceed the Maximum Annual Premium, then the Surviving Corporation shall be obligated to obtain a policy with the greatest coverage
available for a cost not exceeding the Maximum Annual Premium from an insurance carrier with the same or better credit rating as the
Company’s current directors’ and officers’ liability insurance carrier. Prior to the Effective Time, the Company may
purchase a prepaid “tail” policy with respect to the D&O Insurance from an insurance carrier with the same or better
credit rating as the Company’s current directors’ and officers’ liability insurance carrier so long as the aggregate
cost for such “tail” policy does not exceed the Maximum Annual Premium. If the Company elects to purchase such a “tail”
policy prior to the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) maintain such
“tail” policy in full force and effect and continue to honor its obligations thereunder for so long as such “tail”
policy is in full force and effect.

(d)            Successors
and Assigns. If Parent, the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or
merges into any other Person and is not the continuing or surviving corporation or entity in such consolidation or merger; or (ii) transfers
or conveys all or substantially all of its properties and assets to any Person, then proper provisions will be made so that the successors
and assigns of Parent, the Surviving Corporation or any of their respective successors or assigns shall assume all of the obligations
of Parent and the Surviving Corporation set forth in this Section 6.8.

(e)            No
Impairment. The obligations set forth in this Section 6.8 may not be terminated, amended or otherwise modified in any
manner that adversely affects any Indemnified Person (or any other Person who is a beneficiary pursuant to the D&O Insurance or the
“tail” policy referred to in Section 6.8(c) and their heirs and representatives) without the prior written
consent of such affected Indemnified Person or other Person. Each of the Indemnified Persons or other Persons who are beneficiaries pursuant
to the D&O Insurance or the “tail” policy referred to in Section 6.8(c) (and their heirs and representatives)
are intended to be third party beneficiaries of this Section 6.8, with full rights of enforcement as if a Party. The rights
of the Indemnified Persons (and other Persons who are beneficiaries pursuant to the D&O Insurance or the “tail” policy
referred to in Section 6.8(c) (and their heirs and representatives)) pursuant to this Section 6.8 will be
in addition to, and not in substitution for, any other rights that such Persons may have pursuant to (i) the Company’s Organizational
Documents; (ii) the Organizational Documents of the Subsidiaries of the Company; (iii) any and all indemnification agreements
entered into with the Company or any of its Subsidiaries in effect as of the date hereof; or (iv) applicable Law (whether at Law
or in equity).

(f)            Other
Claims. Nothing in this Agreement is intended to, or will be construed to, release, waive or impair any rights to directors’
and officers’ insurance claims pursuant to any applicable insurance policy or indemnification agreement that is or has been in
existence with respect to the Company or any of its Subsidiaries for any of their respective directors, officers or other employees,
it being understood and agreed that the indemnification provided for in this Section 6.8 is not prior to or in substitution
for any such claims pursuant to such policies or agreements.

6.9            Employee
Matters.

(a)            Acknowledgement.
Parent hereby acknowledges and agrees that a “change of control” (or similar phrase) within the meaning of each of the Employee
Plans disclosed in Section 3.20(a)of the Company Disclosure Letter that include such a term or phrase will occur as of the
Effective Time.

(b)            Existing
Arrangements. From and after the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation
to) honor all of the Employee Plans and compensation and severance arrangements in accordance with their terms as in effect immediately
prior to the Effective Time. Notwithstanding the foregoing, nothing will prohibit the Surviving Corporation from amending or terminating
any such Employee Plans or compensation or severance arrangements in accordance with their terms or if otherwise required pursuant to
applicable Law.

(c)            Employment;
Benefits. For a period commencing on the Closing Date and ending on the 12-month anniversary of the Closing Date (or, if shorter,
the applicable Continuing Employee’s period of employment) (the “Continuation Period”), Parent shall (or Parent
shall cause its Subsidiaries, including the Surviving Corporation to) cause each Continuing Employee to be provided with (i) a base
salary or wage rate and a target annual cash incentive opportunity in each case that is no less favorable than such Continuing Employee’s
base salary or wage rate and target annual cash incentive opportunity immediately prior to the Closing; it being understood that Parent
may award any such cash incentive in the form of Parent RSUs, including fully-vested Parent RSUs (or shares of Parent common stock),
and Parent may pay any such cash incentive that is earned in fully-vested RSUs (or shares of Parent common stock), (ii) broad-based
employee benefits (but excluding severance, retention, change-in-control compensation, equity, equity-based
or cash incentive compensation, deferred compensation, defined benefit pension, and retiree medical benefits (collectively, the “Excluded
Benefits”)) that are substantially comparable in the aggregate to (A) those provided to such Continuing Employee immediately
prior to the Closing or (B) those provided to similarly-situated employees of Parent, at Parent’s discretion, and (iii) severance
benefits that are no less favorable than those set forth on Section 6.9(c) of the Company Disclosure Letter. Without
duplication, Continuing Employees will be eligible to participate in Parent’s equity incentive plans, in accordance with the terms
of such plans, in effect from time to time, as determined by, and subject to the approval of, the board of directors of Parent or the
compensation committee thereof, on the same basis as similarly situated employees of Parent.

(d)            New
Plans. With respect to any employee benefit or compensation plans sponsored or maintained by Parent or its Subsidiaries, including
the Surviving Corporation (the “New Plans”), Parent shall (or Parent shall cause its Subsidiaries, including the Surviving
Corporation to) use commercially reasonable efforts to cause each Continuing Employee to be granted credit for all service with the Company
and its Subsidiaries prior to the Effective Time for purposes of eligibility to participate, vesting and entitlement to benefits where
length of service is relevant (including for purposes of vacation or paid time-off accrual and severance pay entitlement) to the same
extent that service was credited under comparable Employee Plans prior to the Closing, except that such service need not be credited
to the extent that it would result in duplication of coverage or benefits. In addition, and without limiting the generality of the foregoing,
Parent shall (or Parent shall cause its Subsidiaries, including the Surviving Corporation to) use commercially reasonable efforts to
cause (i) each Continuing Employee to be immediately eligible to participate, without any waiting period, in any New Plan to the
extent that coverage pursuant to any such New Plan replaces coverage pursuant to a comparable Employee Plan in which such Continuing
Employee participates immediately before the Effective Time (such plans, the “Old Plans”); and (ii) for purposes
of each New Plan providing life insurance, medical, dental, pharmaceutical, vision or disability benefits to any Continuing Employee,
all waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work or similar requirements
of such New Plan to be waived for such Continuing Employee and his or her covered dependents to the same extents such requirements were
waived or satisfied under the comparable Old Plan, and any eligible expenses incurred by such Continuing Employee and his or her covered
dependents during the portion of the plan year of the Old Plan ending on the date that such Continuing Employee’s participation
in the corresponding New Plan begins to be given full credit pursuant to such New Plan for purposes of satisfying all deductible, coinsurance
and maximum out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for the applicable plan
year as if such amounts had been paid in accordance with such New Plan.

(e)            Additional
Matters. Parent and the Company agree to the matters set forth in Section 6.9(e) of the Company Disclosure Letter.

(f)             No
Third Party Beneficiary Rights. Notwithstanding anything to the contrary set forth in this Agreement, this Section 6.9
will not be deemed to (i) guarantee employment for any period of time or any term or condition of employment for, or preclude the
ability of Parent, the Surviving Corporation or any of their respective Subsidiaries to terminate any Continuing Employee or other service
provider for any reason; (ii) require Parent, the Surviving Corporation or any of their respective Subsidiaries to continue any
Employee Plan, New Plan or Old Plan or other compensation or benefit plan, policy, program, agreement, practice or other arrangement
or prevent the amendment, modification or termination thereof after the Effective Time; (iii) be an amendment, waiver or creation
of any Employee Plan, New Plan or Old Plan or other compensation or benefit plan, policy, program, agreement, practice or other arrangement;
or (iv) create any third party beneficiary rights in any Person.

6.10          Obligations
of Merger Sub. Parent shall take all action necessary to cause Merger Sub and the Surviving Corporation to perform their respective
obligations pursuant to this Agreement and to consummate the Merger upon the terms and subject to the conditions set forth in this Agreement.
Parent and Merger Sub shall be jointly and severally liable for the failure by either of them to perform and discharge any of their respective
covenants, agreements and obligations pursuant to this Agreement.

6.11          Public
Statements and Disclosure. The initial press release with respect to the execution and delivery of this Agreement and the Merger
shall be a joint press release reasonably acceptable to the Company and Parent. Thereafter, the Company (other than with respect to the
portion of any communication relating to an Acquisition Proposal or Company Board Recommendation Change, subject to the requirements
of Section 5.4), on the one hand, and Parent and Merger Sub, on the other hand, will use their respective reasonable best
efforts to consult with the other Parties, and provide each other the opportunity to review and comment, before (a) participating
in any media interviews; (b) engaging in any meetings or calls with analysts, institutional investors or other similar Persons;
or (c) providing any statements that are public or are reasonably likely to become public, in any such case to the extent relating
to the Merger, except that no Party will be obligated to engage in such consultation with respect to communications that are (i) required
by applicable Law, regulation or stock exchange rule or listing agreement, or requested by applicable regulator or stock exchange
(provided that the Party making such communication uses its reasonable best efforts to consult with the other Party to the extent practicable);
(ii) consistent with public statements previously made in accordance with this Section 6.11; or (iii) principally
directed to its employees, suppliers, customers, partners or vendors and not inconsistent with public statements previously made in accordance
with this Section 6.11.

6.12          Transaction
Litigation. Prior to the Effective Time, each Party will provide the other Parties with prompt notice of all Transaction Litigation
(including by providing copies of all pleadings with respect thereto) and keep such other Parties reasonably informed with respect to
the status thereof. Each Party will (a) give the other Parties the opportunity to participate in (but not control) the defense,
settlement or prosecution of any Transaction Litigation; and (b) consult with the other Parties with respect to the defense, settlement
and prosecution of any Transaction Litigation. The Company may not compromise or settle, or agree to compromise or settle, any Transaction
Litigation unless Parent has consented thereto in writing (such consent not to be unreasonably withheld, conditioned or delayed). For
purposes of this Section 6.12, “participate” means that (i) the other Party shall be kept apprised of proposed
strategy and other significant decisions with respect to the Transaction Litigation by the first Party receiving notice of Transaction
Litigation (to the extent that the attorney-client privilege between such Party and its counsel is not undermined or otherwise affected),
and (ii) may offer comments or suggestions with respect to such Transaction Litigation but will not be afforded any decision-making
power or other authority over such Transaction Litigation except for the settlement or compromise consent set forth above.

6.13          Stock
Exchange Delisting; Deregistration. Prior to the Effective Time, the Company shall cooperate with Parent and use its reasonable best
efforts to take, or cause to be taken, all actions and do, or cause to be done, all things reasonably necessary, proper or advisable
on its part pursuant to applicable Law and the rules and regulations of Nasdaq to cause (a) the delisting of the Company Common
Stock from Nasdaq as promptly as practicable after the Effective Time; and (b) the deregistration of the Company Common Stock pursuant
to the Exchange Act as promptly as practicable after such delisting.

6.14          Parent
Vote. Immediately following the execution and delivery of this Agreement, Parent, in its capacity as the sole stockholder of Merger
Sub, shall execute and deliver to Merger Sub and the Company a written consent adopting this Agreement in accordance with the DGCL.

6.15          No
Employment Discussions. Except as approved or permitted by the Company Board (or a committee thereof), at all times during the period
commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement
pursuant to Article VIII and the Effective Time, Parent and Merger Sub will not, and will not permit any of their Representatives
to authorize, make or enter into, or commit or agree to enter into, any formal or informal arrangements or other understandings (whether
or not binding) with any executive officer of the Company (i) regarding any continuing employment or consulting relationship with
the Surviving Corporation, Parent or its Affiliates from and after the Effective Time; (ii) pursuant to which any such individual
would be entitled to receive consideration of a different amount or nature than the Merger Consideration in respect of such holder’s
shares of Company Common Stock; or (iii) pursuant to which such individual would agree to provide, directly or indirectly, equity
investment to Parent, Merger Sub or the Company to finance any portion of the Merger.

6.16          Specified
Legal Proceedings. Notwithstanding anything to the contrary in this Agreement (including Section 5.2(i)), from the execution
and delivery of this Agreement until the Effective Time, the Company will (a) reasonably consult with Parent regarding the status
of the Legal Proceedings described on Section 6.16 of the Company Disclosure Letter (such Legal Proceedings, the “Specified
Legal Proceedings”), (b) promptly notify Parent of any material developments in the Specified Legal Proceedings and any
Governmental Proceedings and provide Parent with a reasonable opportunity to review and comment on such material developments in the
Specified Legal Proceedings and (c) consider in good faith all comments reasonably proposed by Parent with respect to the Specified
Legal Proceedings. From the execution and delivery of this Agreement until the Effective Time, the Company will use reasonable efforts
to take the actions specified in Section 6.16 of the Company Disclosure Letter; provided, however, that any failure
to comply with this second sentence of Section 6.16 shall not constitute the failure of any condition set forth in Article VII
to be satisfied unless the underlying fact, circumstance, action or failure to act would independently result in the failure of a
condition set forth in Article VII to be satisfied.

6.17          Tax
Treatment of the Merger. The Parties intend that for U.S. federal income tax purposes the Merger constitutes a taxable stock purchase
and not a reorganization within the meaning of Sections 368(a) of the Code (the “Intended Tax Treatment”). Parent
shall, and shall cause Midco, Merger Sub and the Company to, file all Tax Returns in a manner consistent with the Intended Tax Treatment
except as required by applicable Law following a final determination within the meaning of Section 1313(a) of the Code.

6.18          Real
Estate Plan. During the period from the execution and delivery of this Agreement until the earlier to occur of the termination of
this Agreement pursuant to Article VIII and the Effective Time, the Company shall, and shall cause its Subsidiaries as applicable
to, comply with, in all material respects, the real estate, leasehold improvement, capital expenditure, sublease and other activities
related to the Leased Real Property as detailed in Section 6.18 of the Company Disclosure Letter (the “Real Estate
Plan”); provided, however, that prior to the Effective Time, the Company shall have the right to modify the Real Estate Plan
(a) to the extent necessary to comply with applicable Law, (b) to take any Permitted Action, subject to reasonable prior consultation
with Parent or (c) as approved by Parent (in its sole discretion).

6.19          Additional
Agreements. If at any time after the Effective Time any further action is necessary or desirable to carry out the purposes of this
Agreement or to vest the Surviving Corporation with full title to all properties, assets, rights, approvals, immunities and franchises
of either of the Company or Merger Sub, then the proper officers and directors of each Party shall use their reasonable best efforts
to take such action.

Article VII
CONDITIONS TO THE MERGER

7.1            Conditions
to Each Party’s Obligations to Effect the Merger. The respective obligations of Parent, Merger Sub and the Company to consummate
the Merger are subject to the satisfaction (or waiver by Parent and the Company where permissible pursuant to applicable Law) at or prior
to the Effective Time of each of the following conditions:

(a)            Requisite
Stockholder Approval. The Company’s receipt of the Requisite Stockholder Approval at the Company Stockholder Meeting.

(b)            HSR
Act. The waiting periods (and any extensions thereof), if any, applicable to the Merger pursuant to the HSR Act will have expired
or otherwise been terminated.

(c)            No
Prohibitive Laws or Injunctions. No Law, temporary restraining order, preliminary or permanent injunction issued by any court of
competent jurisdiction or other legal or regulatory restraint or prohibition preventing the consummation of the Merger will be in effect,
and no statute, rule, regulation or order will have been enacted, entered, enforced or deemed applicable to the Merger, that in each
case prohibits, makes illegal, or enjoins the consummation of the Merger.

(d)            Registration
Statement Effectiveness. The Registration Statement shall have become effective in accordance with the provisions of the Securities
Act and no stop order suspending the effectiveness of the Registration Statement shall have been issued by the SEC and remain in effect
and no proceeding to that effect shall have been commenced or threatened unless subsequently withdrawn.

(e)            Exchange
Listing. The shares of Parent Class A Common Stock to be issued in the Merger shall have been authorized and approved for listing
on NYSE (or any successor inter-dealer quotation system or stock exchange thereto) subject to official notice of issuance.

7.2            Conditions
to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger shall be subject to
the satisfaction or waiver (where permissible pursuant to applicable Law) at or prior to the Effective Time of each of the following
conditions, any of which may be waived exclusively by Parent:

(a)            Representations
and Warranties.

(i)            Other
than the representations and warranties listed in Sections 7.2(a)(ii) and 7.2(a)(iii), the representations and warranties
of the Company set forth in Article III shall be true and correct as of the date hereof and as of the Closing Date as if
made at and as of the Closing Date (in each case except to the extent that any such representation and warranty expressly speaks as of
an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date) without giving effect
to any materiality or Company Material Adverse Effect qualifications set forth therein, except for such failures to be true and correct
that have not had, and would not reasonably be expected to have a Company Material Adverse Effect.

(ii)           The
representations and warranties set forth in Section 3.1, Section 3.2, Section 3.3(c), Section 3.4,
Section 3.8(b), the first sentence of Section 3.8(c) and the second sentence of Section 3.13
that (A) are not qualified by Company Material Adverse Effect or other materiality qualifiers shall be true and correct in all material
respects as of the date hereof and as of the Closing Date as if made at and as of the Closing Date (in each case except to the extent
that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall
be true and correct in all material respects as of such earlier date); and (B) that are qualified by Company Material Adverse Effect
or other materiality qualifiers shall be true and correct as of the date hereof and as of the Closing Date as if made at and as of the
Closing Date (in each case except to the extent that any such representation and warranty expressly speaks as of an earlier date, in
which case such representation and warranty shall be true and correct as of such earlier date) without disregarding such Company Material
Adverse Effect or other materiality qualifiers qualifications.

(iii)          The
representations and warranties set forth in Section 3.8(a) shall have been true and correct as of the Company Capitalization
Date, except for de minimis inaccuracies.

(b)            Performance
of Obligations of the Company. Other than the covenants, obligations and conditions set forth in Section 6.18, the Company
shall have performed and complied in all material respects with the covenants, obligations and conditions of this Agreement required
to be performed and complied with by it at or prior to the Closing.

(c)            Certain
Expenses. (i) The Company shall not have incurred or otherwise become liable for additional costs, expenses or liabilities to
the Company or its Subsidiaries with respect to Leased Real Property not contemplated by the Real Estate Plan (whether paid, payable,
or incurred (but not yet paid)), and (ii) the Specified Legal Proceedings and any Governmental Proceedings are not reasonably expected
to result in future money damages payable by the Company or its Subsidiaries (in excess of any applicable insurance deductible and coverage
amounts), where, the aggregate of clauses (i) and (ii), exceed $25,000,000.

(d)            Officer’s
Certificate. Parent and Merger Sub shall have received a certificate of the Company, validly executed for and on behalf of the Company
and in its name by a duly authorized executive officer thereof, certifying that the conditions set forth in Section 7.2(a),
Section 7.2(b), Section 7.2(c) and Section 7.2(e) have been satisfied.

(e)            Company
Material Adverse Effect. No Company Material Adverse Effect shall have occurred after the date of this Agreement that is continuing.

7.3            Conditions
to the Company’s Obligations to Effect the Merger. The obligations of the Company to consummate the Merger are subject to the
satisfaction (or waiver by the Company where permissible pursuant to applicable Law) prior to the Effective Time of each of the following
conditions, any of which may be waived exclusively by the Company:

(a)            Representations
and Warranties.

(i)            Other
than the representations and warranties listed in Sections 7.3(a)(ii) and 7.3(a)(iii), the representations and warranties
of Parent and Merger Sub set forth in Article IV shall be true and correct as of the date hereof and as of the Closing Date
as if made at and as of the Closing Date (in each case except to the extent that any such representation and warranty expressly speaks
as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date) without giving
effect to any materiality or Parent Material Adverse Effect qualifications set forth therein, except for such failures to be true and
correct that have not had, and would not reasonably be expected to have a Parent Material Adverse Effect.

(ii)            The
representations and warranties set forth in Sections 4.1(a) and 4.1(b), Section 4.2, Section 4.9,
Section 4.15(b), the first sentence of Section 4.15(c) and the second sentence of Section 4.19
that (A) are not qualified by Parent Material Adverse Effect or other materiality qualifiers shall be true and correct in all material
respects as of the date hereof and as of the Closing Date as if made at and as of the Closing Date (in each case except to the extent
that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall
be true and correct in all material respects as of such earlier date); and (B) that are qualified by Parent Material Adverse Effect
or other materiality qualifiers shall be true and correct as of the date hereof and as of the Closing Date as if made at and as of the
Closing Date (in each case except to the extent that any such representation and warranty expressly speaks as of an earlier date, in
which case such representation and warranty shall be true and correct as of such earlier date) without disregarding such Parent Material
Adverse Effect or other materiality qualifiers qualifications.

(iii)          The
representations and warranties set forth in Section 4.15(a) shall have been true and correct as of the Parent Capitalization
Date, except for de minimis inaccuracies.

(b)            Performance
of Obligations of Parent and Merger Sub. Parent and Merger Sub shall have performed and complied in all material respects with the
covenants, obligations and conditions of this Agreement required to be performed and complied with by Parent and Merger Sub at or prior
to the Closing.

(c)            Officer’s
Certificate. The Company shall have received a certificate of Parent and Merger Sub, validly executed for and on behalf of Parent
and Merger Sub and in their respective names by a duly authorized officer thereof, certifying that the conditions set forth in Section 7.3(a),
Section 7.3(b) and Section 7.3(d) have been satisfied.

(d)            Parent
Material Adverse Effect. No Parent Material Adverse Effect shall have occurred after the date of this Agreement that is continuing.

Article VIII
TERMINATION, AMENDMENT AND WAIVER

8.1            Termination.
This Agreement may be validly terminated only as follows (it being understood and agreed that this Agreement may not be terminated for
any other reason or on any other basis):

(a)            at
any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval) by mutual written
agreement of Parent and the Company;

(b)            by
either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder
Approval) if (i) any permanent injunction or other judgment or order issued by any court of competent jurisdiction or other legal
or regulatory restraint or prohibition preventing the consummation of the Merger will be in effect, or any action has been taken by any
Governmental Authority of competent jurisdiction, that, in each case, prohibits, makes illegal or enjoins the consummation of the Merger
and has become final and non-appealable; or (ii) any statute, rule, regulation or order will have been enacted, entered, enforced
or deemed applicable to the Merger that prohibits, makes illegal or enjoins the consummation of the Merger, except that the right to
terminate this Agreement pursuant to this Section 8.1(b) will not be available to any Party whose action or failure
to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the primary cause of, or primarily
resulted in such injunction, action, statute, rule, regulation or order;

(c)            by
either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder
Approval) if the Effective Time has not occurred by 11:59 p.m., New York City time, on January 24, 2023 (the “Initial Termination
Date”); provided, that in the event that at the Termination Date, all of the conditions in Article VII other than
or Section 7.1(b) or Section 7.1(c) (to the extent the failure of such condition arises from or relates
to Antitrust Laws) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date) or have
been waived by Parent and Merger Sub or the Company, as applicable, then either the Company or Parent may, in its respective sole discretion,
elect to extend the Termination Date to April 24, 2023 (the “First Extended Termination Date”) by delivering
written notice to the other Party no later than the Initial Termination Date; provided further, that in the event that at the First Extended
Termination Date all of the conditions in Article VII other than Section 7.1(b) or Section 7.1(c) (to
the extent the failure of such condition arises from or relates to Antitrust Laws) have been satisfied (other than conditions that by
their nature can only be satisfied on the Closing Date) or have been waived by Parent and Merger Sub or the Company, as applicable, then
either the Company or Parent may, in its respective sole discretion, elect to extend the Termination Date to July 24, 2023 by delivering
written notice to the other Party no later than the First Extended Termination Date, in each case, unless Parent and the Company mutually
agree to an earlier Termination Date; it being understood that the right to terminate this Agreement pursuant to this Section 8.1(c) will
not be available to any Party whose action or failure to act (which action or failure to act constitutes a breach by such Party of this
Agreement) has been the primary cause of, or primarily resulted in, either (i) the failure to satisfy the conditions to the obligations
of the terminating Party to consummate the Merger set forth in Article VII prior to the then-scheduled Termination Date;
or (ii) the failure of the Effective Time to have occurred prior to the then-scheduled Termination Date;

(d)            by
either Parent or the Company, at any time prior to the Effective Time if the Company fails to obtain the Requisite Stockholder Approval
at the Company Stockholder Meeting (or any adjournment or postponement thereof) at which a vote is taken on the Merger, except that the
right to terminate this Agreement pursuant to this Section 8.1(d) will not be available to any Party whose action or
failure to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the cause of, or resulted
in, the failure to obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment or postponement thereof);

(e)            by
Parent, if the Company has breached or failed to perform in any material respect any of its representations, warranties, covenants or
other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in
Section 7.1 or Section 7.2, except that if such breach is capable of being cured by the Termination Date, Parent
will not be entitled to terminate this Agreement pursuant to this Section 8.1(e) prior to the delivery by Parent to
the Company of written notice of such breach, delivered at least 45 days prior to such termination (or such shorter period of time as
remains prior to the Termination Date, the shorter of such periods, the “Company Breach Notice Period”), stating Parent’s
intention to terminate this Agreement pursuant to this Section 8.1(e) and the basis for such termination, it being understood
that Parent will not be entitled to terminate this Agreement if such breach has been cured within the Company Breach Notice Period (to
the extent capable of being cured);

(f)             by
Parent, if (i) at any time the Company Board (or a committee thereof) has effected a Company Board Recommendation Change, (ii) the
Company shall have committed a Willful and Material Breach of its obligations under Section 5.4(a) or (iii) there
is a Legal Proceedings Development, except that Parent’s right to terminate this Agreement pursuant to this Section 8.1(f)(iii) will
expire at 5:00 p.m., New York City time, on the tenth (10th) day following the date on which the Company informs Parent in writing of
the occurrence of a material development in any Specified Legal Proceeding or any Governmental Proceeding that constitutes a Legal Proceedings
Development;

(g)            by
the Company, if Parent or Merger Sub has breached or failed to perform in any material respect any of its respective representations,
warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform would result in a failure of
a condition set forth in Section 7.1 or Section 7.3, except that if such breach is capable of being cured by
the Termination Date, the Company will not be entitled to terminate this Agreement pursuant to this Section 8.1(g) prior
to the delivery by the Company to Parent of written notice of such breach, delivered at least 45 days prior to such termination (or such
shorter period of time as remains prior to the Termination Date, the shorter of such periods, the “Parent Breach Notice Period”),
stating the Company’s intention to terminate this Agreement pursuant to this Section 8.1(g) and the basis for
such termination, it being understood that the Company will not be entitled to terminate this Agreement if such breach has been cured
within the Parent Breach Notice Period (to the extent capable of being cured); or

(h)            by
the Company, at any time prior to receiving the Requisite Stockholder Approval if (i) the Company has received a Superior Proposal;
and (ii) the Company enters into an Alternative Acquisition Agreement to consummate the Acquisition Transaction contemplated by
that Superior Proposal, and pays the Company Termination Fee in accordance with Section 8.3(b)(iii), substantially concurrently
with the termination of this Agreement pursuant to this Section 8.1(h).

8.2            Manner
and Notice of Termination; Effect of Termination.

(a)            Manner
of Termination. The Party terminating this Agreement pursuant to Section 8.1 (other than pursuant to Section 8.1(a))
must deliver prompt written notice thereof to the other Parties specifying the provision of Section 8.1 pursuant to which
this Agreement is being terminated and setting forth in reasonable detail the facts and circumstances forming the basis for such termination
pursuant to such provision.

(b)            Effect
of Termination. Any proper and valid termination of this Agreement pursuant to Section 8.1 will be effective immediately
upon the delivery of written notice by the terminating Party to the other Parties. In the event of the termination of this Agreement
pursuant to Section 8.1, this Agreement will be of no further force or effect without liability of any Party (or any partner,
member, stockholder, director, officer, employee, Affiliate, agent or other Representative of such Party) to the other Parties, as applicable,
except that Article I, Section 3.28, Section 4.22, the second sentence of Section 6.10,
this Section 8.2, Section 8.3, Section 8.4, Section 8.5 and Article IX (but
not Section 9.8(b) with respect to provisions of this Agreement that have terminated) will each survive the termination
of this Agreement. Nothing in this Agreement or the termination hereof will relieve any Party from any liability for any Willful and
Material Breach of this Agreement. In addition to the foregoing, no termination of this Agreement will affect the rights or obligations
of any Party pursuant to the Confidentiality Agreement, which rights, obligations and agreements will survive the termination of this
Agreement in accordance with their respective terms.

8.3            Fees
and Expenses.

(a)            General.
Except as set forth in this Agreement, all fees and expenses incurred in connection with this Agreement and the Merger shall be paid
by the Party incurring such fees and expenses whether or not the Merger is consummated. For the avoidance of doubt, Parent or the Surviving
Corporation shall be responsible for all fees and expenses of the Exchange Agent.

(b)            Company
Termination Fee.

(i)            If
(A) this Agreement is validly terminated pursuant to Sections 8.1(c), 8.1(d) or 8.1(e); (B) (1) following
the execution and delivery of this Agreement and prior to the termination of this Agreement pursuant to Section 8.1(d), a
bona fide Acquisition Proposal for an Acquisition Transaction has been publicly announced and not publicly withdrawn, or (2) following
the execution and delivery of this Agreement and prior to the termination of this Agreement pursuant to Section 8.1(c) or
8.1(e), a bona fide Acquisition Proposal for an Acquisition Transaction has been communicated to the Company Board or publicly
announced and not withdrawn (publicly in the case of a publicly announced Acquisition Proposal); and (C) within twelve (12) months
following the termination of this Agreement pursuant to Sections 8.1(c), 8.1(d) or 8.1(e) either an Acquisition
Transaction is consummated or the Company enters into a definitive agreement providing for the consummation of an Acquisition Transaction,
then the Company shall promptly (and in any event within two (2) Business Days) after the earlier of (x) entry into a definitive
agreement providing for the consummation of the Acquisition Transaction and (y) such consummation of the Acquisition Transaction,
pay the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent.
For purposes of this Section 8.3(b)(i), all references to “20%” in the definition of “Acquisition Transaction”
will be deemed to be references to “50%”.

(ii)           If
this Agreement is validly terminated pursuant to Section 8.1(f)(i) or Section 8.1(f)(ii), then the Company
must promptly (and in any event within two (2) Business Days) following such termination pay, or cause to be paid, to Parent the
Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent.

(iii)          If
this Agreement is validly terminated pursuant to Section 8.1(h), then the Company must substantially concurrently with such
termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account
or accounts designated in writing by Parent.

(i)            by
Parent or the Company pursuant to Section 8.1(b) (solely to the extent arising from or relating to Antitrust Laws) and,
at the time of such termination, (A) all conditions to the obligations of Parent and Merger Sub to consummate the Merger set forth
in Section 7.1 and Section 7.2 (other than the conditions set forth in Section 7.1(b), Section 7.1(c) (solely
to the extent the failure of such condition arises from or relates to Antitrust Laws) and, if the Company Stockholder Meeting has not
yet occurred, Section 7.1(a)) have been satisfied or waived (other than those conditions that by their nature are to be satisfied
at the Closing, each of which is capable of being satisfied at the Closing)and (B) the Company’s action or failure to act
(which action or failure to act constitutes a breach by the Company of this Agreement) has not been the primary cause of, or primarily
resulted in, such failure of the condition set forth in Section 7.1(b) or Section 7.1(c) to be satisfied;
or

(ii)           by
Parent or the Company pursuant to Section 8.1(c) and, at the time of such termination, (A) the conditions set forth
in at least one of Section 7.1(b) or Section 7.1(c) (solely to the extent the failure of such condition
arises from or relates to Antitrust Laws) shall not have been satisfied or waived, (B) all other conditions to the obligations of
Parent and Merger Sub to effect the Merger set forth in Section 7.1 and Section 7.2 have been satisfied or waived
(other than those conditions that by their nature are to be satisfied at the Closing, each of which is capable of being satisfied at
the Closing) and (C) the Company’s action or failure to act (which action or failure to act constitutes a breach by the Company
of this Agreement) has not been the primary cause of, or primarily resulted in, such failure of the condition set forth in Section 7.1(b) or
Section 7.1(c) to be satisfied;

then, in either case of clauses (i) and
(ii) above, Parent shall pay, or cause to be paid, the Parent Termination Fee by wire transfer of immediately available funds to
an account or accounts designated in writing by the Company.

(d)            Single
Payment Only. The Parties acknowledge and agree that in no event will the Company be required to pay the Company Termination Fee
on more than one occasion or Parent be required to pay the Parent Termination Fee on more than one occasion, whether or not the Company
Termination Fee or the Parent Termination Fee, as applicable, may be payable pursuant to more than one provision of this Agreement at
the same or at different times and upon the occurrence of different events.

(e)            Payments;
Default. The Parties acknowledge that the agreements contained in this Section 8.3 are an integral part of the Merger,
and that, without these agreements, the Parties would not enter into this Agreement. Accordingly, (i) if the Company fails to promptly
pay any amount due pursuant to Section 8.3(b) and, in order to obtain such payment, Parent, on the one hand, or the
Company, on the other hand, commences a Legal Proceeding that results in a judgment against the Company for the amount set forth in Section 8.3(b) or
any portion thereof, the Company shall pay to Parent its out-of-pocket costs and expenses (including attorneys’ fees) in connection
with such Legal Proceeding, together with interest on such amount or portion thereof at the annual rate of 5% plus the prime rate as
published in The Wall Street Journal in effect on the date that such payment or portion thereof was required to be made through
the date that such payment or portion thereof was actually received, or a lesser rate that is the maximum permitted by applicable Law
and (ii) if Parent fails to promptly pay any amount due pursuant to Section 8.3(c) and, in order to obtain such
payment, the Company, on the one hand, or Parent, on the other hand, commences a Legal Proceeding that results in a judgment against
Parent for the amount set forth in Section 8.3(c) or any portion thereof, Parent shall pay to the Company its out-of-pocket
costs and expenses (including attorneys’ fees) in connection with such Legal Proceeding, together with interest on such amount
or portion thereof at the annual rate of 5% plus the prime rate as published in The Wall Street Journal in effect on the date
that such payment or portion thereof was required to be made through the date that such payment or portion thereof was actually received,
or a lesser rate that is the maximum permitted by applicable Law.

(f)             Sole
Remedy of Parent. Notwithstanding anything herein to the contrary, Parent and Merger Sub agree that Company’s payment of the
Company Termination Fee under circumstances in which the Company Termination Fee is payable pursuant to Section 8.3(b) will
be deemed to be liquidated damages, and not a penalty, and will constitute the sole and exclusive monetary remedy available to Parent
and Merger Sub and each of their respective Affiliates against (i) the Company, its Subsidiaries and each of their respective Affiliates;
and (ii) the former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys,
Affiliates, members, managers, general or limited partners, stockholders and assignees of each of the Company, its Subsidiaries and each
of their respective Affiliates (collectively, the “Company Related Parties”) in respect of this Agreement, any agreement
executed in connection herewith and the transactions contemplated hereby and thereby (including any and all losses or damages suffered
or incurred by Parent, Merger Sub, or their respective Affiliates in connection herewith or therewith (including the termination hereof
or thereof or any matter forming a basis for such termination)), and upon payment of such amounts, none of the Company Related Parties
will have any further liability or obligation to Parent or Merger Sub relating to or arising out of this Agreement, any agreement executed
in connection herewith or the transactions contemplated hereby and thereby (except that the Parties (or their Affiliates) will remain
obligated with respect to, and the Company and its Subsidiaries may be entitled to remedies with respect to, the Confidentiality Agreement,
Section 8.2 and Section 8.3, as applicable).

(g)            Sole
Remedy of the Company. Notwithstanding anything herein to the contrary, the Company agrees that Parent’s payment of the Parent
Termination Fee under circumstances in which the Parent Termination Fee is payable pursuant to Section 8.3(c) will be
deemed to be liquidated damages, and not a penalty, and will constitute the sole and exclusive monetary remedy available to the Company
and each of its respective Affiliates against (i) Parent, its Subsidiaries and each of their respective Affiliates; and (ii) the
former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys, Affiliates,
members, managers, general or limited partners, stockholders and assignees of each of Parent, its Subsidiaries and each of their respective
Affiliates (collectively, the “Parent Related Parties”) in respect of this Agreement, any agreement executed in connection
herewith and the transactions contemplated hereby and thereby (including any and all losses or damages suffered or incurred by the Company
or its Affiliates in connection herewith or therewith (including the termination hereof or thereof or any matter forming a basis for
such termination)), and upon payment of such amounts, none of the Parent Related Parties will have any further liability or obligation
to the Company relating to or arising out of this Agreement, any agreement executed in connection herewith or the transactions contemplated
hereby and thereby (except that the Parties (or their Affiliates) will remain obligated with respect to, and Parent and its Subsidiaries
may be entitled to remedies with respect to, the Confidentiality Agreement, Section 8.2 and Section 8.3, as applicable).

(h)            Injunctive
Relief. Notwithstanding anything to the contrary in Section 8.3(f), it is agreed that Parent, Merger Sub and the Company
will be entitled to an injunction, specific performance or other equitable relief as provided in Section 9.8(b) (but
not, following the valid termination of this Agreement, with respect to sections of this Agreement that do not survive such termination).

8.4            Amendment.
Subject to applicable Law and subject to the other provisions of this Agreement, this Agreement may be amended by the Parties at any
time by execution of an instrument in writing signed on behalf of each of Parent, Merger Sub and the Company (pursuant to authorized
action by the Company Board (or a committee thereof)), except that in the event that the Company has received the Requisite Stockholder
Approval, no amendment may be made to this Agreement that requires the approval of the Company Stockholders pursuant to the DGCL without
such approval.

8.5            Extension;
Waiver. At any time and from time to time prior to the Effective Time, any Party may, to the extent legally allowed and except as
otherwise set forth herein, (a) extend the time for the performance of any of the obligations or other acts of the other Party,
as applicable; (b) waive any inaccuracies in the representations and warranties made to such Party contained herein or in any document
delivered pursuant hereto; and (c) subject to the requirements of applicable Law, waive compliance with any of the agreements or
conditions for the benefit of such Party contained herein. Any agreement on the part of a Party to any such extension or waiver will
be valid only if set forth in an instrument in writing signed by such Party. Any delay in exercising any right pursuant to this Agreement
will not constitute a waiver of such right.

Article IX
GENERAL PROVISIONS

9.1            Survival.
The representations, warranties, covenants and agreements of the Company, Parent and Merger Sub contained in this Agreement or in any
certificate delivered pursuant to this Agreement will terminate at the Effective Time (including any rights arising out of any breach
of such representations, warranties, covenants, or agreements (and there shall be no liability after the Closing in respect thereof)),
except that any covenants or agreements that by their terms survive the Effective Time shall survive the Effective Time in accordance
with their respective terms.

9.2            Notices.
All notices and other communications hereunder must be in writing and will be deemed to have been duly delivered and received hereunder
(i) one (1) Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight
courier service; (ii) immediately upon delivery by hand, or (iii) by e-mail, upon written or electronic confirmation of receipt,
in each case to the intended recipient as set forth below:

(a)            if
to Parent or Merger Sub to:

Ginkgo
Bioworks Holdings, Inc.
27 Drydock Avenue, 8^th Floor
Boston, Massachusetts 02210
Attn: Anna Marie Wagner; Karen Tepichin
E-mail: [email protected];

[email protected]

with copies (which will not constitute notice) to:

Ropes & Gray LLP

1211 Avenue of the Americas

New York, NY 10036

Attn:
Suni Sreepada
E-mail: [email protected]

and

Ropes & Gray LLP

800 Boylston Street

Boston, MA 02199

Attn: Marko Zatylny

E-mail: [email protected]

(b)            if
to the Company (prior to the Effective Time) to:

Zymergen
Inc.
5980 Horton Street, Suite 105
Emeryville, CA 94608
Attn: Ena Singh; Celeste Ferber
E-mail: [email protected]; [email protected]

with a copy (which will not constitute notice) to:

Freshfields Bruckhaus Deringer US LLP
855 Main St.
Redwood City, CA 94063
Attn: Joseph Halloum
E-mail: [email protected]

Any notice received by e-mail
or otherwise at the addressee’s location on any Business Day after 5:00 p.m., addressee’s local time, or on any day that
is not a Business Day will be deemed to have been received at 9:00 a.m., addressee’s local time, on the next Business Day. From
time to time, any Party may provide notice to the other Parties of a change in its address or e-mail address through a notice given in
accordance with this Section 9.2, except that that notice of any change to the address or any of the other details specified
in or pursuant to this Section 9.2 will not be deemed to have been received until, and will be deemed to have been received
upon, the later of the date (A) specified in such notice; or (B) that is two (2) Business Days after such notice would
otherwise be deemed to have been received pursuant to this Section 9.2.

9.3            Assignment.
No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder, by operation of Law or otherwise,
without the prior written approval of the other Parties. This Agreement will be binding upon and shall inure to the benefit of the Parties
and their respective successors and assigns. No assignment by any Party will relieve such Party of any of its obligations hereunder.
Any purported assignment of this Agreement without the consent required by this Section 9.3 is null and void.

9.4            Confidentiality
Agreement. Parent, Merger Sub and the Company hereby acknowledge that Parent and the Company have previously executed a confidentiality
letter agreement, dated March 16, 2022, as amended and restated on June 16, 2022 (the “Confidentiality Agreement”),
that shall continue in full force and effect in accordance with its terms. Each of Parent, Merger Sub and their respective Representatives
shall hold and treat all documents and information concerning the Company and its Subsidiaries furnished or made available to Parent,
Merger Sub or their respective Representatives in connection with the Merger in accordance with the Confidentiality Agreement. By executing
this Agreement, each of Parent and Merger Sub agree to be bound by and comply with, and to cause their Representatives to be bound by
and comply with, the terms and conditions of the Confidentiality Agreement as if they were parties thereto, to the extent provided in
the Confidentiality Agreement. The Company and its Representatives shall hold and treat all documents and information concerning Parent
and its Subsidiaries furnished or made available to the Company or its Representatives in connection with the Merger in accordance with
the Confidentiality Agreement. By executing this Agreement, the Company agrees to be bound by and comply with, and to cause its Representatives
to be bound by and comply with, the terms and conditions of the Confidentiality Agreement as if they were parties thereto, to the extent
provided in the Confidentiality Agreement.

9.5            Entire
Agreement. This Agreement and the documents and instruments and other agreements among the Parties as contemplated by or referred
to herein, including the Confidentiality Agreement and the Company Disclosure Letter constitute the entire agreement among the Parties
with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the Parties
with respect to the subject matter hereof. Notwithstanding anything to the contrary in this Agreement, the Confidentiality Agreement
will (a) not be superseded; (b) survive any termination of this Agreement; and (c) continue in full force and effect,
in each case, until the earlier to occur of the Effective Time and the date on which the Confidentiality Agreement expires in accordance
with its terms or is validly terminated by the parties thereto.

9.6            Third
Party Beneficiaries. Except as set forth in Section 6.8 and this Section 9.6, the Parties agree that their
respective representations, warranties and covenants set forth in this Agreement are solely for the benefit of the other Parties in accordance
with and subject to the terms of this Agreement. This Agreement is not intended to, and will not, confer upon any other Person any rights
or remedies hereunder, except (a) as set forth in or contemplated by Section 6.8; (b) if a court of competent jurisdiction
has declined to grant specific performance as set forth in Section 9.8(b) and has instead granted an award of damages,
then the Company may enforce such award and seek additional damages on behalf of the holders of shares of Company Common Stock and Company
Equity Awards (which Parent and Merger Sub acknowledge and agree may include damages based on a decrease in share value or lost premium);
(c) if Parent or Merger Sub Willfully and Materially Breaches this Agreement, then, following the termination of this Agreement,
the Company may seek damages and other relief (including equitable relief) on behalf of the holders of shares of Company Common Stock
and Company Equity Awards; and (d) from and after the Effective Time, the rights of the holders of shares of Company Common Stock,
and Company Equity Awards to receive the consideration set forth in Article II. The rights granted pursuant to clause (b) and
clause (c) of the second sentence of this Section 9.6 will only be enforceable on behalf of the holders of shares of
Company Common Stock and Company Equity Awards by the Company, in its sole and absolute discretion, as agent for such holders, and it
is understood and agreed that any and all interests in such claims will attach to such shares of the Company Common Stock or Company
Equity Awards and subsequently transfer therewith and, consequently, any damages, settlements or other amounts recovered or received
by the Company with respect to such claims (net of expenses incurred by the Company in connection therewith) may, in the Company’s
sole and absolute discretion, be (A) distributed, in whole or in part, by the Company to such holders as of any date determined
by the Company; or (B) retained by the Company for the use and benefit of the Company in any manner that the Company deems fit.

9.7            Severability.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, or incapable of being enforced under any applicable Law, the remainder of this Agreement will continue
in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably
to effect the intent of the Parties. The Parties further agree to replace such void or unenforceable provision of this Agreement with
a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or
unenforceable provision.

9.8            Remedies.

(a)            Remedies
Cumulative. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative
with and not exclusive of any other remedy conferred hereby or by Law or equity upon such Party, and the exercise by a Party of any one
remedy will not preclude the exercise of any other remedy. Although the Company may pursue both a grant of specific performance and monetary
damages, under no circumstances will the Company be permitted or entitled to receive both a grant of specific performance that results
in the occurrence of the Closing and monetary damages for failure to close (including any monetary damages in lieu of specific performance).

(b)            Specific
Performance.

(i)            The
Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the
event that the Parties do not perform the provisions of this Agreement (including any Party failing to take such actions as are required
of it hereunder in order to consummate this Agreement) in accordance with its specified terms or otherwise breach such provisions. The
Parties acknowledge and agree that (A) the Parties will be entitled, in addition to any other remedy to which they are entitled
at Law or in equity, to an injunction, specific performance and other equitable relief to prevent breaches (or threatened breaches) of
this Agreement and to enforce specifically the terms and provisions hereof; (B) the provisions of Section 8.3 are not
intended to and do not adequately compensate the Company, on the one hand, or Parent and Merger Sub, on the other hand, for the harm
that would result from a breach of this Agreement, and will not be construed to diminish or otherwise impair in any respect any Party’s
right to an injunction, specific performance and other equitable relief; and (C) the right of specific enforcement is an integral
part of the Merger and without that right, neither the Company nor Parent would have entered into this Agreement.

(ii)           The
Parties agree not to raise any objections to (A) the granting of an injunction, specific performance or other equitable relief to
prevent or restrain breaches or threatened breaches of this Agreement by the Company, on the one hand, or Parent and Merger Sub, on the
other hand; and (B) the specific performance of the terms and provisions of this Agreement to prevent breaches or threatened breaches
of, or to enforce compliance with, the covenants, obligations and agreements of Parent and Merger Sub pursuant to this Agreement. Any
Party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement will not be required to provide any bond or other security in connection with such injunction or enforcement, and each
Party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security.

9.9            Governing
Law. This Agreement and all actions, proceedings or counterclaims (whether based on contract, tort or otherwise) arising out of or
relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement
thereof, shall be governed by, and construed in accordance with the Laws of the State of Delaware, including its statute of limitations,
without giving effect to any choice or conflict of Laws (whether of the State of Delaware or any other jurisdiction) that would cause
the application of the Laws of any jurisdiction other than the State of Delaware.

9.10          Consent
to Jurisdiction. Each of the Parties (a) irrevocably consents to the service of the summons and complaint and any other process
(whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the Merger, for and
on behalf of itself or any of its properties or assets, in accordance with Section 9.2 or in such other manner as may be
permitted by applicable Law, and nothing in this Section 9.10 will affect the right of any Party to serve legal process in
any other manner permitted by applicable Law; (b) irrevocably and unconditionally consents and submits itself and its properties
and assets in any Legal Proceeding to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state
appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction
over a particular matter, any state or federal court within the State of Delaware) (the “Chosen Courts”) in the event
that any dispute or controversy arises out of this Agreement or the transactions contemplated hereby; (c) agrees that it shall not
attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (d) agrees that any
Legal Proceeding arising in connection with this Agreement or the transactions contemplated hereby shall be brought, tried and determined
only in the Chosen Courts; (e) waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding
in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim the same; and
(f) agrees that it shall not bring any Legal Proceeding relating to this Agreement or the transactions contemplated hereby in any
court other than the Chosen Courts. Each of Parent, Merger Sub and the Company agrees that a final judgment in any Legal Proceeding in
the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by applicable Law.

9.11         Waiver
of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE)
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE MERGER. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN
THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER;
(iii) IT MAKES THIS WAIVER VOLUNTARILY; AND (iv) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE
MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.11.

9.12          No
Recourse. This Agreement may only be enforced against, and any claims or causes of action that may be based upon, arise out of or
relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the entities that are
expressly identified as Parties hereto and no Company Related Parties and no Affiliates or Representatives of Parent (other than Merger
Sub under this Agreement) shall have any liability for any obligations or liabilities of the Parties to this Agreement or for any claim
(whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect
of any oral representations made or alleged to be made in connection herewith.

9.13          Disclosure
Letter References. The Parties agree that the disclosure set forth in any particular section or subsection of the Company Disclosure
Letter or Parent Disclosure Letter, as applicable, shall be deemed to be an exception to (or, as applicable, a disclosure for purposes
of) (a) the representations and warranties (or covenants, as applicable) of the Company or Parent and Merger Sub, as applicable,
that are set forth in the corresponding Section or subsection of this Agreement; and (b) any other representations and warranties
(or covenants, as applicable) of the Company or Parent and Merger Sub, as applicable, that are set forth in this Agreement, but in the
case of this clause (b) only to the extent the relevance of that disclosure as an exception to (or a disclosure for purposes of)
such other representations and warranties (or covenants, as applicable) is reasonably apparent on the face of such disclosure.

9.14          Counterparts.
This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will be considered one and the same
agreement and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other
Parties, it being understood that all Parties need not sign the same counterpart. Any such counterpart, to the extent delivered by fax
or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”),
will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal
effect as if it were the original signed version thereof delivered in person. No Party may raise the use of an Electronic Delivery to
deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an
Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to the extent
such defense relates to lack of authenticity.

Signature page follows.

IN WITNESS WHEREOF, the Parties
have caused this Agreement to be executed and delivered by their respective duly authorized officers as of the date first written above.

	Parent:

	GINKGO BIOWORKS HOLDINGS, INC.

	Name:	Jason Kelly
	Title:	Chief Executive Officer

	Merger Sub:

	PEPPER MERGER SUBSIDIARY INC.

	Name:	Jason Kelly
	Title:	President

[Signature Page to Agreement and Plan
of Merger]

	Company:

	ZYMERGEN INC.

	Name:	Jay Flatley
	Title:	Acting Chief Executive Officer (Principal Executive Officer)

[Signature Page to Agreement and Plan
of Merger]

Exhibit A

Form of Certificate of Incorporation of the
Surviving Corporation

Agreed Form

SECOND AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION

ZYMERGEN INC.

A
PUBLIC BENEFIT CORPORATION

1.
The name of this corporation is Zymergen Inc. (the “Corporation”).

2.
The registered office of this Corporation in the State of Delaware is located at: c/o The Corporation Trust Company, 1209 Orange
Street, Corporation Trust Center, Wilmington, County of New Castle, DE 19801. The name of the registered agent at such address is The
Corporation Trust Company.

3.
The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General
Corporation Law of the State of Delaware (the “DGCL”).

4.
The Corporation shall be a public benefit corporation, as contemplated by subchapter XV of the DGCL, and is to be managed in a
manner that balances the stockholders’ pecuniary (financial) interests, the best interests of those materially affected by the Corporation’s
conduct (including customers, employees, partners, and the communities in which the Corporation operates), and the public benefit or benefits
identified in this Second Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”).

5.
The specific public benefit to be promoted by the Corporation is to displace the petrochemicals that pollute the Planet by designing,
developing, and commercializing bio-based materials that deliver better performance than existing products, at attractive costs. The
Corporation makes products with broad applications and global reach that are safer for the people who manufacture them, healthier for
the people who use them and better for the environment.

6.
The total number of shares of stock that the Corporation shall have authority to issue is 100 shares of common stock, $0.0001 par
value per share (“Common Stock”). Each share of Common Stock shall be entitled to one vote.

7.
Shares of Common Stock may be issued in fractions of a share. Each fractional share of Common Stock shall be entitled to a vote
in proportion to such fractional share.

8.
Except as otherwise provided in the provisions establishing a class of stock, the number of authorized shares of any class or
series of stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of
the holders of a majority of the voting power of the Corporation entitled to vote irrespective of the provisions of Section 242(b)(2)
of the DGCL.

9.
The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. The size of
the Board of Directors shall be determined as set forth in the bylaws of the Corporation, as in effect from time to time (the “Bylaws”).
The election of directors need not be by written ballot unless the Bylaws shall so require.

10.
In furtherance and not in limitation of the power conferred upon the Board of Directors by law, the Board of Directors shall have
power to make, adopt, alter, amend and repeal from time to time the Bylaws, subject to the right of the stockholders entitled to vote
with respect thereto to alter and repeal Bylaws made by the Board of Directors.

11.
To the maximum extent permitted from time to time under the laws of the State of Delaware, the Corporation renounces any interest
or expectancy of the Corporation in, or in being offered an opportunity to participate in, business opportunities that are from time
to time presented to its officers, directors or stockholders, other than those officers, directors or stockholders who are employees
of the Corporation or, with respect to any individual, each spouse or child or other descendants of such individual, each trust, limited
liability company or limited partnership created solely for the benefit of one or more of the aforementioned Persons and/or their spouses
and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian,
of officers, directors or stockholders who are employees of the Corporation. No amendment or repeal of this Section 10 shall apply to
or have any effect on the liability or alleged liability of any officer, director or stockholder of the Corporation for or with respect
to any opportunities of which such officer, director, or stockholder becomes aware prior to such amendment or repeal. To the fullest
extent permitted by law, any Person purchasing or otherwise acquiring any interest in any shares of capital stock of the Corporation
shall be deemed to have notice of and to have consented to the provisions of this Section 10. As used herein, “Person”
shall mean any individual, partnership, corporation, association, trust, joint venture, limited liability company, unincorporated organization,
entity or division, or any government, governmental department or agency or political subdivision thereof.

12.
To the fullest extent permitted by the DGCL or any other law of the State of Delaware, as it exists or may hereafter be amended
or modified from time to time, no director of the Corporation shall be personally liable to the Corporation or any of its stockholders
for monetary damages for breach of fiduciary duty as a director, except for liability for any breach of the director’s duty of loyalty
to the Corporation or its stockholders; any act or omission not in good faith or which involved intentional misconduct or a knowing violation
of law; unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL; and any transaction
from which the director derived an improper personal benefit.

13.
To the fullest extent permitted by the DGCL or any other law of the State of Delaware, as it exists or may hereafter be amended
or modified from time to time, including to the extent that such law or amendment permits the Corporation to provide broader indemnification
rights than permitted prior to such law or amendment, the Corporation is authorized to provide indemnification of (and advancement of
expenses to) its current or former directors, officers, employees and agents of the Corporation (and any other persons to which DGCL permits
the Corporation to provide indemnification) through Bylaw provisions, agreements with such persons, vote of stockholders or disinterested
directors or otherwise.

14.
No amendment or repeal of Section 12, Section 13 or this Section 14, nor the adoption of any provision of
this Certificate of Incorporation inconsistent with Section 12, Section 13 or Section 14, nor, to the fullest extent
permitted by the DGCL, any modification of law, shall adversely affect any right or protection hereunder of any person in respect of any
act or omission occurring prior to the time of such amendment, repeal or adoption of an inconsistent provision.

15.
The books of the Corporation may (subject to any statutory requirements) be kept outside the State of Delaware as may be designated
by the Board of Directors or in the Bylaws.

16.
If at any time the Corporation shall have a class of stock registered pursuant to the provisions of the Securities Exchange Act
of 1934, for so long as such class is so registered, any action by the stockholders of such class must be taken at an annual or special
meeting of stockholders and may not be taken by written consent.

17.
The Corporation shall not be governed by Section 203 of the DGCL.

18.
(a) Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State
of Delaware (the “Chancery Court”) shall, to the fullest extent permitted by law, be the sole and exclusive forum for
(i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary
duty owed by any director, officer, employee or agent of the Corporation to the Corporation or its stockholders, (iii) any action asserting
a claim against the Corporation arising pursuant to any provision of the DGCL, this Certificate of Incorporation or the Bylaws, or (iv)
any action asserting a claim against the Corporation governed by the internal affairs doctrine, in all cases, subject to the court’s
having personal jurisdiction over the indispensable parties named as defendants. Any person or entity purchasing or otherwise acquiring
any interest in the shares of capital stock of the Corporation will be deemed to have notice of and consented to the provisions of this
Section 18.

(b)
Any person or entity that purchases or otherwise acquires any interest in the shares of capital
stock of the Corporation will be deemed to have (i) consented and submitted to the personal jurisdiction of the Chancery Court in connection
with any action described in Section 16(a) above (an “Action”), (ii) waived any objection to the exercise of personal
jurisdiction over such stockholder in the Chancery Court, (iii) waived any argument relating to the inconvenience of the forums referenced
above in connection with any Action, (iv) agreed not to commence any such Action other than before the Chancery Court nor to make any
motion or take any other action seeking or intending to cause the transfer or removal of any such Action to any court other than the Chancery
Court whether on the grounds of inconvenient forum or otherwise, and (v) consented to having service of process made upon such person
or entity by service upon such person’s or entity’s counsel as agent for such person or entity in the event that such person
or entity brings an Action in a court other than the Chancery Court.

Exhibit 99.1

Ginkgo to Acquire Zymergen

●

Acquisition is expected to accelerate the development of Ginkgo’s innovative horizontal synthetic biology platform

●

Expect integration of Zymergen’s complementary automation, software, and data science tools as well as biological assets
to significantly enhance the capacity, capabilities, and efficiency of Ginkgo’s platform for its diverse customer base and enable
new growth opportunities across many end markets

●

Zymergen’s core technical team is expected to help fill significant planned hiring by Ginkgo across its cell engineering,
automation, digital technology, and data teams, accelerating scaling efforts while minimizing incremental run-rate operating expenses
following integration of the acquisition

●

Ginkgo’s platform serves customers across industries as an enabling platform and Ginkgo will support Zymergen’s plans
to evaluate strategic alternatives for their Advanced Materials and Drug Discovery businesses

●

Zymergen stockholders will own 5.25% of the pro forma combined company following the transaction

BOSTON,
MA and EMERYVILLE, CA – July 25, 2022 – Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform
for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement
under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders
will receive a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share, representing 5.25% pro forma ownership of Ginkgo
following the transaction.

This
transaction brings together two highly complementary organizations that share the vision that biology can transform a wide range of industries
including manufacturing, agriculture, and medicine. Ginkgo plans to integrate Zymergen’s core automation and software technologies
for scaling strain engineering capacity into its Foundry, including Zymergen’s machine learning and data science tools for exploring
known and unknown genetic design space. Ginkgo customers will also benefit from the expansion of Ginkgo’s library of biological
assets (“Codebase”) following the transaction.

The agreement announced today represents Ginkgo’s largest acquisition
to date and is expected to significantly enhance Ginkgo’s platform by integrating strong automation and software capabilities as
well as a wealth of experience across diverse biological engineering approaches. Ginkgo is a horizontal platform, serving customers across
industries rather than producing its own products, and will support Zymergen’s plans to evaluate strategic alternatives for their
Advanced Materials and Drug Discovery businesses, which have established valuable product pipelines and rapid prototyping capabilities.
Additionally, Zymergen will continue its standalone cost restructuring initiatives, including headcount reductions and program rationalization.
Finally, the addition of Zymergen personnel is expected to help fill planned hiring by Ginkgo as it scales the platform. Taken together,
Ginkgo expects these actions to minimize incremental run-rate operating expenses in connection with the combination once integration is
completed.

“We have always had incredible respect for the Zymergen team
and the strength of the technologies that they have built for cell programming,” said Jason Kelly, CEO and co-founder of Ginkgo
Bioworks. “We are thrilled to integrate Zymergen’s capabilities into our Foundry, which we expect to accelerate the growth
of our platform as we continue to deliver on our mission to make biology easier to engineer for our customers, helping us drive down the
costs of cell programming as we invest in scale. We can’t wait to welcome Zymergen’s technical teams, who will support our scaling
objectives.”

“At Zymergen, our team has built a world class and innovative
technology platform which will complement Ginkgo’s cell programming capabilities,” said Jay Flatley, Chairman and Acting CEO
of Zymergen. “We’re excited about the opportunities created by combining our technologies to accelerate Ginkgo’s platform
development to better serve customers, promote Zymergen’s public benefit purpose, and achieve our shared vision of sustainability
and a world built on biology. The transaction also represents a compelling opportunity for our stockholders to participate in the future
growth and upside potential of the combined company.”

Timing and Approvals

The transaction is expected to be completed by the first quarter of
2023, subject to approval by Zymergen’s stockholders, receipt of regulatory approvals, and satisfaction or waiver of other closing
conditions.

Advisors

Allen & Company LLC is serving as financial advisor and Ropes &
Gray LLP is serving as legal advisor to Ginkgo. Cowen and Company, LLC is serving as financial advisor and Freshfields Bruckhaus Deringer
US LLP is serving as legal advisor to Zymergen.

Ginkgo Webcast and Conference
Call Information

Ginkgo will host a conference
call beginning at 8:30 AM Eastern Time today to discuss this announcement. A webcast of the conference call can be accessed at https://investors.ginkgobioworks.com.

Zymergen Webcast Information

Zymergen will host a conference
call beginning at 5:00 PM Eastern Time, 2:00 PM Pacific Time today to discuss this announcement as well as additional business updates.
A webcast of the conference call can be accessed at https://investors.zymergen.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells
as easily as we can program computers. The company’s platform is enabling biotechnology applications across diverse markets, from food
and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts,
including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

About Zymergen

Zymergen is a biotech company that designs and produces molecules,
microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world. For
more information visit www.zymergen.com.

Additional Information
and Where to Find It

In connection with the
proposed transaction between Zymergen and Ginkgo, Ginkgo intends to file with the U.S. Securities and Exchange Commission (the “SEC”)
a registration statement on Form S-4 that will include a proxy statement of Zymergen and that also constitutes a prospectus of Ginkgo.
Each of Zymergen and Ginkgo may also file other relevant documents with the SEC regarding the proposed transaction. This document is
not a substitute for the proxy statement/prospectus or registration statement or any other document that Zymergen or Ginkgo may file
with the SEC. The definitive proxy statement/prospectus (if and when available) will be mailed to stockholders of Zymergen. INVESTORS
AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY
BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY
BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders
will be able to obtain free copies of the registration statement and proxy statement/prospectus (if and when available) and other documents
containing important information about Zymergen, Ginkgo and the proposed transaction, once such documents are filed with the SEC through
the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Zymergen will be available free
of charge on Zymergen’s website at https://investors.Zymergen.com or by contacting Zymergen’s Investor Relations department
by email at [email protected] Copies of the documents filed with the SEC by Ginkgo will be available free of charge on Ginkgo’s
website at https://investors.ginkgobioworks.com or by contacting Ginkgo’s Investor Relations department by email at [email protected]

Participants in the
Solicitation

Zymergen, Ginkgo, their
respective directors and certain of their executive officers and other employees may be deemed to be participants in the solicitation
of proxies from Zymergen’s stockholders in connection with the proposed transaction. Information regarding the persons who may,
under the rules of the SEC, be deemed participants in the solicitation of Zymergen’s stockholders in connection with the proposed
transaction, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the
proxy statement/prospectus when it is filed with the SEC. Information about the directors and executive officers of Zymergen, including
a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Zymergen’s proxy statement
for its 2022 annual meeting of shareholders, which was filed with the SEC on April 20, 2022, and Zymergen’s Annual Report on Form
10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 30, 2022. Information about the directors and
executive officers of Ginkgo, including a description of their direct or indirect interests, by security holdings or otherwise, is set
forth in Ginkgo’s proxy statement for its 2022 annual meeting of shareholders, which was filed with the SEC on April 26, 2022, and
Ginkgo’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 29, 2022.
Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security
holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding
the proposed transaction when such materials become available. Investors should read the proxy statement/prospectus carefully when it
becomes available before making any voting or investment decisions. You may obtain free copies of these documents from Zymergen or Ginkgo
using the sources indicated above.

No Offer or Solicitation

This communication is
not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation
of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall
be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Forward Looking Statements

This communication contains
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the use of forward-looking terminology such
as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,”
“predict,” “project,” “seek,” “should,” or “will,” or the negative thereof
or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown
risks and uncertainties, many of which are beyond Zymergen’s and Ginkgo’s control. Statements in this communication regarding
Zymergen, Ginkgo and the combined company that are forward-looking, including projections as to the anticipated benefits of the proposed
transaction, the impact of the proposed transaction on Zymergen’s and Ginkgo’s businesses and future financial and operating
results, the amount and timing of synergies from the proposed transaction, the aggregate amount of indebtedness of the combined company
following the closing of the proposed transaction are based on management’s estimates, assumptions and projections, and are subject
to significant uncertainties and other factors, many of which are beyond Zymergen’s and Ginkgo’s control. These factors include,
among other things, general economic and business conditions; changes in global, political, economic, business, competitive, market and
regulatory forces; judicial decisions; changes in tax laws, regulations, rates and policies; future business acquisitions or disposals;
litigation and the ability of the combined company to protect its intellectual property rights; and the timing and occurrence (or non-occurrence)
of other events or circumstances that may be beyond Zymergen’s and Ginkgo’s control. Additional information concerning these
risks, uncertainties and assumptions can be found in Zymergen’s and Ginkgo’s respective filings with the SEC, including the
risk factors discussed in Zymergen’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q, in
Ginkgo’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and in each company’s future
filings with the SEC. Important risk factors could cause actual future results and other future events to differ materially from those
currently estimated by management, including, but not limited to, the risks that: a condition to the closing the proposed acquisition
may not be satisfied; a regulatory approval that may be required for the proposed acquisition is delayed, is not obtained or is obtained
subject to conditions that are not anticipated; Ginkgo is unable to achieve the synergies and value creation contemplated by the proposed
acquisition; Ginkgo is unable to promptly and effectively integrate Zymergen’s businesses; management’s time and attention
is diverted on transaction related issues; disruption from the transaction makes it more difficult to maintain business, contractual and
operational relationships; legal proceedings are instituted against Zymergen, Ginkgo or the combined company; Zymergen, Ginkgo or the
combined company is unable to retain key personnel; and the announcement or the consummation of the proposed acquisition has a negative
effect on the market price of the capital stock of Zymergen or Ginkgo or on Zymergen’s or Ginkgo’s operating results. No assurances
can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do occur,
what impact they will have on the results of operations, financial condition or cash flows of Zymergen or Ginkgo. Should any risks and
uncertainties develop into actual events, these developments could have a material adverse effect on the proposed transaction and/or Zymergen
or Ginkgo, Ginkgo’s ability to successfully complete the proposed transaction and/or realize the expected benefits from the proposed
transaction. You are cautioned not to rely on Zymergen’s and Ginkgo’s forward-looking statements. These forward-looking statements
are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and
are applicable only as of the dates of such statements. Neither Zymergen nor Ginkgo assumes any duty to update or revise forward-looking
statements, whether as a result of new information, future events or otherwise, as of any future date.

GINKGO BIOWORKS INVESTOR CONTACT:

[email protected]

GINKGO BIOWORKS MEDIA CONTACT:

[email protected]

ZYMERGEN INVESTOR CONTACT:

[email protected]

Exhibit 99.2

Execution Version

VOTING
AGREEMENT

This
Voting Agreement (this “Agreement”), dated as of July 24, 2022, is made and entered into by and between
Ginkgo Bioworks Holdings, Inc., a Delaware corporation (“Parent”), and SVF Excalibur (Cayman) Limited
(the “Stockholder”), a stockholder of Zymergen Inc., a Delaware public benefit corporation (the “Company”).
Parent and Stockholder are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

WHEREAS,
the Company, Parent and Pepper Merger Subsidiary Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Merger
Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended from time to time, the “Merger
Agreement”), providing for, among other things, the merger of Merger Sub with and into the Company (the “Merger”),
pursuant to the terms of the Merger Agreement;

WHEREAS, Stockholder is willing to make certain
representations, warranties, covenants, and agreements as set forth in this Agreement with respect to the 26,614,219 shares of common
stock, par value $0.001 per share, of the Company (“Company Common Stock”) Beneficially Owned (as defined below)
by Stockholder (the “Subject Shares” and, together with any additional shares of Company Common Stock pursuant
to Section 7 hereof, the “Shares”); and

WHEREAS,
as a condition to their willingness to enter into the Merger Agreement, Parent and the Company have required that Stockholder, and Stockholder
has (solely in its capacity as such and not as a director or fiduciary) agreed to, execute and deliver this Agreement.

NOW,
THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants, and agreements set forth below
and for other good and valuable consideration, the receipt, sufficiency, and adequacy of which are hereby acknowledged, the Parties hereto,
intending to be legally bound, do hereby agree as follows:

1.             Definitions.

For
purposes of this Agreement, capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to such
terms in the Merger Agreement. When used in this Agreement, the following terms in all of their tenses, cases, and correlative forms
shall have the meanings assigned to them in this Section 1.

(a)            “Affiliate”
means with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by, or under common control
with, such Person; provided, however, that solely for purposes of this Agreement, notwithstanding anything to the contrary set forth
herein, neither the Company nor any of its Subsidiaries shall be deemed to be a Subsidiary or Affiliate of Stockholder; provided, further,
that, for the avoidance of doubt, any member of Stockholder shall be deemed an Affiliate of Stockholder; and provided, further, that
an Affiliate of Stockholder shall include any investment fund, vehicle or holding company of which Stockholder or an affiliate thereof
serves as the general partner, managing member or discretionary manager or advisor, or which shares the same investment manager and/or
the same investment advisor. For purposes of this definition, the term “control” (including, with correlative meanings, the
terms “controlling,” “controlled by” and “under common control with”), as used with respect to any
Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of
that Person, whether through the ownership of voting securities or partnership or other ownership interests, by Contract or otherwise.

(b)            “Beneficial
Owner” shall mean the Person who Beneficially Owns the referenced securities.

(c)            “Beneficially
Own” or “Beneficial Ownership” has the meaning assigned to such term in Rule 13d-3 under
the Exchange Act, and a Person’s beneficial ownership of securities shall be calculated in accordance with the provisions of such
rule (in each case, irrespective of whether or not such rule is actually applicable in such circumstance). For the avoidance
of doubt, “Beneficially Own” and “Beneficial Ownership” shall also include record
ownership of securities.

2.      
      Representations of Stockholder.
Stockholder (solely in its capacity as such and not as a director or fiduciary) represents and warrants to Parent that:

(a)            Ownership
of Shares. Stockholder (i) is the Beneficial Owner of all of Stockholder’s Subject Shares free and clear of any proxy,
voting restriction, adverse claim, or other Liens, other than those created by this Agreement or under applicable federal or state securities
laws; and (ii) has the sole voting and sole disposition power over all of such Subject Shares. Except as expressly provided by this
Agreement, there are no options, warrants, or other rights, agreements, arrangements, or commitments of any character to which Stockholder
is a party relating to the pledge, disposition, or voting of any of Stockholder’s Subject Shares and there are no voting trusts
or voting agreements with respect to such Subject Shares.

(b)            Disclosure
of All Shares Owned. Neither Stockholder nor any of its Affiliates Beneficially Owns any shares of Company Common Stock other than
the Subject Shares.

(c)            Organization;
Power and Authority; Binding Agreement. Stockholder is duly organized, validly existing and in good standing under the Laws of the
Cayman Islands. Stockholder has full entity power and authority to enter into, execute, and deliver this Agreement and to perform fully
such Stockholder’s obligations hereunder. This Agreement has been duly and validly executed and delivered by Stockholder and assuming
the due authorization, execution and delivery of this Agreement by Parent, constitutes the legal, valid, and binding obligation of Stockholder,
enforceable against Stockholder in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other similar Laws affecting or relating to creditors’ rights generally.

(d)            Voting
Power. Stockholder has full voting power (or the power to effect the full voting power) with respect to all Stockholder’s Subject
Shares, full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree
to all of the matters set forth in this Agreement, in each case, with respect to all of Stockholder’s Subject Shares. None of Stockholder’s
Subject Shares are subject to any stockholders’ agreement, proxy, voting trust, or other agreement or arrangement with respect
to the voting of such Subject Shares, except as provided hereunder.

(e)            No
Conflict. The execution and delivery of this Agreement by Stockholder does not, and the consummation of the transactions contemplated
hereby and the compliance with the provisions hereof will not, (i) conflict with or violate any Law applicable to Stockholder or
(ii) result in any breach of or violation of, or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration, or cancellation of, or result in the creation
of any Lien on any of such Stockholder’s Shares pursuant to, any agreement or other instrument or obligation, including organizational
documents binding upon Stockholder or any of its Shares, except for breaches, violations or defaults that would not, individually or
in the aggregate, materially impair the ability of Stockholder to perform its obligations hereunder.

(f)            No
Consents. No consent, approval, order, or authorization of, or registration, declaration, or filing with, any Governmental Authority
or any other Person on the part of Stockholder is required in connection with the valid execution and delivery of this Agreement, except
for such filings and approvals as may be required by any applicable federal or state securities Laws, including compliance with any applicable
requirements of the Exchange Act or the HSR Act.

(g)            No
Litigation. As of the time of execution of this Agreement, there is no Legal Proceeding pending against, or to the knowledge of Stockholder,
threatened against, Stockholder that could reasonably be expected to materially impair or materially adversely affect the ability of
Stockholder to perform Stockholder’s obligations hereunder or to consummate the transactions contemplated by this Agreement on
a timely basis.

3.              Representations
of Parent. Parent represents and warrants to each Stockholder that:

(a)            Organization;
Power and Authority; Binding Agreement. Parent is duly organized, validly existing and in good standing under the Laws of Delaware.
Parent has the requisite power and authority to execute and deliver this Agreement and to perform fully its obligations hereunder. This
Agreement has been duly executed and delivered by Parent and assuming the due authorization, execution and delivery of this Agreement
by each Stockholder, constitutes the legal, valid and binding obligation of Parent, enforceable against Parent in accordance with its
terms, except as such enforceability (i) may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other
similar Laws affecting or relating to creditors’ rights generally and (ii) is subject to general principles of equity.

(b)            No
Conflict. The execution and delivery of this Agreement by Parent does not, and the consummation of the transactions contemplated
hereby will not, (i) conflict with or violate any Law applicable to such Party; (ii) result in any breach of or violation of,
or constitute a default (or an event that with notice or lapse of time or both would become a default) pursuant to, result in the termination
of, accelerate the performance required by, or result in a right of termination or acceleration pursuant to the terms, conditions or
provisions of any material Contract to which Parent may be bound; or (iii) result in the creation of any Lien (other than Permitted
Liens) upon any of the properties or assets of Parent, except for such violations, conflicts, breaches defaults, terminations, accelerations
or Liens that would not prevent or materially delay Parent’s performance of its obligations under this Agreement.

(c)            No
Governmental Authorizations. No Governmental Authorization is required on the part of Parent in connection with the execution and
delivery of this Agreement, except for (i) such filings and approvals as may be required by any applicable federal or state securities
Laws, including compliance with any applicable requirements of the Exchange Act and (ii) such other Governmental Authorizations
the failure of which to obtain would not prevent or materially delay Parent’s performance of its obligations under this Agreement.

4.              Agreement
to Vote Shares.

Prior
to the Expiration Time, Stockholder (in its capacity as such) irrevocably and unconditionally agrees during the term of this Agreement,
at any annual or special meeting of the Company called with respect to the following matters, and at every adjournment or postponement
thereof (each, a “Covered Meeting”), to appear at any such meeting or otherwise cause Stockholder’s Shares
to be counted as present thereat for purpose of establishing a quorum, respond to each request by the Company for written consent, if
any, and vote or cause the holder of record to vote Stockholder’s Shares entitled to vote at such meeting (a) in favor of
(i) approval of the Merger Agreement and the Merger and the other transactions contemplated by the Merger Agreement and (ii) any
proposal to adjourn or postpone such meeting of stockholders of the Company to a later date if there are not sufficient votes to approve
the Merger Agreement, the Merger and any other matters necessary for the Merger; and (b) against (i) any action, proposal,
transaction, or agreement which would reasonably be expected to result in any of the conditions to the Company’s obligations to
consummate the Merger set forth in Article VII of the Merger Agreement not being fulfilled, and (ii) any action, proposal,
transaction, or agreement that could reasonably be expected to impede, interfere with, delay, discourage, adversely affect, or inhibit
the timely consummation of the Merger or the fulfillment of Parent’s, Merger Sub’s or the Company’s conditions under
the Merger Agreement or change in any manner the voting rights of any class of shares of the Company (including any amendments to the
Company’s Organizational Documents). Any attempt by Stockholder to vote, consent or express dissent with respect to (or otherwise
to utilize the voting power of), Stockholder’s Shares in contravention of this Section 4 shall be null and void ab
initio. Notwithstanding the foregoing, Stockholder shall retain at all times the right to vote Stockholder’s Shares in its
sole discretion and without any other limitation on those matters other than those set forth in this Section 4 that
are at any time or from time to time presented for consideration to the Company’s stockholders.

5.              No
Voting Trusts or Other Arrangement.

Stockholder
agrees that during the term of this Agreement, Stockholder will not, and will not permit any Affiliate to, deposit any of Stockholder’s
Shares in a voting trust, grant any proxies with respect to Stockholder’s Shares, or subject any of Stockholder’s Shares
to any arrangement with respect to the voting of Stockholder’s Shares other than agreements entered into with Parent.

6.              Transfer
and Encumbrance.

Stockholder
agrees that prior to the earlier of (i) the Expiration Time and (ii) the date on which the Requisite Stockholder Approval shall
have been obtained, Stockholder will not, directly or indirectly, transfer, sell, offer, exchange, assign, pledge, convey any legal or
Beneficial Ownership interest in or otherwise dispose of (by merger, by tendering into any tender or exchange offer, by operation of
Law or otherwise) or encumber (“Transfer”) any of Stockholder’s Shares or enter into any contract, option
or other agreement with respect to, or consent to, a Transfer of any of Stockholder’s Shares or Stockholder’s voting or economic
interest therein. This Section 6 shall not prohibit a Transfer of the Shares by Stockholder to an Affiliate of Stockholder;
provided, that a Transfer referred to in this sentence shall be permitted only if, as a precondition to such Transfer, the transferee
agrees in a writing, reasonably satisfactory in form and substance to Parent, to be bound by all of the terms of this Agreement. Any
attempted Transfer of Stockholder’s Shares or any interest therein in violation of this Section 6 shall, to the fullest
extent permitted by Law, be null and void ab initio. If any involuntary Transfer of any of Stockholder’s Shares shall occur,
the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee)
shall take and hold Stockholder’s Shares subject to all of the restrictions, liabilities and rights under this Agreement, which
shall continue in full force and effect until valid termination of this Agreement.

7.              Additional
Purchases; Adjustments.

Stockholder
agrees that any shares of Company Common Stock and any other shares of capital stock or other equity of the Company that Stockholder
purchases, acquires the voting power or otherwise acquires Beneficial Ownership of after the execution of this Agreement and prior to
the record date for any Covered Meeting shall be subject to the terms and conditions of this Agreement to the same extent as if they
constituted Shares as of the date hereof for all purposes of this Agreement, and Stockholder shall promptly notify Parent of the existence
of any such after-acquired Shares. In the event of any stock split, stock dividend, merger, reorganization, recapitalization, reclassification,
combination, exchange of shares or the like of the capital stock of the Company affecting the Shares, the terms of this Agreement shall
apply to the resulting securities and such resulting securities shall be subject to the terms and conditions of this Agreement to the
same extent as if they constituted Shares as of the date hereof for all purposes of this Agreement.

8.             Waiver
of Certain Actions.

Stockholder
hereby agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class in any class action with respect
to, any Legal Proceeding, derivative or otherwise, against Parent, Merger Sub or the Company or any of their respective Affiliates and
each of their successors or directors relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or
the consummation of the transactions contemplated hereby or thereby, including any claim (a) challenging the validity of, or seeking
to enjoin the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoin or delay the
Closing) or (b) alleging a breach of any fiduciary duty of the Company Board in connection with the negotiation and entry into this
Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, and hereby irrevocably waives any claim or rights
whatsoever with respect to any of the foregoing.

9.     
        Termination.

This
Agreement shall terminate upon the earliest to occur of (the “Expiration Time”): (a) the Closing; (b) the
date on which the Merger Agreement is terminated in accordance with its terms; (c) the Outside Date; (d) any change to the
terms of the Merger without the prior written consent of Stockholder that (i) reduces the Merger Consideration with respect to the
Company Common Stock or any consideration otherwise payable with respect to the Shares beneficially owned by Stockholder (subject to
adjustments in compliance with Section 2.8 of the Merger Agreement), (ii) changes the form of consideration payable in the
Merger or any consideration otherwise payable with respect to the Company Common Stock beneficially owned by Stockholder, (iii) modifies
the closing conditions set forth in Article VII of the Merger Agreement in a manner adverse to the interest of Stockholder, (iv) modifies
the definition of “Outside Date” under the Merger Agreement in a manner adverse to the interest of Stockholder or (v) modifies
Article II of the Merger Agreement in a manner adverse to the interests of Stockholder; and (e) with respect to any Stockholder,
the mutual written consent of Stockholder and Parent to terminate this Agreement. Nothing in this Section 9 shall relieve
or otherwise limit the liability of any Party for any willful and material breach of this Agreement incurred prior to such termination.

10.        
   No Solicitation.

Subject
to Section 11, Stockholder agrees it shall not, it shall cause its Affiliates not to and it shall direct its and their respective
Representatives not to, directly or indirectly, take any of the actions listed in clauses (i) – (vi) of Section 5.4(a) of
the Merger Agreement (without giving effect to any amendment or modification of such clauses after the date hereof). Stockholder shall,
and shall cause its Affiliates to, and shall use its reasonable best efforts to cause its and their Representatives to, immediately cease,
and cause to be terminated, any solicitations, discussions or negotiations with any Person other than Parent with respect to any inquiry,
proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal.

11.     
      Fiduciary Duties.

Stockholder
is entering into this Agreement solely in its capacity as the record or Beneficial Owner of the Shares and nothing herein is intended
to or shall limit or affect any actions taken by any of Stockholder’s designees serving in his or her capacity as a director of
the Company (or a Subsidiary of the Company). The taking of any actions (or failures to act) by Stockholder’s designees serving
as a director of the Company (in such capacity as a director) shall not be deemed to constitute a breach of this Agreement.

12.     
      Specific Performance.

The
Parties agree that irreparable damage, for which monetary damages would not be an adequate remedy, would occur in the event that any
of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached by the Parties.
Prior to the Expiration Time, it is accordingly agreed that the Parties shall be entitled to an injunction or injunctions, or any other
appropriate form of specific performance or equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms
and provisions hereof in any court of competent jurisdiction, in each case in accordance with this Section 12, this being
in addition to any other remedy to which they are entitled under the terms of this Agreement at Law or in equity. Each Party accordingly
agrees not to raise any objections to the availability of the equitable remedy of specific performance to prevent or restrain breaches
or threatened breaches of, or to enforce compliance with, the covenants and obligations of such Party under this Agreement, all in accordance
with the terms of this Section 12. Each Party further agrees that no other Party or any other Person shall be required to
obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this
Section 12, and each Party irrevocably waives any right it may have to require the obtaining, furnishing or posting of any
such bond or similar instrument.

13.      
     Entire Agreement.

This
Agreement (together with the Merger Agreement and any other documents and instruments executed pursuant hereto) supersedes all prior
agreements, written or oral, between the Parties hereto with respect to the subject matter hereof and contains the entire agreement between
the Parties with respect to the subject matter hereof. The Parties agree that (a) the representations, warranties and covenants
set forth herein are solely for the benefit of the other Parties, in accordance with and subject to the terms of this Agreement, and
(b) this Agreement is not intended to, and does not, confer upon any Person other than the Parties any rights or remedies hereunder,
including the right to rely upon the representations and warranties set forth herein.

14.         
  Notification of Certain Matters.

From
the date hereof and through the Expiration Time, Stockholder shall promptly deliver to Parent written notice, upon becoming aware of
(a) any injunction, writ or order of any nature issued and directing that the transactions provided for herein not be consummated
as herein provided or (b) any Proceeding pending or threatened with respect to the transactions contemplated hereby, in each such
case if and only to the extent that such injunction, writ, order or Proceeding would cause any of the conditions set forth in Article VII
of the Merger Agreement not to be satisfied at such time.

15.       
    Notices.

All
notices and other communications hereunder must be in writing and will be deemed to have been duly delivered and received hereunder:
(a) one (1) Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight
courier service; (b) immediately upon delivery by hand; or (c) by e-mail, upon written or electronic confirmation of receipt,
in each case to the intended recipient as set forth below:

If to Parent,
to:

Ginkgo Bioworks Holdings, Inc.

27 Drydock Avenue, 8th Floor

Boston, Massachusetts 02210
Attn: Anna Marie Wagner; Karen Tepichin
E-mail: [email protected];

[email protected]

with copies
(which will not constitute notice) to:

Ropes &
Gray LLP

1211 Avenue
of the Americas

New York,
NY 10036

Attn: Suni
Sreepada

E-mail: [email protected]

and

Ropes &
Gray LLP

800 Boylston
Street

Boston, MA
02199

Attn: Marko
Zatylny

E-mail: [email protected]

If to Stockholder,
to:

c/o SB Investment
Advisers (UK) Limited

69 Grosvenor
Street

London, W1K
3JP

Attn: Legal

E-mail: [email protected]

Any
notice received by e-mail or otherwise at the addressee’s location on any Business Day after 5:00 p.m., addressee’s local
time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressee’s local time, on the
next Business Day. From time to time, any Party may provide notice to the other Parties of a change in its address or e-mail address
through a notice given in accordance with this Section 15, except that that notice of any change to the address or any of
the other details specified in or pursuant to this Section 15 will not be deemed to have been received until, and will be
deemed to have been received upon, the later of the date (i) specified in such notice; or (ii) that is two (2) Business
Days after such notice would otherwise be deemed to have been received pursuant to this Section 15.

16.           Miscellaneous.

(a)            Governing
Law. This Agreement and all actions, proceedings or counterclaims (whether based on contract, tort or otherwise) arising out of or
relating to this Agreement, shall be governed by, and construed in accordance with the Laws of the State of Delaware, including its statute
of limitations, without giving effect to any choice or conflict of Laws (whether of the State of Delaware or any other jurisdiction)
that would cause the application of the Laws of any jurisdiction other than the State of Delaware.

(b)            Consent
to Jurisdiction. Each of the Parties (i) irrevocably consents to the service of the summons and complaint and any other process
(whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding arising out of this Agreement or
the transactions contemplated hereby, for and on behalf of itself or any of its properties or assets, in accordance with Section 15 or in such other manner as may be permitted by applicable Law, and nothing in this Section 16(b) will affect the
right of any Party to serve legal process in any other manner permitted by applicable Law; (ii) irrevocably and unconditionally
consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive general jurisdiction of the Court
of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery
of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware)
(the “Chosen Courts”) in the event that any dispute or controversy arises out of this Agreement or the transactions
contemplated hereby; (iii) agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request
for leave from any such court; (iv) agrees that any Legal Proceeding arising in connection with this Agreement or the transactions
contemplated hereby shall be brought, tried and determined only in the Chosen Courts; (v) waives any objection that it may now or
hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient
court and agrees not to plead or claim the same; and (vi) agrees that it shall not bring any Legal Proceeding relating to this Agreement
or the transactions contemplated hereby in any court other than the Chosen Courts. Each of the Parties agrees that a final judgment in
any Legal Proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in
any other manner provided by applicable Law.

(c)            Waiver
of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE)
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE MERGER AGREEMENT OR THE MERGER OR ANY OF THE OTHER TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT OR THE MERGER AGREEMENT. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i) NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVER; (ii) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (iii) IT MAKES
THIS WAIVER VOLUNTARILY; AND (iv) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS SECTION 16(c).

(d)            Expenses.
All costs and expenses incurred in connection with this Agreement shall be paid by the Party incurring such cost or expense, whether
or not the Merger is consummated.

(e)            Severability.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, or incapable of being enforced under any applicable Law, the remainder of this Agreement will continue
in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably
to effect the intent of the Parties. The Parties further agree to replace such void or unenforceable provision of this Agreement with
a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or
unenforceable provision.

(f)            Counterparts.
This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will be considered one and the
same agreement and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other
Parties, it being understood that all Parties need not sign the same counterpart. Any such counterpart, to the extent delivered by Electronic
Delivery, will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding
legal effect as if it were the original signed version thereof delivered in person. No Party may raise the use of an Electronic Delivery
to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of
an Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to the extent
such defense relates to lack of authenticity.

(g)            Interpretation.
In the event that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted
jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship
of any provision of this Agreement. When a reference is made in this Agreement to Sections, such reference shall be to a Section of
this Agreement unless otherwise indicated. The headings contained in this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement. Whenever the words “include,” “includes” or “including”
are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” References to “the
date hereof” shall mean the date of this Agreement. As used in this Agreement, the “knowledge” of a Stockholder means
the actual knowledge of any officer of such Stockholder after due inquiry.

(h)            Assignment.
No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder, by operation of Law or otherwise,
without the prior written approval of the other Parties; provided that such prior written approval shall not be required for the assignment
to an Affiliate in connection with a Transfer made in accordance with the provisions of Section 6. This Agreement will be
binding upon and shall inure to the benefit of the Parties and their respective successors and assigns. No assignment by any Party will
relieve such Party of any of its obligations hereunder unless made in connection with a Transfer or series of Transfers of all of a Stockholder’s
Shares made in accordance with the provisions of Section 6. Any purported assignment of this Agreement without the consent
required by this Section 16(h) is null and void.

(i)            No
Third-Party Beneficiaries; Non-Recourse. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person
other than the Parties and their respective successors and permitted assigns any legal or equitable right, benefit, or remedy of any
nature under or by reason of this Agreement.

(j)            No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Parent any direct or indirect ownership or incidence
of ownership of or with respect to the Shares. All rights, ownership and economic benefits of and relating to the Shares shall remain
vested in and belong to Stockholder, and Parent shall not have any authority to manage, direct, restrict, regulate, govern or administer
any of the policies or operations of the Company or exercise any power or authority to direct Stockholder in the voting or disposition
of any Shares, except as otherwise expressly provided herein.

(k)            No
Partnership, Agency or Joint Venture. This Agreement is intended to create, and creates, a contractual relationship and is not intended
to create, and does not create, any agency, partnership, joint venture, any like relationship between the Parties or a presumption that
the Parties are in any way acting in concert or as a group with respect to the obligations or the transactions contemplated by this Agreement.

(l)            Disclosure.
Stockholder shall not issue any press release or otherwise make any public announcement regarding this Agreement or the transactions
contemplated hereby without the prior written consent of Parent, except as may be required by applicable Law (provided that to
the extent legally permitted and reasonably practicable, Stockholder shall provide reasonable notice of any such disclosure to Parent,
other than an amendment to and report on Schedule 13D or any filing made pursuant to Section 16 of the Exchange Act solely to disclose
this Agreement and report that it has been entered into). Stockholder consents to and hereby authorizes the Company and Parent to publish
and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company or
Parent reasonably determines to be necessary in connection with the Merger, Stockholder’s identity and ownership of Stockholder’s
Shares, the existence of this Agreement, and the nature of Stockholder’s commitments and obligations under this Agreement and any
other information that the Company reasonably determines is required to be disclosed by Law, and Stockholder acknowledges that the Company
and Parent may, in the Company’s sole discretion, file this Agreement or a form hereof with the SEC or any other applicable Governmental
Authority. Stockholder agrees, upon written request by Parent, to promptly provide Parent with any information it may reasonably require
for the preparation of any such disclosure documents, and Stockholder agrees to promptly notify the Company of any required corrections
with respect to any information regarding this Agreement supplied by Stockholder specifically for use in any such disclosure document,
if and to the extent that Stockholder has become aware that any such information shall have become false or misleading in any material
respect. Nothing set forth herein shall limit any disclosure by Stockholder to its or its Affiliates’ general or limited partners
on a confidential basis.

(m)            Amendment.
This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument
in writing specifically designated as an amendment hereto, signed on behalf of each of the Parties. By an instrument in writing, Parent,
on the one hand, or Stockholder, on the other hand, may waive compliance by the other Party with any term or provision of this Agreement
that such other Party was or is obligated to comply with or perform. The failure or delay of any Party to assert any rights or remedies
shall not constitute a waiver of such rights or remedies, nor shall any single or partial exercise thereof preclude any other or further
exercise of any other right or remedy hereunder.

(n)            Reliance.
Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon Stockholder’s
execution and delivery of this Agreement.

[Signature Page Follows]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	GINKGO BIOWORKS HOLDINGS, INC.


	By:	/s/ Jason Kelly
		Name: Jason Kelly
		Title: Chief Executive Officer

[Signature Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	SVF EXCALIBUR (CAYMAN) LIMITED


	By:	/s/ Karey Schreck
		Name: Karey Schreck
		Title: Authorised Signatory

[Signature Page to Voting Agreement]

Exhibit 99.3

Execution Version

VOTING
AGREEMENT

This
Voting Agreement (this “Agreement”), dated as of July 24, 2022, is made and entered into by and among Ginkgo
Bioworks Holdings, Inc., a Delaware corporation (“Parent”), and the stockholders of Zymergen Inc., a
Delaware public benefit corporation (the “Company”), identified on Exhibit A (each, a
“Stockholder” and collectively, the “Stockholders”). Parent and each Stockholder
are sometimes referred to herein individually as a “Party” and collectively as the
“Parties.”

WHEREAS,
each Stockholder is willing to make certain representations, warranties, covenants, and agreements as set forth in this Agreement with
respect to the shares of common stock, par value $0.001 per share, of the Company (“Company Common Stock”)
Beneficially Owned (as defined below) by such Stockholder set forth across from such Stockholder’s name on Exhibit A
(the “Subject Shares” and, together with any additional shares of Company Common Stock pursuant to Section 7 hereof, the “Shares”); and

WHEREAS,
as a condition to their willingness to enter into the Merger Agreement, Parent and the Company have required that each Stockholder, and
each Stockholder has (solely in its capacity as such and not as a director or fiduciary) agreed to, execute and deliver this Agreement.

1.             Definitions.

(a)            “Affiliate”
means with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by, or under common control
with, such Person; provided, however, that solely for purposes of this Agreement, notwithstanding anything to the contrary set forth
herein, neither the Company nor any of its Subsidiaries shall be deemed to be a Subsidiary or Affiliate of any Stockholder; provided,
further, that, for the avoidance of doubt, any member of a Stockholder shall be deemed an Affiliate of such Stockholder; and provided,
further, that an Affiliate of a Stockholder shall include any investment fund, vehicle or holding company of which such Stockholder or
an affiliate thereof serves as the general partner, managing member or discretionary manager or advisor, or which shares the same investment
manager and/or the same investment advisor. For purposes of this definition, the term “control” (including, with correlative
meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with
respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of that Person, whether through the ownership of voting securities or partnership or other ownership interests, by Contract
or otherwise.

(b)            “Beneficial
Owner” shall mean the Person who Beneficially Owns the referenced securities.

2.              Representations
of the Stockholders. Each Stockholder (solely in its capacity as such and not as a director
or fiduciary) represents and warrants to Parent (only as to such Stockholder and not any other Stockholder) that:

(a)            Ownership
of Shares. Stockholder (i) is the Beneficial Owner of all of such Stockholder’s Subject Shares free and clear of any proxy,
voting restriction, adverse claim, or other Liens, other than those created by this Agreement or under applicable federal or state securities
laws; and (ii) has the sole voting and sole disposition power over all of such Subject Shares. Except as expressly provided
by this Agreement, there are no options, warrants, or other rights, agreements, arrangements, or commitments of any character to which
Stockholder is a party relating to the pledge, disposition, or voting of any of such Stockholder’s Subject Shares and there are
no voting trusts or voting agreements with respect to such Subject Shares.

(b)            Disclosure
of All Shares Owned. Neither Stockholder nor any of its Affiliates Beneficially Owns any shares of Company Common Stock other than
the Subject Shares set forth across from such Stockholder’s name on Exhibit A.

(c)            Organization;
Power and Authority; Binding Agreement. Stockholder is duly organized, validly existing and in good standing under the Laws
of Delaware. Stockholder has full entity power and authority to enter into, execute, and deliver this Agreement and to perform fully
such Stockholder’s obligations hereunder. This Agreement has been duly and validly executed and delivered by Stockholder and assuming
the due authorization, execution and delivery of this Agreement by Parent, constitutes the legal, valid, and binding obligation of such
Stockholder, enforceable against such Stockholder in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other similar Laws affecting or relating to creditors’ rights generally.

(d)            Voting
Power. Stockholder has full voting power (or the power to effect the full voting power) with respect to all such Stockholder’s
Subject Shares, full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power
to agree to all of the matters set forth in this Agreement, in each case, with respect to all of such Stockholder’s Subject Shares.
None of Stockholder’s Subject Shares are subject to any stockholders’ agreement, proxy, voting trust, or other agreement
or arrangement with respect to the voting of such Subject Shares, except as provided hereunder.

(e)            No
Conflict. The execution and delivery of this Agreement by Stockholder does not, and the consummation of the transactions contemplated
hereby and the compliance with the provisions hereof will not, (i) conflict with or violate any Law applicable to such Stockholder
or (ii) result in any breach of or violation of, or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration, or cancellation of, or result in
the creation of any Lien on any of such Stockholder’s Shares pursuant to, any agreement or other instrument or obligation, including
organizational documents binding upon such Stockholder or any of its Shares, except for breaches, violations or defaults that would not,
individually or in the aggregate, materially impair the ability of Stockholder to perform its obligations hereunder.

(g)            No
Litigation. As of the time of execution of this Agreement, there is no Legal Proceeding pending against, or to the knowledge of Stockholder,
threatened against, Stockholder that could reasonably be expected to materially impair or materially adversely affect the ability of
such Stockholder to perform such Stockholder’s obligations hereunder or to consummate the transactions contemplated by this Agreement
on a timely basis.

3.              Representations
of Parent. Parent represents and warrants to each Stockholder that:

4.              Agreement
to Vote Shares.

Prior
to the Expiration Time, each Stockholder (in its capacity as such) irrevocably and unconditionally agrees during the term of this Agreement,
at any annual or special meeting of the Company called with respect to the following matters, and at every adjournment or postponement
thereof (each, a “Covered Meeting”), to appear at any such meeting or otherwise cause such Stockholder’s
Shares to be counted as present thereat for purpose of establishing a quorum, respond to each request by the Company for written consent,
if any, and vote or cause the holder of record to vote such Stockholder’s Shares entitled to vote at such meeting (a) in favor
of (i) approval of the Merger Agreement and the Merger and the other transactions contemplated by the Merger Agreement and (ii) any
proposal to adjourn or postpone such meeting of stockholders of the Company to a later date if there are not sufficient votes to approve
the Merger Agreement, the Merger and any other matters necessary for the Merger; and (b) against (i) any action, proposal,
transaction, or agreement which would reasonably be expected to result in any of the conditions to the Company’s obligations to
consummate the Merger set forth in Article VII of the Merger Agreement not being fulfilled, and (ii) any action, proposal,
transaction, or agreement that could reasonably be expected to impede, interfere with, delay, discourage, adversely affect, or inhibit
the timely consummation of the Merger or the fulfillment of Parent’s, Merger Sub’s or the Company’s conditions under
the Merger Agreement or change in any manner the voting rights of any class of shares of the Company (including any amendments to the
Company’s Organizational Documents). Any attempt by Stockholder to vote, consent or express dissent with respect to (or otherwise
to utilize the voting power of), such Stockholder’s Shares in contravention of this Section 4 shall be null and void
ab initio. Notwithstanding the foregoing, Stockholder shall retain at all times the right to vote such Stockholder’s Shares
in its sole discretion and without any other limitation on those matters other than those set forth in this Section 4
that are at any time or from time to time presented for consideration to the Company’s stockholders.

5.              No
Voting Trusts or Other Arrangement.

Each
Stockholder agrees that during the term of this Agreement, such Stockholder will not, and will not permit any Affiliate to, deposit any
of such Stockholder’s Shares in a voting trust, grant any proxies with respect to such Stockholder’s Shares, or subject any
of such Stockholder’s Shares to any arrangement with respect to the voting of such Stockholder’s Shares other than agreements
entered into with Parent.

6.              Transfer
and Encumbrance.

Each
Stockholder agrees that prior to the earlier of (i) the Expiration Time and (ii) the date on which the Requisite Stockholder
Approval shall have been obtained, such Stockholder will not, directly or indirectly, transfer, sell, offer, exchange, assign, pledge,
convey any legal or Beneficial Ownership interest in or otherwise dispose of (by merger, by tendering into any tender or exchange offer,
by operation of Law or otherwise) or encumber (“Transfer”) any of such Stockholder’s Shares or enter
into any contract, option or other agreement with respect to, or consent to, a Transfer of any of such Stockholder’s Shares or
such Stockholder’s voting or economic interest therein. This Section 6 shall not prohibit a Transfer of the Shares
by a Stockholder to an Affiliate of such Stockholder; provided, that a Transfer referred to in this sentence shall be permitted
only if, as a precondition to such Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to Parent,
to be bound by all of the terms of this Agreement. Any attempted Transfer of a Stockholder’s Shares or any interest therein in
violation of this Section 6 shall, to the fullest extent permitted by Law, be null and void ab initio. If any involuntary
Transfer of any of a Stockholder’s Shares shall occur, the transferee (which term, as used herein, shall include any and all transferees
and subsequent transferees of the initial transferee) shall take and hold such Stockholder’s Shares subject to all of the restrictions,
liabilities and rights under this Agreement, which shall continue in full force and effect until valid termination of this Agreement.

7.       
      Additional Purchases;
Adjustments.

Each
Stockholder agrees that any shares of Company Common Stock and any other shares of capital stock or other equity of the Company that
such Stockholder purchases, acquires the voting power or otherwise acquires Beneficial Ownership of after the execution of this Agreement
and prior to the record date for any Covered Meeting shall be subject to the terms and conditions of this Agreement to the same extent
as if they constituted Shares as of the date hereof for all purposes of this Agreement, and each Stockholder shall promptly notify Parent
of the existence of any such after-acquired Shares. In the event of any stock split, stock dividend, merger, reorganization, recapitalization,
reclassification, combination, exchange of shares or the like of the capital stock of the Company affecting the Shares, the terms of
this Agreement shall apply to the resulting securities and such resulting securities shall be subject to the terms and conditions of
this Agreement to the same extent as if they constituted Shares as of the date hereof for all purposes of this Agreement.

8.       
      Waiver of Certain Actions.

Each
Stockholder hereby agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class in any class action
with respect to, any Legal Proceeding, derivative or otherwise, against Parent, Merger Sub or the Company or any of their respective
Affiliates and each of their successors or directors relating to the negotiation, execution or delivery of this Agreement or the Merger
Agreement or the consummation of the transactions contemplated hereby or thereby, including any claim (a) challenging the validity
of, or seeking to enjoin the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoin
or delay the Closing) or (b) alleging a breach of any fiduciary duty of the Company Board in connection with the negotiation and
entry into this Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, and hereby irrevocably waives any
claim or rights whatsoever with respect to any of the foregoing.

9.       
      Termination.

This
Agreement shall terminate upon the earliest to occur of (the “Expiration Time”): (a) the Closing;
(b) the date on which the Merger Agreement is terminated in accordance with its terms; (c) the Outside Date; (d) any
change to the terms of the Merger without the prior written consent of each Stockholder that (i) reduces the Merger Consideration
with respect to the Company Common Stock or any consideration otherwise payable with respect to the Shares beneficially owned by such
Stockholder (subject to adjustments in compliance with Section 2.8 of the Merger Agreement), (ii) changes the form of consideration
payable in the Merger or any consideration otherwise payable with respect to the Company Common Stock beneficially owned by such Stockholder,
(iii) modifies the closing conditions set forth in Article VII of the Merger Agreement in a manner adverse to the interest
of the Stockholders, (iv) modifies the definition of “Outside Date” under the Merger Agreement in a manner adverse to
the interest of the Stockholders or (v) modifies Article II of the Merger Agreement in a manner adverse to the interests of
the Stockholders; and (e) with respect to any Stockholder, the mutual written consent of such Stockholder and Parent to terminate
this Agreement. Nothing in this Section 9 shall relieve or otherwise limit the liability of any Party for any willful and
material breach of this Agreement incurred prior to such termination.

10.            No
Solicitation.

Subject
to Section 11, each Stockholder agrees it shall not, it shall cause its Affiliates not to and it shall direct its and their
respective Representatives not to, directly or indirectly, take any of the actions listed in clauses (i) – (vi) of Section 5.4(a) of
the Merger Agreement (without giving effect to any amendment or modification of such clauses after the date hereof). Each Stockholder
shall, and shall cause its Affiliates to, and shall use its reasonable best efforts to cause its and their Representatives to, immediately
cease, and cause to be terminated, any solicitations, discussions or negotiations with any Person other than Parent with respect to any
inquiry, proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal.

11.            Fiduciary
Duties.

Each
Stockholder is entering into this Agreement solely in its capacity as the record or Beneficial Owner of the Shares and nothing herein
is intended to or shall limit or affect any actions taken by any of such Stockholder’s designees serving in his or her capacity
as a director of the Company (or a Subsidiary of the Company). The taking of any actions (or failures to act) by any Stockholder’s
designees serving as a director of the Company (in such capacity as a director) shall not be deemed to constitute a breach of this Agreement.

12.            Specific
Performance.

13.            Entire
Agreement.

14.            Notification
of Certain Matters.

From
the date hereof and through the Expiration Time, each Stockholder shall promptly deliver to Parent written notice, upon becoming aware
of (a) any injunction, writ or order of any nature issued and directing that the transactions provided for herein not be consummated
as herein provided or (b) any Proceeding pending or threatened with respect to the transactions contemplated hereby, in each such
case if and only to the extent that such injunction, writ, order or Proceeding would cause any of the conditions set forth in Article VII
of the Merger Agreement not to be satisfied at such time.

15.            Notices.

If to Parent,
to:

Ginkgo Bioworks Holdings, Inc.

27 Drydock Avenue, 8th Floor

Boston, Massachusetts 02210
Attn: Anna Marie Wagner; Karen Tepichin
E-mail: [email protected];

[email protected]

with copies
(which will not constitute notice) to:

Ropes &
Gray LLP

1211 Avenue
of the Americas

New York,
NY 10036

Attn: Suni
Sreepada

E-mail: [email protected]

and

Ropes &
Gray LLP

800 Boylston
Street

Boston, MA
02199

Attn: Marko
Zatylny

E-mail: [email protected]

If to a Stockholder,
to such Stockholder’s address set forth on Exhibit A.

Any
notice received by e-mail or otherwise at the addressee’s location on any Business Day after 5:00 p.m., addressee’s local
time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressee’s local time, on the
next Business Day. From time to time, any Party may provide notice to the other Parties of a change in its address or e-mail address
through a notice given in accordance with this Section 15, except that that notice of any change to the address or any of
the other details specified in or pursuant to this Section 15 will not be deemed to have been received until, and will be
deemed to have been received upon, the later of the date (i) specified in such notice; or (ii) that is two (2) Business
Days after such notice would otherwise be deemed to have been received pursuant to this Section 15.

16.            Miscellaneous.

(i)            No
Third-Party Beneficiaries; Non-Recourse. Nothing in this Agreement, express or implied, is intended to or shall confer upon
any Person other than the Parties and their respective successors and permitted assigns any legal or equitable right, benefit, or remedy
of any nature under or by reason of this Agreement.

(j)            No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Parent any direct or indirect ownership or incidence
of ownership of or with respect to the Shares. All rights, ownership and economic benefits of and relating to the Shares shall remain
vested in and belong to the Stockholders, and Parent shall not have any authority to manage, direct, restrict, regulate, govern or administer
any of the policies or operations of the Company or exercise any power or authority to direct any Stockholder in the voting or disposition
of any Shares, except as otherwise expressly provided herein.

(l)            Disclosure.
No Stockholder shall issue any press release or otherwise make any public announcement regarding this Agreement or the transactions contemplated
hereby without the prior written consent of Parent, except as may be required by applicable Law (provided that to the extent legally
permitted and reasonably practicable, any such Stockholder shall provide reasonable notice of any such disclosure to Parent, other than
an amendment to and report on Schedule 13D or any filing made pursuant to Section 16 of the Exchange Act solely to disclose this
Agreement and report that it has been entered into). Each Stockholder consents to and hereby authorizes the Company and Parent to publish
and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company or
Parent reasonably determines to be necessary in connection with the Merger, such Stockholder’s identity and ownership of such Stockholder’s
Shares, the existence of this Agreement, and the nature of such Stockholder’s commitments and obligations under this Agreement
and any other information that the Company reasonably determines is required to be disclosed by Law, and such Stockholder acknowledges
that the Company and Parent may, in the Company’s sole discretion, file this Agreement or a form hereof with the SEC or any other
applicable Governmental Authority. Each Stockholder agrees, upon written request by Parent, to promptly provide Parent with any information
it may reasonably require for the preparation of any such disclosure documents, and such Stockholder agrees to promptly notify the Company
of any required corrections with respect to any information regarding this Agreement supplied by such Stockholder specifically for use
in any such disclosure document, if and to the extent that such Stockholder has become aware that any such information shall have become
false or misleading in any material respect. Nothing set forth herein shall limit any disclosure by any Stockholder to its or its Affiliates’
general or limited partners on a confidential basis.

(m)            Amendment.
This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument
in writing specifically designated as an amendment hereto, signed on behalf of each of the Parties. By an instrument in writing, Parent,
on the one hand, or any Stockholder, on the other hand, may waive compliance by the other Party with any term or provision of this Agreement
that such other Party was or is obligated to comply with or perform. The failure or delay of any Party to assert any rights or remedies
shall not constitute a waiver of such rights or remedies, nor shall any single or partial exercise thereof preclude any other or further
exercise of any other right or remedy hereunder.

(n)            Reliance.
Each Stockholder understands and acknowledges that Parent and the Company are entering into the Merger Agreement in reliance upon such
Stockholder’s execution and delivery of this Agreement.

[Signature Page Follows]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	GINKGO BIOWORKS HOLDINGS, INC.


	By:	/s/ Jason Kelly
		Name: Jason Kelly
		Title: Chief Executive Officer

[Signature Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	DATA COLLECTIVE II, L.P.


	By:	/s/ Zack Bogue
		Name: Zack Bogue
		Title: Managing Partner

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	DCVC OPPORTUNITY FUND, L.P.


	By:	/s/ Zack Bogue
		Name: Zack Bogue
		Title: Managing Partner

Exhibit A

Name and Address of Stockholder	Total Shares of Common Stock Owned
Data Collective II, L.P. 270 University Avenue Palo Alto, CA 94301		2,448,901
DCVC Opportunity Fund, L.P. 270 University Avenue Palo Alto, CA 94301		4,917,734
Total		7,366,635

Exhibit 99.4

Execution
Version

VOTING
AGREEMENT

1.              Definitions.

(b)            “Beneficial
Owner” shall mean the Person who Beneficially Owns the referenced securities.

2.             Representations
of the Stockholders. Each Stockholder (solely in its capacity as such and not as a director or fiduciary) represents and warrants
to Parent (only as to such Stockholder and not any other Stockholder) that:

(e)            No
Conflict. The execution and delivery of this Agreement by Stockholder does not, and the consummation of the transactions contemplated
hereby and the compliance with the provisions hereof will not, (i) conflict with or violate any Law applicable to such Stockholder
or (ii) result in any breach of or violation of, or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration, or cancellation of, or result in
the creation of any Lien on any of such Stockholder’s Shares pursuant to, any agreement or other instrument or obligation, including
organizational documents binding upon such Stockholder or any of its Shares, except for breaches, violations or defaults that would not,
individually or in the aggregate, materially impair the ability of Stockholder to perform its obligations hereunder.

(g)            No
Litigation. As of the time of execution of this Agreement, there is no Legal Proceeding pending against, or to the knowledge of Stockholder,
threatened against, Stockholder that could reasonably be expected to materially impair or materially adversely affect the ability of
such Stockholder to perform such Stockholder’s obligations hereunder or to consummate the transactions contemplated by this Agreement
on a timely basis.

3.              Representations
of Parent. Parent represents and warrants to each Stockholder that:

4.              Agreement
to Vote Shares.

5.             No
Voting Trusts or Other Arrangement.

6.              Transfer
and Encumbrance.

7.              Additional
Purchases; Adjustments.

8.              Waiver
of Certain Actions.

9.              Termination.

10.            No
Solicitation.

11.            Fiduciary
Duties.

12.            Specific
Performance.

13.            Entire
Agreement.

14.            Notification
of Certain Matters.

15.            Notices.

If
to Parent, to:

Ginkgo
Bioworks Holdings, Inc.

27
Drydock Avenue, 8th Floor

Boston,
Massachusetts 02210
Attn: Anna Marie Wagner; Karen Tepichin
E-mail: [email protected];

[email protected]

with
copies (which will not constitute notice) to:

Ropes &
Gray LLP

1211
Avenue of the Americas

New
York, NY 10036

Attn:
Suni Sreepada

E-mail:
[email protected]

and

Ropes &
Gray LLP

800
Boylston Street

Boston,
MA 02199

Attn:
Marko Zatylny

E-mail:
[email protected]

If
to a Stockholder, to such Stockholder’s address set forth on Exhibit A.

Any
notice received by e-mail or otherwise at the addressee’s location on any Business Day after 5:00 p.m., addressee’s local
time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressee’s local time, on the
next Business Day. From time to time, any Party may provide notice to the other Parties of a change in its address or e-mail address
through a notice given in accordance with this Section 15, except that that notice of any change to the address or any of
the other details specified in or pursuant to this Section 15 will not be deemed to have been received until, and will be
deemed to have been received upon, the later of the date (i) specified in such notice; or (ii) that is two (2) Business
Days after such notice would otherwise be deemed to have been received pursuant to this Section 15.

16.            Miscellaneous.

(j)            No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Parent any direct or indirect ownership or incidence
of ownership of or with respect to the Shares. All rights, ownership and economic benefits of and relating to the Shares shall remain
vested in and belong to the Stockholders, and Parent shall not have any authority to manage, direct, restrict, regulate, govern or administer
any of the policies or operations of the Company or exercise any power or authority to direct any Stockholder in the voting or disposition
of any Shares, except as otherwise expressly provided herein.

(m)            Amendment.
This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument
in writing specifically designated as an amendment hereto, signed on behalf of each of the Parties. By an instrument in writing, Parent,
on the one hand, or any Stockholder, on the other hand, may waive compliance by the other Party with any term or provision of this Agreement
that such other Party was or is obligated to comply with or perform. The failure or delay of any Party to assert any rights or remedies
shall not constitute a waiver of such rights or remedies, nor shall any single or partial exercise thereof preclude any other or further
exercise of any other right or remedy hereunder.

[Signature
Page Follows]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	GINKGO BIOWORKS HOLDINGS, INC.


	By:	/s/ Jason Kelly
		Name: Jason Kelly
		Title: Chief Executive Officer

[Signature
Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	TRUE VENTURES IV L.P. for itself and as Nominee for True Ventures IV-A, L.P. By: True Venture Partners IV, L.L.C. Its: General Partner


	By:	/s/ James G. Stewart
		Name: James G. Stewart
		Title: COO

[Signature
Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	TRUE VENTURES SELECT I L.P. By: True Venture Partners I, L.L.C. Its: General Partner


	By:	/s/ James G. Stewart
		Name: James G. Stewart
		Title: COO

[Signature
Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	TRUE VENTURES SELECT II L.P. By: True Venture Partners Select II, L.L.C. Its: General Partner


	By:	/s/ James G. Stewart
		Name: James G. Stewart
		Title: COO

[Signature
Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	TRUE VENTURES SELECT III LP. By: True Venture Partners Select III, L.L.C. Its: General Partner


	By:	/s/ James G. Stewart
		Name: James G. Stewart
		Title: COO

[Signature
Page to Voting Agreement]

IN
WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the date first written above.

	TRUE VENTURES SELECT IV LP. By: True Venture Partners Select IV, L.L.C. Its: General Partner


	By:	/s/ James G. Stewart
		Name: James G. Stewart
		Title: COO

[Signature
Page to Voting Agreement]

Exhibit A

Name and Address of Stockholder	Total Shares of Common Stock Owned
True Ventures IV L.P. 575 High Street Suite 400 Palo Alto, CA 94301		2,659,857
True Ventures IV-A L.P. 575 High Street Suite 400 Palo Alto, CA 94301		364,929
True Ventures Select I L.P. 575 High Street Suite 400 Palo Alto, CA 94301		930,790
True Ventures Select II L.P. 575 High Street Suite 400 Palo Alto, CA 94301		706,563
True Ventures Select III LP. 575 High Street Suite 400 Palo Alto, CA 94301		1,463,333
True Ventures Select IV L.P. 575 High Street Suite 400 Palo Alto, CA 94301		1,152,734
Total		7,278,206

link

Business Proposal

Form 425 Zymergen Inc. Filed by: Zymergen Inc.

Leave a Reply Cancel reply

Goldman (GS) Gets Exit Proposal From Apple on Consumer Business – November 29, 2023

Business Proposal To King The Land: 4 Must Watch Korean Dramas With The Best Female Friendships

‘Business Proposal’ actor Ahn Hyo Seop secures military service exemption; Here’s why

Business Proposal actress Kim Sejeong to make her theatrical debut with Temple